-
Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?
Authors:
Russell B., Beyer K., Lawlor A., Roobol M. J., Venderbos L. D., Remmers S., Briers E., MacLennan S. J., MacLennan S., Omar M. I., Van Hemelrijck M., Smith E., N'Dow J., Plass K., Ribal M., Mottet N., Shepherd R., Abbott T., Mastris K. & Lancet D. (2024),
-
Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma
Authors:
Kirschenbaum D., Xie K., Ingelfinger F., Katzenelenbogen Y., Abadie K., Look T., Sheban F., Phan T. S., Li B., Zwicky P., Yofe I., David E., Mazuz K., Hou J., Chen Y., Shaim H., Shanley M., Becker S., Qian J., Colonna M., Ginhoux F., Rezvani K., Theis F. J., Yosef N., Weiss T., Weiner A. & Amit I. (2024),
Cell. 187, 1, p. 149-165.e23
-
Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker
Authors:
Liubomirski Y., Tiram G., Scomparin A., Gnaim S., Das S., Gholap S., Ge L., Yeini E., Shelef O., Zauberman A., Berger N., Kalimi D., Toister-Achituv M., Schröter C., Dickgiesser S., Tonillo J., Shan M., Deutsch C., Sweeney-Lasch S., Shabat D. & Satchi-Fainaro R. (2024),
Journal of Controlled Release. 367, p. 148-157
-
Recycled melanoma-secreted melanosomes regulate tumor-associated macrophage diversification
Authors:
Parikh R., Parikh S., Berzin D., Vaknine H., Ovadia S., Likonen D., Greenberger S., Scope A., Elgavish S., Nevo Y., Plaschkes I., Nizri E., Kobiler O., Maliah A., Zaremba L., Mohan V., Sagi I., Ashery-Padan R., Carmi Y., Luxenburg C., Hoheisel J. D., Khaled M., Levesque M. P. & Levy C. (2024),
EMBO Journal.
-
IL-23 stabilizes an effector Treg cell program in the tumor microenvironment
Authors:
Wertheimer T., Zwicky P., Rindlisbacher L., Sparano C., Vermeer M., de Melo B. M. S., Haftmann C., Rückert T., Sethi A., Schärli S., Huber A., Ingelfinger F., Xu C., Kim D., Häne P., Fonseca da Silva A., Muschaweckh A., Nunez N., Krishnarajah S., Köhler N., Zeiser R., Oukka M., Korn T., Tugues S. & Becher B. (2024),
Nature Immunology. 25, 3, p. 512-524
-
Longitudinal single-cell data informs deterministic modelling of inflammatory bowel disease
Authors:
Kilian C., Ulrich H., Zouboulis V. A., Sprezyna P., Schreiber J., Landsberger T., Büttner M., Biton M., Villablanca E. J., Huber S. & Adlung L. (2024),
npj Systems Biology and Applications. 10, 69
-
Unlocking the Role of Age-Related Changes to Fibroblasts in Pancreatic Cancer
Authors:
Isaacson A., Barki D. & Scherz-Shouval R. (2024),
-
ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response
Authors:
Lim L. Q. J., Adler L., Hajaj E., Soria L. R., Perry R. B. T., Darzi N., Brody R., Furth N., Lichtenstein M., Bab-Dinitz E., Porat Z., Melman T., Brandis A., Aylon Y., Ben-Dor S., Orr I., Pri-Or A., Seger R., Shaul Y., Ruppin E., Oren M., Perez M., Meier J., Brunetti-Pierri N., Shema E., Ulitsky I., Erez A., Malitsky S. & Itkin M. (2024),
Nature metabolism.
-
Measuring and modeling the dynamics of mitotic error correction
-
Embracing cancer complexity: Hallmarks of systemic disease
Authors:
Swanton C., Bernard E., Abbosh C., André F., Auwerx J., Balmain A., Bar-Sagi D., Bernards R., Bullman S., DeGregori J., Elliott C., Erez A., Evan G., Febbraio M. A., Hidalgo A., Jamal-Hanjani M., Joyce J. A., Kaiser M., Lamia K., Locasale J. W., Loi S., Malanchi I., Merad M., Musgrave K., Patel K. J., Quezada S., Wargo J. A., Weeraratna A., White E., Winkler F., Wood J. N., Vousden K. H. & Hanahan D. (2024),
Cell. 187, 7, p. 1589-1616
-
The tumor-driven antibody-mediated immune response in cancer
-
Cell-penetrating peptide and cationic liposomes mediated siRNA delivery to arrest growth of chronic myeloid leukemia cells in vitro
Authors:
Vysochinskaya V., Zabrodskaya Y., Dovbysh O., Emelyanov A., Klimenko V., Knyazev N., Terterov I., Egorova M., Bogdanov A., Maslov M., Vasin A. & Dubina M. (2024),
Biochimie. 221, p. 1-12
-
Loss-of-function cancer-linked mutations in the EIF4G2 non-canonical translation initiation factor
-
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma
Authors:
Spitzer A., Gritsch S., Nomura M., Jucht A., Fortin J., Raviram R., Weisman H. R., Gonzalez Castro L. N., Druck N., Chanoch-Myers R., Lee J. J., Mylvaganam R., Lee Servis R., Fung J. M., Lee C. K., Nagashima H., Miller J. J., Arrillaga-Romany I., Louis D. N., Wakimoto H., Pisano W., Wen P. Y., Mak T. W., Sanson M., Touat M., Landau D. A., Ligon K. L., Cahill D. P., Suvà M. L. & Tirosh I. (2024),
Cancer Cell. 42, 5, p. 904-914.e9
-
ARTS and small-molecule ARTS mimetics upregulate p53 levels by promoting the degradation of XIAP
Authors:
Abbas R., Hartmann O., Asiss D. T., Abbas R., Kagan J., Kim H. T., Oren M., Diefenbacher M., Orian A. & Larisch S. (2024),
Apoptosis.
-
Elemental Characterization of Ambient Particulate Matter for a Globally Distributed Monitoring Network: Methodology and Implications
Authors:
Liu X., Turner J. R., Oxford C. R., McNeill J., Walsh B., Le Roy E., Weagle C. L., Stone E., Zhu H., Liu W., Wei Z., Hyslop N. P., Giacomo J., Dillner A. M., Salam A., Hossen A., Islam Z., Abboud I., Akoshile C., Amador-Muñoz O., Anh N. X., Asfaw A., Balasubramanian R., Chang R. Y., Coburn C., Dey S., Diner D. J., Dong J., Farrah T., Gahungu P., Garland R. M., Grutter de la Mora M., Hasheminassab S., John J., Kim J., Kim J. S., Langerman K., Lee P., Lestari P., Liu Y., Mamo T., Martins M., Mayol-Bracero O. L., Naidoo M., Park S. S., Schechner Y., Schofield R., Tripathi S. N., Windwer E., Wu M., Zhang Q., Brauer M., Rudich Y. & Martin R. V. (2024),
ACS EST Air. 1, 4, p. 283-293
-
Cancer Hallmarks: Piecing the Puzzle Together
Authors:
Alcolea M. P., Alonso-Curbelo D., Ambrogio C., Bullman S., Correia A. L., Ernst A., Halbrook C. J., Kelly G. L., Lund A. W., Quail D. F., Ruscetti M., Shema E., Stromnes I. M. & Tam W. L. (2024),
Cancer Discovery. 14, 4, p. 674-682
-
A unique chaperoning mechanism in class A JDPs recognizes and stabilizes mutant p53
Authors:
Zoltsman G., Dang T. L., Kuchersky M., Faust O., Silva M. S., Ilani T., Wentink A. S., Bukau B. & Rosenzweig R. (2024),
Molecular Cell. 84, 8, p. 1512-1526.e9
-
FcγRIIB is an immune checkpoint limiting the activity of Treg-targeting antibodies in the tumor microenvironment
Authors:
Knorr D. A., Blanchard L., Leidner R. S., Jensen S. M., Meng R., Jones A., Ballesteros-Merino C., Bell R. B., Baez M., Marino A., Sprott D., Bifulco C. B., Piening B., Dahan R., Osorio J. C., Fox B. A. & Ravetch J. V. (2024),
Cancer Immunology Research. 12, 3, p. 322-333
-
Genomic linkages dictate cancer evolution
Authors:
Snarski Y. B. O. & Shoshani O. (2024),
-
Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model
Authors:
Budhu S., Kim K., Yip W., La Rosa S., Jebiwott S., Cai L., Holland A., Thomas J., Preise D., Somma A., Gordon B., Scherz A., Wolchok J. D., Erinjeri J., Merghoub T. & Coleman J. A. (2024),
Frontiers in Oncology. 14, 1405486
-
From the Inside Out: Exposing the Roles of Urea Cycle Enzymes in Tumors and Their Micro and Macro Environments: Exposing the Roles of Urea Cycle Enzymes in Tumors and Their Micro and Macro Environments
-
Molecular mechanisms underlying the modulation of T-cell proliferation and cytotoxicity by immobilized CCL21 and ICAM1
-
Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity
Authors:
Farhat-Younis L., Na M., Zarfin A., Khateeb A., Santana-Magal N., Richter A., Gutwillig A., Rasoulouniriana D., Gleiberman A., Beck L., Giger T., Ashkenazi A., Barzel A., Rider P. & Carmi Y. (2024),
eLife. 12, RP91999
-
Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability
Authors:
Lü Y. Q., Cho T., Mukherjee S., Suarez C. F., Gonzalez-Foutel N. S., Malik A., Martinez S., Dervovic D., Oh R. H., Langille E., Al-Zahrani K. N., Hoeg L., Lin Z. Y., Tsai R., Mbamalu G., Rotter V., Ashton-Prolla P., Moffat J., Chemes L. B., Gingras A. C., Oren M., Durocher D. & Schramek D. (2024),
Molecular Systems Biology. 20, 6, p. 719-740
-
Update on current and new potential immunotherapies in breast cancer, from bench to bedside
-
The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine
-
Molecular imaging of tumor metabolism: Insight from pyruvate- and glucose-based deuterium MRI studies
-
Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment
Authors:
Averbuch I., Tschernichovsky R., Yust-Katz S., Rotem O., Limon D., Kurman N., Icht O., Reinhorn D., Moskovitz M., Hanovich E., Benouaich-Amiel A., Siegal T., Zer A. & Gal O. (2024),
Journal of Neuro-Oncology. 166, p. 461-469
-
The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects
Authors:
Van Der Byl W., Nüssing S., Peters T. J., Ahn A., Li H., Ledergor G., David E., Koh A. S., Wagle M. V., Deguit C. D. T., de Menezes M. N., Travers A., Sampurno S., Ramsbottom K. M., Li R., Kallies A., Beavis P. A., Jungmann R., Bastings M. M., Belz G. T., Goel S., Trapani J. A., Crabtree G. R., Chang H. Y., Amit I., Goodnow C. C., Luciani F. & Parish I. A. (2024),
Immunity. 57, 6, p. 1324-1344.e8
-
Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response
-
A snapshot into the transcriptomic landscape of apoptosis and ferroptosis in cancer
Authors:
Vinik Y. & Lev S. (2024),
-
Detecting bone lesions in X-ray under diverse acquisition conditions
Authors:
Zimbalist T., Rosen R., Peri-Hanania K., Caspi Y., Rinott B., Zeltser-Dekel C., Bercovich E., Eldar Y. C. & Bagon S. (2024),
Journal of Medical Imaging. 11, 2, 024502
-
A microbial iron fist to fight tumors
Authors:
Nobs S. P. & Elinav E. (2024),
-
Bispecific dendritic-T cell engager potentiates anti-tumor immunity
Authors:
Shapir Itai Y., Barboy O., Salomon R., Bercovich A., Xie K., Winter E., Shami T., Porat Z., Erez N., Tanay A., Amit I. & Dahan R. (2024),
Cell. 187, 2, p. 375-389.e18
-
Programming a Ferroptosis-to-Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy
Authors:
Vinik Y., Maimon A., Dubey V., Raj H., Abramovitch I., Malitsky S., Itkin M., Ma'ayan A., Westermann F., Gottlieb E., Ruppin E. & Lev S. (2024),
Advanced Science. 11, 17, 2307263
-
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols
Authors:
Barboy O., Bercovich A., Li H., Lubling Y., Yalin A., Shapir Itai Y., Abadie K., Zada M., David E., Shlomi S., Katzenelenbogen Y., Adhemar D., Gur C., Yofe I., Feferman T., Cohen M., Dahan R., Newell E., Lifshitz A., Tanay A. & Amit I. (2024),
Nature Cancer. 5, 5, p. 742-759
-
Sortilin in Biliary Epithelial Cells Promotes Ductular Reaction and Fibrosis during Cholestatic Injury
Authors:
Hubel E., Neumann A., Fishman S., Schaffer O., Erez N., Shrkihe B. A., Shteingard Y., Gross T., Shibolet O., Varol C. & Zvibel I. (2024),
American Journal of Pathology.
-
p53: A tale of complexity and context
Authors:
Oren M. & Prives C. (2024),
-
Mutant p53 reactivation restricts the protumorigenic consequences of wild type p53 loss of heterozygosity in Li-Fraumeni syndrome patient-derived fibroblasts
-
Integrative spatial analysis reveals a multi-layered organization of glioblastoma
Authors:
Greenwald A. C., Darnell N. G., Hoefflin R., Simkin D., Mount C. W., Gonzalez Castro L. N., Harnik Y., Dumont S., Hirsch D., Nomura M., Talpir T., Kedmi M., Goliand I., Medici G., Laffy J., Li B., Mangena V., Keren-Shaul H., Weller M., Addadi Y., Neidert M. C., Suvà M. L. & Tirosh I. (2024),
Cell. 187, 10, p. 2485-2501.e26
-
Signaling lymphocytic activation molecule family receptors as potential immune therapeutic targets in solid tumors
-
Loss of EIF4G2 mediates aggressiveness in distinct human endometrial cancer subpopulations with poor survival outcome in patients
Authors:
Meril S., Muhlbauer Avni M., Lior C., Bahlsen M., Olender T., Savidor A., Krausz J., Belhanes Peled H., Birisi H., David N., Bialik S., Scherz-Shouval R., Ben David Y. & Kimchi A. (2024),
Oncogene. 43, 15, p. 1098-1112
-
Melanoma and microbiota: Current understanding and future directions
Authors:
Routy B., Jackson T., Mählmann L., Baumgartner C. K., Blaser M., Byrd A., Corvaia N., Couts K., Davar D., Derosa L., Hang H. C., Hospers G., Isaksen M., Kroemer G., Malard F., McCoy K. D., Meisel M., Pal S., Ronai Z., Segal E., Sepich-Poore G. D., Shaikh F., Sweis R. F., Trinchieri G., van den Brink M., Weersma R. K., Whiteson K., Zhao L., McQuade J., Zarour H. & Zitvogel L. (2024),
Cancer Cell. 42, 1, p. 16-34
-
CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods
Authors:
Jain S., Bakolitsa C., Brenner S. E., Radivojac P., Moult J., Repo S., Hoskins R. A., Andreoletti G., Barsky D., Chellapan A., Chu H., Dabbiru N., Kollipara N. K., Ly M., Neumann A. J., Pal L. R., Odell E., Fishilevich S., Lancet D. & Yosef N. (2024),
Genome Biology. 25, 1, 53
-
Targeting SRSF2 mutations in leukemia with RKI-1447: A strategy to impair cellular division and nuclear structure
Authors:
Su M., Fleischer T., Grosheva I., Horev M. B., Olszewska M., Mattioli C. C., Barr H., Plotnikov A., Carvalho S., Moskovich Y., Minden M. D., Chapal-Ilani N., Wainstein A., Papapetrou E. P., Dezorella N., Cheng T., Kaushansky N., Geiger B. & Shlush L. I. (2024),
iScience. 27, 4, 109443
-
Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells
Authors:
Ligumsky H., Amir S., Arbel Rubinstein T., Guion K., Scherf T., Karasik A., Wolf I. & Rubinek T. (2024),
Medical Oncology. 41, 6, 138
-
PRC2-independent actions of H3.3K27M in embryonic stem cell differentiation
Authors:
Cohen L. R. Z., Kaffe B., Deri E., Leibson C., Nissim-Rafinia M., Maman M., Harpaz N., Ron G., Shema E. & Meshorer E. (2023),
Nucleic Acids Research. 51, 4, p. 1662-1673
-
In Synergy: Optimizing CAR T Development and Personalizing Patient Care Using Single-Cell Technologies
-
Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: A prospective cohort study
Authors:
Moore C. M., Frangou E., McCartan N., Santaolalla A., Kopcke D., Brembilla G., Hadley J., Giganti F., Marsden T., Hemelrijck M. V., Gong F., Freeman A., Haider A., Tuck S., Pashayan N., Callender T., Green S., Brown L. C., Punwani S. & Domany E. (2023),
BMJ Oncology. 2, 1, e000057
-
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
Authors:
Stein-Thoeringer C. K., Saini N. Y., Zamir E., Blumenberg V., Schubert M. L., Mor U., Fante M. A., Schmidt S., Hayase E., Hayase T., Rohrbach R., Chang C. C., McDaniel L., Flores I., Gaiser R., Edinger M., Wolff D., Heidenreich M., Strati P., Nair R., Chihara D., Fayad L. E., Ahmed S., Iyer S. P., Steiner R. E., Jain P., Nastoupil L. J., Westin J., Arora R., Wang M. L., Turner J., Menges M., Hidalgo-Vargas M., Reid K., Dreger P., Schmitt A., Müller-Tidow C., Locke F. L., Davila M. L., Champlin R. E., Flowers C. R., Shpall E. J., Poeck H., Neelapu S. S., Schmitt M., Subklewe M., Jain M. D., Jenq R. R. & Elinav E. (2023),
Nature Medicine. 29, 4, p. 906-916
-
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets
Authors:
Beumers L., Vlachavas E. I., Borgoni S., Schwarzmüller L., Penso-Dolfin L., Michels B. E., Sofyali E., Burmester S., Heiss D., Wilhelm H., Yarden Y., Helm D., Will R., Goncalves A. & Wiemann S. (2023),
NPJ Breast Cancer. 9, 1, 97
-
High-sensitivity deuterium metabolic MRI differentiates acute pancreatitis from pancreatic cancers in murine models
-
A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy
Authors:
Golan S., Bar V., Salpeter S. J., Neev G., Creiderman G., Kedar D., Aharon S., Turovsky L., Zundelevich A., Shahar H., Shapira H., Mallel G., Stossel E., Gavert N., Straussman R., Dotan Z., Berger R., Stossel C., Golan T., Halperin S., Leibovici D., Breuer S., Rottenberg Y., Applebaum L., Hubert A., Nechushtan H., Peretz T., Zick A., Chertin B., Koulikov D., Sonnenblick A. & Rosenbaum E. (2023),
Frontiers in Medicine. 10, 1221484
-
Early death after a diagnosis of metastatic solid cancer–raising awareness and identifying risk factors from the SEER database
-
Actin Filaments Couple the Protrusive Tips to the Nucleus through the I-BAR Domain Protein IRSp53 during the Migration of Cells on 1D Fibers
Authors:
Mukherjee A., Ron J. E., Hu H. T., Nishimura T., Hanawa-Suetsugu K., Behkam B., Mimori-Kiyosue Y., Gov N. S., Suetsugu S. & Nain A. S. (2023),
Advanced Science. 10, 7, 2207368
-
Characterisation of knowledge of cancer, illness perceptions and their interaction among high-school students
-
Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma
Authors:
Ofek P., Yeini E., Arad G., Danilevsky A., Pozzi S., Luna C. B., Dangoor S. I., Grossman R., Ram Z., Shomron N., Brem H., Hyde T. M., Geiger T. & Satchi-Fainaro R. (2023),
International Journal of Cancer. 153, 3, p. 654-668
-
Spatial profiling technologies illuminate the tumor microenvironment
-
Definition of the contribution of an Osteopontin-producing CD11c+ microglial subset to Alzheimer’s disease
Authors:
Qiu Y., Shen X., Ravid O., Atrakchi D., Rand D., Wight A. E., Kim H. J., Liraz-Zaltsman S., Cooper I., Beeri M. S. & Cantor H. (2023),
Proceedings of the National Academy of Sciences of the United States of America. 120, 6, e221891512
-
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation—Immune signature correlates with response
Authors:
Apostolova P., Kreutmair S., Toffalori C., Punta M., Unger S., Burk A. C., Wehr C., Maas-Bauer K., Melchinger W., Haring E., Hoefflin R., Shoumariyeh K., Hupfer V., Lauer E. M., Duquesne S., Lowinus T., Gonzalo Núñez N., Alberti C., da Costa Pereira S., Merten C. H., Power L., Weiss M., Böke C., Pfeifer D., Marks R., Bertz H., Wäsch R., Ihorst G., Gentner B., Duyster J., Boerries M., Andrieux G., Finke J., Becher B., Vago L. & Zeiser R. (2023),
British Journal of Haematology. 203, 2, p. 264-281
-
Author Correction: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis (doi 10.1038/s41467-022-34863-9 , 28 Nov, 2022)
Authors:
Aylon Y., Furth N., Mallel G., Friedlander G., Nataraj N. B., Dong M., Hassin O., Zoabi R., Cohen B., Drendel V., Salame T. M., Mukherjee S., Harpaz N., Johnson R., Aulitzky W. E., Yarden Y., Shema E. & Oren M. (2023),
-
Distinct spatiotemporal features of microglia and monocyte-derived macrophages in glioma
-
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab
Authors:
Marrocco I., Giri S., Simoni-Nieves A., Gupta N., Rudnitsky A., Haga Y., Romaniello D., Sekar A., Zerbib M., Oren R., Lindzen M., Fard D., Tsutsumi Y., Lauriola M., Tamagnone L. & Yarden Y. (2023),
Cell Reports Medicine. 4, 8, 101142
-
Global analysis of contact-dependent human-to-mouse intercellular mRNA and lncRNA transfer in cell culture
Authors:
Dasgupta S., Dayagi D. Y., Haimovich G., Wyler E., Olender T., Singer R. H., Landthaler M. & Gerst J. E. (2023),
eLife. 12, e83584
-
Large-Scale Immunopeptidome Analysis Reveals Recurrent Posttranslational Splicing of Cancer- and Immune-Associated Genes
Authors:
Levy R., Alter Regev T., Paes W., Gumpert N., Cohen Shvefel S., Bartok O., Dayan-Rubinov M., Alon M., Shmueli M., Levin Y., Merbl Y., Ternette N. & Samuels Y. (2023),
Molecular and Cellular Proteomics. 22, 4, 100519
-
Arterial Thromboembolism in Patients With AF and CHA2DS2-VASc Score 0-2 With and Without Cancer
Authors:
Leader A., Mendelson Cohen N., Afek S., Jaschek R., Frajman A., Itzhaki Ben Zadok O., Raanani P., Lishner M. & Spectre G. (2023),
JACC: CardioOncology. 5, 2, p. 174-185
-
Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours
Authors:
Gavish A., Tyler M., Greenwald A. C., Hoefflin R., Simkin D., Tschernichovsky R., Galili Darnell N., Somech E., Barbolin C., Antman T., Kovarsky D., Barrett T., Gonzalez Castro L. N., Halder D., Chanoch-Myers R., Laffy J., Mints M., Wider A., Tal R., Spitzer A., Hara T., Raitses-Gurevich M., Stossel C., Golan T., Tirosh A., Suvà M. L., Puram S. V. & Tirosh I. (2023),
Nature. 618, 7965, p. 598-606
-
Shearing of surface mucin saps tumor cell strength
-
Probing lipids relaxation times in breast cancer using magnetic resonance spectroscopic fingerprinting
Authors:
Nissan N., Kulpanovich A., Agassi R., Allweis T., Haas I., Carmon E., Furman-Haran E., Anaby D., Sklair-Levy M. & Tal A. (2023),
European Radiology. 33, p. 3744-3753
-
Neoantigens in cancer immunotherapy: quantity vs. quality
-
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
Authors:
Kotsiliti E., Leone V., Schuehle S., Govaere O., Li H., Wolf M. J., Horvatic H., Bierwirth S., Hundertmark J., Inverso D., Zizmare L., Sarusi-Portuguez A., Gupta R., O'Connor T., Giannou A. D., Shiri A. M., Schlesinger Y., Beccaria M. G., Rennert C., Pfister D., Öllinger R., Gadjalova I., Ramadori P., Rahbari M., Rahbari N., Healy M. E., Fernández-Vaquero M., Yahoo N., Janzen J., Singh I., Fan C., Liu X., Rau M., Feuchtenberger M., Schwaneck E., Wallace S. J., Cockell S., Wilson-Kanamori J., Ramachandran P., Kho C., Kendall T. J., Leblond A. L., Keppler S. J., Bielecki P., Steiger K., Hofmann M., Rippe K., Zitzelsberger H., Weber A., Malek N., Luedde T., Vucur M., Augustin H. G., Flavell R., Parnas O., Rad R., Pabst O., Henderson N. C., Huber S., Macpherson A., Knolle P., Claassen M., Geier A., Trautwein C., Unger K., Elinav E., Waisman A., Abdullah Z., Haller D., Tacke F., Anstee Q. M. & Heikenwalder M. (2023),
Journal of Hepatology. 79, 2, p. 296-313
-
MYC Induces Immunotherapy and IFNg Resistance Through Downregulation of JAK2
Authors:
Markovits E., Harush O., Baruch E. N., Shulman E. D., Debby A., Itzhaki O., Anafi L., Danilevsky A., Shomron N., Ben-Betzalel G., Asher N., Shapira-Frommer R., Schachter J., Barshack I., Geiger T., Elkon R., Besser M. J. & Markel G. (2023),
Cancer Immunology Research. 11, 7, p. 909-924
-
Green Synthesis of Silver Nanoparticles Using the Leaf Extract of the Medicinal Plant, Uvaria narum and Its Antibacterial, Antiangiogenic, Anticancer and Catalytic Properties
Authors:
Ajaykumar A. P., Mathew A., Chandni A. P., Varma S. R., Jayaraj K. N., Sabira O., Rasheed V. A., Binitha V. S., Swaminathan T. R., Basheer V. S., Giri S. & Chatterjee S. (2023),
Antibiotics. 12, 3, 564
-
Compromised Blood-Brain Barrier Junctions Enhance Melanoma Cell Intercalation and Extravasation
Authors:
Saltarin F., Wegmüller A., Bejarano L., Ildiz E. S., Zwicky P., Vianin A., Spadin F., Soukup K., Wischnewski V., Engelhardt B., Deutsch U., J. Marques I., Frenz M., Joyce J. A. & Lyck R. (2023),
Cancers. 15, 20, 5071
-
Mutually communicated model based on multi-parametric MRI for automated segmentation and classification of prostate cancer
Authors:
Liu K., Li P., Otikovs M., Ning X., Xia L., Wang X., Yang L., Pan F., Zhang Z., Wu G., Xie H., Bao Q., Zhou X. & Liu C. (2023),
Medical Physics. 50, 6, p. 3445-3458
-
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer
Authors:
Jbara A., Lin K. T., Stossel C., Siegfried Z., Shqerat H., Amar-Schwartz A., Elyada E., Mogilevsky M., Raitses-Gurevich M., Johnson J. L., Yaron T. M., Ovadia O., Jang G. H., Danan-Gotthold M., Cantley L. C., Levanon E. Y., Gallinger S., Krainer A. R., Golan T. & Karni R. (2023),
Nature. 617, 7959, p. 147-153
-
Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell-dependent regression of glioblastoma
Authors:
Look T., Puca E., Bühler M., Kirschenbaum D., De Luca R., Stucchi R., Ravazza D., Di Nitto C., Roth P., Katzenelenbogen Y., Weiner A., Rindlisbacher L., Becher B., Amit I., Weller M., Neri D., Hemmerle T. & Weiss T. (2023),
Science Translational Medicine. 15, 697, p. eadf2281, adf2281
-
Relaxation–Diffusion T2–ADC Correlations in Breast Cancer Patients: A Spatiotemporally Encoded 3T MRI Assessment
Authors:
Otikovs M., Nissan N., Furman-Haran E., Anaby D., Agassi R., Sklair-Levy M. & Frydman L. (2023),
Diagnostics. 13, 23, 3516
-
The microbial genotoxin colibactin exacerbates mismatch repair mutations in colorectal tumors
Authors:
Dougherty M. W., Valdés-Mas R., Wernke K. M., Gharaibeh R. Z., Yang Y., Brant J. O., Riva A., Muehlbauer M., Elinav E., Puschhof J., Herzon S. B. & Jobin C. (2023),
Neoplasia (United States). 43, 100918
-
EMSY stabilization in KEAP1-mutant lung cancer disrupts genome stability and type I interferon signaling
Authors:
Sheban D. & Merbl Y. (2023),
-
It takes two to tango: the role of tumor-associated macrophages in T cell-directed immune checkpoint blockade therapy
-
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
Authors:
Stossel C., Raitses-Gurevich M., Atias D., Beller T., Glick Gorman Y., Halperin S., Peer E., Denroche R. E., Zhang A., Notta F., Wilson J. M., O'Kane G. M., Haimov Talmoud E., Amison N., Schvimer M., Salpeter S. J., Bar V., Zundelevich A., Tirosh I., Tal R., Dinstag G., Kinar Y., Eliezer Y., Ben-David U., Gavert N. S., Straussman R., Gallinger S. J., Berger R. & Golan T. (2023),
Cancer Discovery. 13, 8, p. 1826-1843
-
Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics
Authors:
Fedyuk V., Erez N., Furth N., Beresh O., Andreishcheva E. N., Shinde A., Jones D., Bar Zakai B., Mavor Y., Peretz T., Hubert A., Cohen J., Salah A., Temper M., Grinshpun A., Maoz M., Zick A., Ron G. & Shema E. (2023),
Nature Biotechnology. 41, 2, p. 212-221
-
Unanswered questions in prostate cancer - findings of an international multi-stakeholder consensus by the PIONEER consortium
Authors:
Omar M. I., MacLennan S., Ribal M. J., Roobol M. J., Dimitropoulos K., van den Broeck T., MacLennan S. J., Axelsson S. E., Gandaglia G., Willemse P., Mastris K., Ransohoff J. B., Devecseri Z., Abbott T., De Meulder B., Bjartell A., Asiimwe A., N'Dow J., Smith E., Lancet D. & Bernstein G. (2023),
Nature Reviews Urology. 20, 8, p. 494-501
-
The tumor microenvironment shows a hierarchy of cell-cell interactions dominated by fibroblasts
Authors:
Mayer S., Milo T., Isaacson A., Halperin C., Miyara S., Stein Y., Lior C., Pevsner-Fischer M., Tzahor E., Mayo A., Alon U. & Scherz-Shouval R. (2023),
Nature Communications. 14, 1, 5810
-
CAR-T Cell Therapy and the Gut Microbiota
-
The landscape of T cell antigens for cancer immunotherapy
-
Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma
Authors:
Puram S. V., Mints M., Pal A., Qi Z., Reeb A., Gelev K., Barrett T. F., Gerndt S., Liu P., Parikh A. S., Ramadan S., Law T., Mroz E. A., Rocco J. W., Adkins D., Thorstad W. L., Gay H. A., Ding L., Paniello R. C., Pipkorn P., Jackson R. S., Wang X., Mazul A., Chernock R., Zevallos J. P., Silva-Fisher J. & Tirosh I. (2023),
Nature Genetics. 55, 4, p. 640-650
-
Immunometabolism at the crossroads of obesity and cancer—a Keystone Symposia report
Authors:
Cable J., Rathmell J. C., Pearce E. L., Ho P. C., Haigis M. C., Mamedov M. R., Wu M. J., Kaech S. M., Lynch L., Febbraio M. A., Bapat S. P., Hong H. S., Zou W., Belkaid Y., Sullivan Z. A., Keller A., Wculek S. K., Green D. R., Postic C., Amit I., Benitah S. A., Jones R. G., Reina-Campos M., Torres S. V., Beyaz S., Brennan D., O'Neill L. A., Perry R. J. & Brenner D. (2023),
Annals of the New York Academy of Sciences. 1523, 1, p. 38-50
-
Intracellular bacteria in cancer—prospects and debates
-
Functional Impact of Protein-RNA Variation in Clinical Cancer Analyses
-
Depleting the 19S proteasome regulatory PSMD1 subunit as a cancer therapy strategy
-
A Novel Modality Enables New Evidence-Based Individual Risk Stratification That Can Potentially Lead to Decisive Management and Treatment Decisions in Prostate Cancer
Authors:
Weksler M., Simon A., Lenkinski R. E., Landsman H., Matzkin H., Mabjeesh N. & Leibovitch I. (2023),
Diagnostics. 13, 3, 424
-
The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumab
Authors:
Leshem Y., Etan T., Dolev Y., Nikolaevski-Berlin A., Miodovnik M., Shamai S., Merimsky O., Wolf I., Havakuk O., Tzuberi M., Topilsky Y., Banai S., Rozenbaum Z. & Laufer-Perl M. (2023),
International Journal of Cardiology. 131642
-
Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators
-
Folylpolyglutamate synthetase mRNA G-quadruplexes regulate its cell protrusion localization and enhance a cancer cell invasive phenotype upon folate repletion
-
UV irradiation remodels the specificity landscape of transcription factors
Authors:
Mielko Z., Zhang Y., Sahay H., Liu Y., Schaich M. A., Schnable B., Morrison A. M., Burdinski D., Adar S., Pufall M., Van Houten B., Gordân R. & Afek A. (2023),
Proceedings of the National Academy of Sciences of the United States of America. 120, 11, e221742212
-
A natural goldmine of binding proteins and soluble receptors simplified their translation to blockbuster drugs, all in one decade
Authors:
Novick D. (2023),
-
Glioma synapses recruit mechanisms of adaptive plasticity
Authors:
Taylor K. R., Barron T., Hui A., Spitzer A., Yalçin B., Ivec A. E., Geraghty A. C., Hartmann G. G., Arzt M., Gillespie S. M., Kim Y. S., Maleki Jahan S., Zhang H., Shamardani K., Su M., Ni L., Du P. P., Woo P. J., Silva-Torres A., Venkatesh H. S., Mancusi R., Ponnuswami A., Mulinyawe S., Keough M. B., Chau I., Aziz-Bose R., Tirosh I., Suvà M. L. & Monje M. (2023),
Nature. 623, 7986, p. 366-374
-
Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology
-
Deciphering the involvement of the Hippo pathway co-regulators, YAP/TAZ in invadopodia formation and matrix degradation
-
Fungi and cancer
-
Spatial and temporal mapping of breast cancer lung metastases identify TREM2 macrophages as regulators of the metastatic boundary
Authors:
Yofe I., Shami T., Cohen N., Landsberger T., Sheban F., Stoler-Barak L., Yalin A., Phan T. S., Li B., Monteran L., Scharff Y., Giladi A., Elbaz M., David E., Gurevich-Shapiro A., Gur C., Shulman Z., Erez N. & Amit I. (2023),
Cancer Discovery. 13, 12, p. 2610-2631
-
A Highly Sensitive Flow Cytometric Approach to Detect Rare Antigen-Specific T Cells: Development and Comparison to Standard Monitoring Tools
Authors:
Dror Levinsky M., Brenner B., Yalon M., Levi Z., Livneh Z., Cohen Z., Paz-Elizur T., Grossman R., Ram Z. & Volovitz I. (2023),
Cancers. 15, 3, 574
-
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC
Authors:
Javitt A., Shmueli M. D., Kramer M. P., Kolodziejczyk A. A., Cohen I. J., Radomir L., Sheban D., Kamer I., Litchfield K., Bab-Dinitz E., Zadok O., Neiens V., Ulman A., Wolf-Levy H., Eisenberg-Lerner A., Kacen A., Alon M., Rêgo A. T., Stacher-Priehse E., Lindner M., Koch I., Bar J., Swanton C., Samuels Y., Levin Y., da Fonseca P. C., Elinav E., Friedman N., Meiners S. & Merbl Y. (2023),
Nature Cancer. 4, 5, p. 629-647
-
Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo
-
Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency
Authors:
Rein A., Geron I., Kugler E., Fishman H., Gottlieb E., Abramovich I., Giladi A., Amit I., Mulet-Lazaro R., Delwel R., Gröschel S., Levin-Zaidman S., Dezorella N., Holdengreber V., Rao T. N., Yacobovich J., Steinberg-Shemer O., Huang Q., Tan Y., Chen S., Izraeli S. & Birger Y. (2023),
Haematologica. 108, 9, p. 2316-2330
-
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy
-
PYK2, a hub of signaling networks in breast cancer progression
-
Identification of Lung Cancer Biomarkers by Nanosensors Based on Titanium Carbide (Ti3C2Tx) MXenes
Authors:
Panigrahi P., Vovusha H., Pal Y., Bae H., Lee H., Kaewmaraya T., Nazir S., Shiddiky M. J. & Hussain T. (2023),
ACS Applied Nano Materials. 6, 23, p. 22117-22127
-
Computational design of BclxL inhibitors that target transmembrane domain interactions
-
TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironment
Authors:
Gershoni A., Hassin O., Nataraj N. B., Baruch S., Avioz-Seligman A., Pirona A. C., Fellus-Alyagor L., Meir Salame T., Mukherjee S., Mallel G., Yarden Y., Aylon Y. & Oren M. (2023),
Molecular Oncology. 17, 12, p. 2675-2693
-
A single-molecule liquid biopsy for cancer diagnosis
Authors:
Shema E. (2023),
-
Tackling tumor complexity with single-cell proteomics
-
Clinical trial links oncolytic immunoactivation to survival in glioblastoma
Authors:
Ling A. L., Solomon I. H., Landivar A. M., Nakashima H., Woods J. K., Santos A., Masud N., Fell G., Mo X., Yilmaz A. S., Grant J., Zhang A., Bernstock J. D., Torio E., Ito H., Liu J., Shono N., Nowicki M. O., Triggs D., Halloran P., Piranlioglu R., Soni H., Stopa B., Bi W. L., Peruzzi P., Chen E., Malinowski S. W., Prabhu M. C., Zeng Y., Carlisle A., Rodig S. J., Wen P. Y., Lee E. Q., Nayak L., Chukwueke U., Gonzalez Castro L. N., Dumont S. D., Batchelor T., Kittelberger K., Tikhonova E., Miheecheva N., Tabakov D., Shin N., Gorbacheva A., Shumskiy A., Frenkel F., Aguilar-Cordova E., Aguilar L. K., Krisky D., Wechuck J., Manzanera A., Matheny C., Tak P. P., Barone F., Kovarsky D., Tirosh I., Suvà M. L., Wucherpfennig K. W., Ligon K., Reardon D. A. & Antonio Chiocca E. (2023),
Nature. 623, 7985, p. 157-166
-
Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis
Authors:
Goldman O., Adler L. N., Hajaj E., Croese T., Darzi N., Galai S., Tishler H., Ariav Y., Lavie D., Fellus-Alyagor L., Oren R., Kuznetsov Y., David E., Jaschek R., Stossel C., Singer O., Malitsky S., Barak R., Seger R., Erez N., Amit I., Tanay A., Saada A., Golan T., Rubinek T., Sang Lee J., Ben-Shachar S., Wolf I. & Erez A. (2023),
Cancer Discovery. 13, 7, p. 1616-1635
-
Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer
Authors:
Rowell M. C., Deschênes-Simard X., Lopes-Paciencia S., Le Calvé B., Kalegari P., Mignacca L., Fernandez-Ruiz A., Guillon J., Lessard F., Bourdeau V., Igelmann S., Duman A. M., Stanom Y., Kottakis F., Deshpande V., Krizhanovsky V., Bardeesy N. & Ferbeyre G. (2023),
Cell Cycle. 22, 19, p. 2172-2193
-
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
-
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Authors:
Light N., Layeghifard M., Attery A., Subasri V., Zatzman M., Anderson N. D., Hatkar R., Blay S., Chen D., Novokmet A., Fuligni F., Tran J., de Borja R., Agarwal H., Waldman L., Abegglen L. M., Albertson D., Finlay J. L., Hansford J. R., Behjati S., Villani A., Gerstung M., Alexandrov L. B., Somers G. R., Schiffman J. D., Rotter V., Malkin D. & Shlien A. (2023),
Nature Communications. 14, 1, 77
-
The C-terminal tail of CSNAP attenuates the CSN complex
-
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
Authors:
Siltari A., Lönnerbro R., Pang K., Shiranov K., Asiimwe A., Evans-Axelsson S., Franks B., Kiran A., Murtola T. J., Schalken J., Steinbeisser C., Bjartell A., Auvinen A., N'Dow J., Smith E. J., Shepherd R., Ribal M., Mottet N., Moris L. & Lancet D. (2023),
Clinical Genitourinary Cancer. 21, 2, p. 316.e1-316.e11
-
An Increase in Mucin2 Expression Is Required for Colon Cancer Progression Mediated by L1
-
Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis
Authors:
Tsitsou-Kampeli A., Suzzi S., Kenigsbuch M., Satomi A., Strobelt R., Singer O., Feldmesser E., Purnapatre M., Colaiuta S. P., David E., Cahalon L., Hahn O., Wyss-Coray T., Shaul Y., Amit I. & Schwartz M. (2023),
Cell Reports Medicine. 4, 11, 101278
-
Integrative study of whole exome variation and expression in gingivo-buccal oral squamous cell carcinoma revealed alteration in TLR-activated MAP-Kinase signalling
Authors:
Singh R., Chattopadhyay E., Ray A., Roy R., Biswas N. K., Ghose S. & Roy B. (2023),
Human Gene. 36, 201183
-
TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer
-
Clonal evolution of leukemia from G6PD studies
-
Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma
Authors:
Hedegger K., Blutke A., Hommel T., Auer K. E., Nataraj N. B., Lindzen M., Yarden Y. & Dahlhoff M. (2023),
Molecular Oncology.
-
Insights into the co-evolution of epithelial cells and fibroblasts in the esophageal tumor microenvironment
-
Drugging p53 in cancer: one protein, many targets
-
From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts
-
αβ+/CD19+-depleted haploidentical stem cell transplantation for children with acute leukemia: Is there a protective effect of increased γδ+ T-cell content in the graft?
-
Association between diabetes mellitus and reduced efficacy of pembrolizumab in non–small cell lung cancer
Authors:
Leshem Y., Dolev Y., Siegelmann-Danieli N., Sharman Moser S., Apter L., Chodick G., Nikolaevski-Berlin A., Shamai S., Merimsky O. & Wolf I. (2023),
Cancer.
-
Capturing the diversity of protein modifications on presented tumor antigens
-
p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells
Authors:
Hassin O., Sernik M., Seligman A., Vogel F. C., Wellenstein M. D., Smollich J., Halperin C., Pirona A. C., Toledano L. N., Caballero C. D., Schlicker L., Salame T. M., Portuguez A. S., Aylon Y., Scherz-Shouval R., Geiger T., de Visser K. E., Schulze A. & Oren M. (2023),
Proceedings of the National Academy of Sciences of the United States of America. 120, 52, e231146012
-
Final Results of a Phase i Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma
Authors:
Yip W., Sjoberg D. D., Nogueira L. M., Tracey A. T., Alvim R. G., Reisz P. A., Demac Q., Benfante N. E., Vanden Berg R. W., Kim K., Al-Ahmadie H., Lin O., Bochner B. H., Dalbagni G., Donat S. M., Pietzak E. J., Hakimi A. A., Solit D. B., Scherz A., Bajorin D. F. & Coleman J. A. (2023),
-
Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors
Authors:
Kacen A., Javitt A., Kramer M. P., Morgenstern D., Tsaban T., Shmueli M. D., Teo G. C., Leprevost F. d. V., Barnea E., Yu F., Admon A., Eisenbach L., Samuels Y., Schueler-Furman O., Levin Y., Nesvizhskii A. & Merbl Y. (2023),
Nature Biotechnology. 41, 2, p. 239-251
-
The proteasome regulator PSME4 drives immune evasion and abrogates anti-tumor immunity in NSCLC
Authors:
Javitt A., Shmueli M., Kramer M., Kolodziejczyk A., Cohen I., Kamer I., Litchfield K., Bab-Dinitz E., Zadok O., Neiens V., Ulman A., Radomir L., Wolf-Levy H., Eisenberg-Lerner A., Kacen A., Alon M., Toste Rêgo A., Stacher-Priehse E., Lindner M., Koch I., Bar J., Swanton C., Samuels Y., Levin Y., da Fonseca P. C. A., Elinav E., Friedman N., Meiners S. & Merbl Y. (2023),
bioArxiv.
-
Modulating the proliferative and cytotoxic properties of patient-derived TIL by a synthetic immune niche of immobilized CCL21 and ICAM1
-
BBB opening by low pulsed electric fields, depicted by delayed-contrast MRI, enables efficient delivery of therapeutic doxorubicin doses into mice brains
Authors:
Cooper I., Last D., Ravid O., Rand D., Matsree E., Omesi L., Shemesh C., Liberman M., Zach L., Furman O., Daniels D., Liraz-Zaltsman S., Mardor Y. & Sharabi S. (2023),
Fluids and Barriers of the CNS. 20, 1, 67
-
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy
Authors:
Shouval R., Alarcon Tomas A., Fein J. A., Flynn J. R., Markovits E., Mayer S., Olaide Afuye A., Alperovich A., Anagnostou T., Besser M. J., Batlevi C. L., Dahi P. B., Devlin S. M., Fingrut W. B., Giralt S. A., Lin R. J., Markel G., Salles G., Sauter C. S., Scordo M., Shah G. L., Shah N., Scherz-Shouval R., van den Brink M., Perales M. & Palomba M. L. (2022),
Journal of Clinical Oncology. 40, 4, p. 369-381
-
Cancer and cell cycle
-
Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progression
Authors:
Sciacovelli M., Dugourd A., Jimenez L. V., Yang M., Nikitopoulou E., Costa A. S. H., Tronci L., Caraffini V., Rodrigues P., Schmidt C., Ryan D. G., Young T., Zecchini V. R., Rossi S. H., Massie C., Lohoff C., Masid M., Hatzimanikatis V., Kuppe C., Kramann R., Von Kriegsheim A., Gnanapragasam V., Warren A. Y., Stewart G. D., Erez A., Vanharanta S., Saez-Rodriguez J. & Frezza C. (2022),
Nature Communications. 13, 1, 7830
-
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting
Authors:
Salomon R., Rotem H., Katzenelenbogen Y., Weiner A., Cohen Saban N., Feferman T., Amit I. & Dahan R. (2022),
Nature Cancer. 3, p. 287-302
-
Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
-
ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells
Authors:
Regev O., Kizner M., Roncato F., Dadiani M., Saini M., Castro-Giner F., Yajuk O., Kozlovski S., Levi N., Addadi Y., Golani O., Ben-Dor S., Granot Z., Aceto N. & Alon R. (2022),
Frontiers in Immunology. 13, 849701
-
Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling
Authors:
Yofe I., Landsberger T., Yalin A., Solomon I., Costoya C., Demane D. F., Shah M., David E., Borenstein C., Barboy O., Matos I., Peggs K. S., Quezada S. A. & Amit I. (2022),
Nature Cancer. 3, p. 1336-1350
-
Cancer microbiome
Authors:
Zitvogel L., Straussman R., Sepich-Poore G. D., Knight R., Iliev I. D., Sears C. L., Bullman S., Jobin C. & Zarour H. M. (2022),
-
Tumor-reactive antibodies evolve from non-binding and autoreactive precursors
Authors:
Mazor R. D., Nathan N., Gilboa A., Stoler-Barak L., Moss L., Solomonov I., Hanuna A., Divinsky Y., Shmueli M. D., Hezroni H., Zaretsky I., Mor M., Golani O., Sabah G., Jakobson-Setton A., Yanichkin N., Feinmesser M., Tsoref D., Salman L., Yeoshoua E., Peretz E., Erlich I., Mendelson Cohen N., Gershoni J. M., Freund N., Merbl Y., Yaari G., Eitan R., Sagi I. & Shulman Z. (2022),
Cell. 185, 7, p. 1208-1222
-
A new function for the serine protease HtrA2 in controlling radiation-induced senescence in cancer cells
Authors:
Hammer L., Levin-Salomon V., Yaeli-Slonim N., Weiss M., Dekel-Bird N. P., Olender T., Porat Z., Winograd-Katz S., Savidor A., Levin Y., Bialik S., Geiger B. & Kimchi A. (2022),
Molecular Oncology. 16, 6
-
Elucidating the diversity of malignant mesenchymal states in glioblastoma by integrative analysis
-
DestVI identifies continuums of cell types in spatial transcriptomics data
Authors:
Lopez R., Li B., Keren-Shaul H., Boyeau P., Kedmi M., Pilzer D., Jelinski A., Yofe I., David E., Wagner A., Ergen C., Addadi Y., Golani O., Ronchese F., Jordan M. I., Amit I. & Yosef N. (2022),
Nature biotechnology. 40, 9, p. 1360-1369
-
Targeted Drug Delivery for the Treatment of Blood Cancers
-
Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors
Authors:
Belugali Nataraj N., Noronha A., Lee J. S., Ghosh S., Mohan Raju H. R., Sekar A., Zuckerman B., Lindzen M., Tarcitano E., Srivastava S., Selitrennik M., Livneh I., Drago-Garcia D., Rueda O. M., Caldas C., Lev S., Geiger T., Ciechanover A., Ulitsky I., Seger R., Ruppin E. & Yarden Y. (2022),
Cell Reports. 38, 8, 110418
-
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis
Authors:
Aylon Y., Furth N., Mallel G., Friedlander G., Nataraj N. B., Dong M., Hassin O., Zoabi R., Cohen B., Drendel V., Salame T. M., Mukherjee S., Harpaz N., Johnson R., Aulitzky W. E., Yarden Y., Shema E. & Oren M. (2022),
Nature Communications. 13, 1, 7199
-
Pseudo-mutant P53 is a unique phenotype of DNMT3Amutated pre-leukemia
Authors:
Tuval A., Brilon Y., Azogy H., Moskovitz Y., Leshkowitz D., Salame T. M., Minden M. D., Tal P., Rotter V., Oren M., Kaushansky N. & Shlush L. I. (2022),
Haematologica. 107, 11, p. 2548-2561
-
Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers
Authors:
Bahar-Shany K., Barnabas G. D., Deutsch L., Deutsch N., Glick-Saar E., Dominissini D., Sapoznik S., Helpman L., Perri T., Blecher A., Katz G., Yagel I., Rosenblatt O., Shai D., Brandt B., Meyer R., Mohr-Sasson A., Volodarsky-Perel A., Zilberman I., Armon S., Jakobson-Setton A., Eitan R., Kadan Y., Beiner M., Josephy D., Brodsky M., Friedman E., Anafi L., Molchanov Y., Korach J., Geiger T. & Levanon K. (2022),
International Journal of Cancer. 152, 4, p. 781-793
-
BREAst Cancer Personalised NuTrition (BREACPNT): dietary intervention in breast cancer survivors treated with endocrine therapy – a protocol for a randomised clinical trial
Authors:
Rein M. S., Dadiani M., Godneva A., Bakalenik-Gavry M., Morzaev-Sulzbach D., Vachnish Y., Kolobkov D., Lotan-Pompan m., Weinberger A., Segal E. & Gal-Yam E. N. (2022),
BMJ Open. 12, 11, e062498
-
Aptamer-Modified Au Nanoparticles: Functional Nanozyme Bioreactors for Cascaded Catalysis and Catalysts for Chemodynamic Treatment of Cancer Cells
Authors:
Ouyang Y., Fadeev M., Zhang P., Carmieli R., Li J., Sohn Y. S., Karmi O., Nechushtai R., Pikarsky E., Fan C. & Willner I. (2022),
ACS Nano. 16, 11, p. 18232-18243
-
Mechanisms of immune activation and regulation: lessons from melanoma
-
A necessary role for increased biglycan expression during L1‐mediated colon cancer progression
-
Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions
Authors:
Kolodkin-Gal D., Roitman L., Ovadya Y., Azazmeh N., Assouline B., Schlesinger Y., Kalifa R., Horwitz S., Khalatnik Y., Hochner-Ger A., Imam A., Demma J. A., Winter E., Benyamini H., Elgavish S., Khatib A. A., Meir K., Atlan K., Pikarsky E., Parnas O., Dor Y., Zamir G., Ben-Porath I. & Krizhanovsky V. (2022),
Gut. 71, 2, p. 345-355
-
Author Correction: Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability (Genome Biology, (2018), 19, 1, (37), 10.1186/s13059-018-1401-9)
Authors:
Galanos P., Pappas G., Polyzos A., Kotsinas A., Svolaki I., Giakoumakis N. N., Glytsou C., Pateras I. S., Swain U., Souliotis V. L., Georgakilas A. G., Geacintov N., Scorrano L., Lukas C., Lukas J., Livneh Z., Lygerou Z., Chowdhury D., Sørensen C. S., Bartek J. & Gorgoulis V. G. (2022),
-
ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells
Authors:
Fishman H., Madiwale S., Geron I., Bari V., Van Loocke W., Kirschenbaum Y., Ganmore I., Kugler E., Rein-Gil A., Friedlander G., Schiby G., Birger Y., Strehl S., Soulier J., Knoechel B., Ferrando A., Noy-Lotan S., Nagler A., Mulloy J. C., Van Vlierberghe P. & Izraeli S. (2022),
Blood. 139, 3, p. 399-412
-
The industrial genomic revolution: A new era in neuroimmunology
-
NRas activity is regulated by dynamic interactions with nanoscale signaling clusters at the plasma membrane
-
Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer
Authors:
Deshet-Unger N., Horn G., Rawet-Slobodkin M., Waks T., Laskov I., Michaan N., Raz Y., Bar V., Zundelevich A., Aharon S., Turovsky L., Mallel G., Salpeter S., Neev G., Hollander K. S., Katz B. Z., Grisaru D. & Globerson Levin A. (2022),
Biomedicines. 10, 9, 2216
-
Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant
Authors:
Eytan K., Versano Z., Oren R., Jacob-Hirsch J., Leitner M., Harmelin A., Rechavi G., Toren A., Paglin S. & Yalon M. (2022),
Frontiers in Oncology. 12, 959133
-
Targeting Chemotherapy to Decondensed H3K27me3-Marked Chromatin of AML Cells Enhances Leukemia Suppression
Authors:
Porazzi P., Petruk S., Pagliaroli L., De Dominici M., Deming, 2nd D., Puccetti M. V., Kushinsky S., Kumar G., Minieri V., Barbieri E., Deliard S., Trizzino M., Gardini A., Canaani E., Palmisiano N., Porcu P., Ertel A., Fortina P., Eischen C. M., Mazo A. & Calabretta B. (2022),
Cancer Research. 82, 3, p. 458-471
-
Small molecule inhibitor of Igf2bp1 represses Kras and a pro-oncogenic phenotype in cancer cells
Authors:
Wallis N., Oberman F., Shurrush K., Germain N., Greenwald G., Gershon T., Pearl T., Abis G., Singh V., Singh A., Sharma A. K., Barr H. M., Ramos A., Spiegelman V. S. & Yisraeli J. K. (2022),
RNA Biology. 19, 1, p. 26-43
-
De novo-designed transmembrane domains tune engineered receptor functions
Authors:
Elazar A., Chandler N. J., Davey A. S., Weinstein J. Y., Nguyen J. V., Trenker R., Cross R. S., Jenkins M. R., Call M. J., Call M. E. & Fleishman S. J. (2022),
eLife. 11, e75660
-
DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors, and prognostic value relevant to triple-negative breast cancer patients
-
Downregulation of the Tumor Suppressor TFF1 Is Required during Induction of Colon Cancer Progression by L1
-
Di-genic inheritance of germline POLE and PMS2 pathogenic variants causes a unique condition associated with pediatric cancer predisposition
Authors:
Michaeli O., Ladany H., Erez A., Shachar S. B., Izraeli S., Lidzbarsky G., Basel-Salmon L., Biskup S., Maruvka Y. E., Toledano H. & Goldberg Y. (2022),
Clinical Genetics. 101, 4, p. 442-447
-
IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cells
Authors:
Nachmias B., Khan D. H., Voisin V., Mer A. S., Thomas G. E., Segev N., St-Germain J., Hurren R., Gronda M., Botham A., Wang X., Maclean N., Seneviratne A. K., Duong N., Xu C., Arruda A., Orouji E., Algouneh A., Hakem R., Shlush L., Minden M. D., Raught B., Bader G. D. & Schimmer A. D. (2022),
Leukemia. 36, 5, p. 1283-1295
-
Dependence of ABCB1 transporter expression and function on distinct sphingolipids generated by ceramide synthases-2 and -6 in chemoresistant renal cancer
Authors:
Lee W., Maaß M., Quach A., Poscic N., Prangley H., Pallott E., Kim J. L., Pierce J. S., Ogretmen B., Futerman A. H. & Thévenod F. (2022),
The journal of Biological chemistry. 298, 2, 101492
-
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer
Authors:
Gavert N., Zwang Y., Weiser R., Greenberg O., Halperin S., Jacobi O., Mallel G., Sandler O., Berger A. J., Stossel E., Rotin D., Grinshpun A., Kamer I., Barzs J., Pines G., Saidian D., Bar I., Golan S., Rosenbaum E., Nadu A., Ben-Ami E., Weitzen R., Nechushtan H., Golanz T., Brenner B., Nissan A., Margalitzs O., Hershkovitz D., Lahat G. & Straussman R. (2022),
Nature Cancer. 3, 2, p. 219-231
-
Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution
Authors:
Yang D., Jones M. G., Naranjo S., Rideout W. M., Min K. H. (., Ho R., Wu W., Replogle J. M., Page J. L., Quinn J. J., Horns F., Qiu X., Chen M. Z., Freed-Pastor W. A., McGinnis C. S., Patterson D. M., Gartner Z. J., Chow E. D., Bivona T. G., Chan M. M., Yosef N., Jacks T. & Weissman J. S. (2022),
Cell. 185, 11, p. 1905-1923.e25
-
Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies
Authors:
Bergado-Báez G., Gonzalez Suarez N., García L. C., Pérez-Martínez D., Hernández-Fernández D. R., Fundora-Barrios T., Rodríguez-Álvarez A., Díaz-Ordaz G. D., Lindzen M., Yarden Y. & Sánchez-Ramírez B. (2022),
Frontiers in Oncology. 12, 951267
-
H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscape
Authors:
Furth N., Algranati D., Dassa B., Beresh O., Fedyuk V., Morris N., Kasper L. H., Jones D., Monje M., Baker S. J. & Shema E. (2022),
Cell Reports. 39, 7, 110836
-
Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects
-
Stochastic transitions as a major source of cancer heterogeneity
Authors:
Tirosh I. (2022),
-
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Authors:
Narunsky-Haziza L., Sepich-Poore G. D., Livyatan I., Asraf O., Martino C., Nejman D., Gavert N., Stajich J. E., Amit G., González A., Wandro S., Perry G., Ariel R., Meltser A., Shaffer J. P., Zhu Q., Balint-Lahat N., Barshack I., Dadiani M., Gal-Yam E. N., Patel S. P., Bashan A., Swafford A. D., Pilpel Y., Knight R. & Straussman R. (2022),
Cell. 185, 20, p. 3789-3806
-
A coalition to heal—the impact of the cardiac microenvironment
-
Cancer-associated fibroblasts in the single-cell era
-
CD74 as a regulator of transcription in normal B cells
Authors:
David K., Friedlander G., Pellegrino B., Radomir L., Lewinsky H., Leng L., Bucala R., Becker-Herman S. & Shachar I. (2022),
Cell reports (Cambridge). 41, 5, 111572
-
An exercise-induced metabolic shield in distant organs blocks cancer progression and metastatic dissemination
Authors:
Sheinboim D., Parikh S., Manich P., Markus I., Dahan S., Parikh R., Stubbs E., Cohen G., Zemser-Werner V., Bell R. E., Arciniegas Ruiz S., Percik R., Brenner R., Leibou S., Vaknine H., Arad G., Gerber Y., Keinan Boker L., Shimony T., Goldstein N., Bikovski L., Constantini K., Labes S., Mordechai S., Doron H., Ionescu A., Ziv T., Nizri E., Choshen G., Eldar-Finkelman H., Tabach Y., Helman A., Ben-Eliyahu S., Erez N., Perlson E., Geiger T., Ben-Zvi D., Khaled M., Gepner Y. & Levy C. (2022),
Cancer research (Chicago, Ill.). 82, 22, p. 4164-4178
-
It's all in the combination: decoding the epigenome for cancer research and diagnostics
-
Single-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomas
Authors:
Harpaz N., Mittelman T., Beresh O., Griess O., Furth N., Salame T., Oren R., Fellus-Alyagor L., Harmelin A., Alexandrescu S., Marques J. G., Filbin M. G., Ron G. & Shema E. (2022),
Molecular Cell. 82, 14, p. 2696-2713
-
Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations
Authors:
Calvillo-Argüelles O., Schoffel A., Capo-Chichi J., Abdel-Qadir H., Schuh A., Carrillo-Estrada M., Liu S., Gupta V., Schimmer A. D., Yee K., Shlush L. I., Natarajan P. & Thavendiranathan P. (2022),
JACC CardioOncology. 4, 1, p. 38-49
-
Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
-
Aptamer-Functionalized Ce4+-Ion-Modified C-Dots: Peroxidase Mimicking Aptananozymes for the Oxidation of Dopamine and Cytotoxic Effects toward Cancer Cells
Authors:
Ouyang Y., Fadeev M., Zhang P., Carmieli R., Sohn Y. S., Karmi O., Qin Y., Chen X., Nechushtai R. & Willner I. (2022),
ACS applied materials & interfaces. 14, 50, p. 55365-55375
-
On the development of a neoantigen vaccine for the prevention of Lynch Syndrome
-
The brain-immune ecosystem: Implications for immunotherapy in defeating neurodegenerative diseases
Authors:
Schwartz M., Abellanas M. A., Tsitsou-Kampeli A. & Suzzi S. (2022),
-
5’isomiR-183-5p|+2 elicits tumor suppressor activity in a negative feedback loop with E2F1
Authors:
Li X., Michels B. E., Tosun O. E., Jung J., Kappes J., Ibing S., Nataraj N. B., Sahay S., Schneider M., Wörner A., Becki C., Ishaque N., Feuerbach L., Heßling B., Helm D., Will R., Yarden Y., Müller-Decker K., Wiemann S. & Körner C. (2022),
Journal of Experimental and Clinical Cancer Research. 41, 1, 190
-
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins
Authors:
Mukherjee S., Maddalena M., Lü Y., Martinez S., Nataraj N. B., Noronha A., Sinha S., Teng K., Cohen-Kaplan V., Ziv T., Arandkar S., Hassin O., Chatterjee R., Pirona A., Shreberk-Shaked M., Gershoni A., Aylon Y., Elazar Z., Yarden Y., Schramek D. & Oren M. (2022),
Proceedings of the National Academy of Sciences. 119, 17, e211964411
-
BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling
Authors:
Shaashua L., Ben-Shmuel A., Pevsner-Fischer M., Friedman G., Levi-Galibov O., Nandakumar S., Barki D., Nevo R., Brown L. E., Zhang W., Stein Y., Lior C., Kim H. S., Bojmar L., Jarnagin W. R., Lecomte N., Mayer S., Stok R., Bishara H., Hamodi R., Levy-Lahad E., Golan T., Porco J. A., Iacobuzio-Donahue C. A., Schultz N., Tuveson D. A., Lyden D., Kelsen D. & Scherz-Shouval R. (2022),
Nature Communications. 13, 1, 6513
-
The interaction of CD4+ helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response
Authors:
Cohen M., Giladi A., Barboy O., Hamon P., Li B., Zada M., Gurevich-Shapiro A., Beccaria C. G., David E., Maier B. B., Buckup M., Kamer I., Deczkowska A., Le Berichel J., Bar J., Iannacone M., Tanay A., Merad M. & Amit I. (2022),
Nature Cancer. 3, p. 303-317
-
Global DNA Methylation Analysis of Cancer-Associated Fibroblasts Reveals Extensive Epigenetic Rewiring Linked with RUNX1 Upregulation in Breast Cancer Stroma
-
SmMIP-tools: a computational toolset for processing and analysis of single-molecule molecular inversion probes-derived data
-
Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanism
Authors:
He C., Maniyar R. R., Avraham Y., Zappasodi R., Rusinova R., Newman W., Heath H., Wolchok J. D., Dahan R., Merghoub T. & Meyerson J. (2022),
Science advances. 8, 8, eabm4552
-
Controls for Phylogeny and Robust Analysis in Pareto Task Inference
Authors:
Adler M., Tendler A., Hausser J., Korem Y., Szekely P., Bossel N., Hart Y., Karin O., Mayo A. & Alon U. (2022),
Molecular Biology and Evolution. 39, 1, msab297
-
An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes
Authors:
Jaiswal A., Verma A., Dannenfelser R., Melssen M., Tirosh I., Izar B., Kim T., Nirschl C. J., Devi K. S. P., Olson W. C., Slingluff C. L., Engelhard V. H., Garraway L., Regev A., Minkis K., Yoon C. H., Troyanskaya O., Elemento O., Suárez-Fariñas M. & Anandasabapathy N. (2022),
Cancer Cell. 40, 5, p. 524-544.e5
-
Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern
Authors:
Cohen-Dvashi H., Weinstein J., Katz M., Ashkenazy-Eilon M., Mor Y., Shimon A., Achdout H., Tamir H., Israely T., Strobelt R., Shemesh M., Stoler-Barak L., Shulman Z., Paran N., Fleishman S. J. & Diskin R. (2022),
iScience. 25, 10, 105193
-
Divergence of mutational signatures in association with breast cancer subtype
Authors:
Perry G., Dadiani M., Kahana-Edwin S., Pavlovski A., Markus B., Hornung G., Balint-Lahat N., Yosepovich A., Hout-Siloni G., Jacob-Hirsch J., Sklair-Levy M., Friedman E., Barshack I., Kaufman B., Gal-Yam E. N. & Paluch-Shimon S. (2022),
Molecular Carcinogenesis. 61, 11, p. 1056-1070
-
A Functional Pre-Screening Platform for Identifying Points of Vulnerability in the Cell Death Map of Human Melanoma Tumors
Authors:
Dekel-Bird N. P., Bialik S., Itzhaki O., Meir Salame T., Yaeli-Slonim N., Levin-Salomon V., Dasari S. K., Besser M. & Kimchi A. (2022),
Journal of Cancer Science and Clinical Therapeutics. 6, 1, p. 39-60
-
Cytoplasmic forces functionally reorganize nuclear condensates in oocytes
Authors:
Al Jord A., Letort G., Chanet S., Tsai F. C., Antoniewski C., Eichmuller A., Da Silva C., Huynh J. R., Gov N. S., Voituriez R., Terret M. É. & Verlhac M. H. (2022),
Nature Communications. 13, 1, 5070
-
Interactive, integrated analysis of single-cell transcriptomic and phylogenetic data with PhyloVision
-
Bacterial infection disrupts established germinal center reactions through monocyte recruitment and impaired metabolic adaptation
Authors:
Biram A., Liu J., Hezroni-Bravyi H., Davidzohn N., Schmiedel D., Khatib-Massalha E., Haddad M., Grenov C. A., Lebon S., Salame T. M., Dezorella N., Hoffman D., Abou Karam P., Biton M., Lapidot T., Bemark M., Avraham R., Jung S. & Shulman Z. (2022),
Immunity. 55, 3, p. 442-458.e8
-
The magnitude of LFA-1/ICAM-1 forces fine-tune TCR-triggered T cell activation
Authors:
Ma V. P., Hu Y., Kellner A. V., Brockman J. M., Velusamy A., Blanchard A. T., Evavold B. D., Alon R. & Salaita K. (2022),
Science Advances. 8, 8, eabg4485
-
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients
Authors:
Hassin O., Nataraj N. B., Shreberk-Shaked M., Aylon Y., Yaeger R., Fontemaggi G., Mukherjee S., Maddalena M., Avioz A., Iancu O., Mallel G., Gershoni A., Grosheva I., Feldmesser E., Ben-Dor S., Golani O., Hendel A., Blandino G., Kelsen D., Yarden Y. & Oren M. (2022),
Nature Communications. 13, 1, 2800
-
Visual barcodes for clonal-multiplexing of live microscopy-based assays
Authors:
Kaufman T., Nitzan E., Firestein N., Ginzberg M. B., Iyengar S., Patel N., Ben-Hamo R., Porat Z., Hunter J., Hilfinger A., Rotter V., Kafri R. & Straussman R. (2022),
Nature Communications. 13, 1, 2725
-
Whole-exome sequencing of HPV positive tonsillar and base of tongue squamous cell carcinomas reveals a global mutational pattern along with relapse-specific somatic variants
Authors:
Ährlund-Richter A., Holzhauser S., Dalianis T., Näsman A. & Mints M. (2022),
Cancers. 14, 1, 77
-
Early antitumor activity of oral Langerhans cells is compromised by a carcinogen
Authors:
Saba Y., Aizenbud I., Matanes D., Koren N., Barel O., Zubeidat K., Capucha T., David E., Eli-Berchoer L., Stoitzner P., Wilensky A., Amit I., Czerninski R., Yona S. & Hovav A. (2022),
Proceedings of the National Academy of Sciences of the United States of America. 119, 3, e211842411
-
Nine receptors and binding proteins, four drugs, and one woman: Historical and personal perspectives
-
Genetic insight into Birt–Hogg–Dubé syndrome in Indian patients reveals novel mutations at FLCN
Authors:
Ray A., Chattopadhyay E., Singh R., Ghosh S., Bera A., Sarma M., Munot M., Desai U., Rajan S., Prabhudesai P., Prakash A. K., Roy Chowdhury S., Bhowmick N., Dhar R., Udwadia Z. F., Dey A., Mitra S., Joshi J. M., Maitra A. & Roy B. (2022),
Orphanet Journal of Rare Diseases. 17, 1, 176
-
Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma
Authors:
Risom T., Glass D. R., Averbukh I., Liu C. C., Baranski A., Kagel A., McCaffrey E. F., Greenwald N. F., Rivero-Gutierrez B., Strand S. H., Varma S., Kong A., Keren L., Srivastava S., Zhu C., Khair Z., Veis D. J., Deschryver K., Vennam S., Maley C., Hwang E. S., Marks J. R., Bendall S. C., Colditz G. A., West R. B. & Angelo M. (2022),
Cell. 185, 2, p. 299-310.e18
-
DOP53 In-depth characterisation of the serum antibody epitope repertoire in Inflammatory Bowel Disease by high-throughput phage-displayed immunoprecipitation sequencing
Authors:
Bourgonje A. R., Andreu-Sánchez S., Vogl T., Hu S., Vich Vila A., Leviatan S., Kurilshikov A., Klompus S., Kalka I. N., van Dullemen H. M., Weinberger A., Visschedijk M. C., Festen E. A. M., Faber K. N., Wijmenga C., Dijkstra G., Segal E., Fu J., Zhernakova A. & Weersma R. K. (2022),
Journal of Crohn's and Colitis. 16, Supplement_1, p. i100-i102
-
CXCR4 and CD74 together enhance cell survival in response to macrophage migration-inhibitory factor in chronic lymphocytic leukemia
Authors:
Thavayogarajah T., Sinitski D., El Bounkari O., Torres-Garcia L., Lewinsky H., Harjung A., Chen H., Panse J., Vankann L., Shachar I., Bernhagen J. & Koschmieder S. (2022),
Experimental Hematology. 115, p. 30-43
-
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
Authors:
Noronha A., Belugali Nataraj N., Sang Lee J., Zhitomirsky B., Oren Y., Oster S., Lindzen M., Mukherjee S., Will R., Ghosh S., Simoni-Nieves A., Verma A., Chatterjee R., Borgoni S., Robinson W., Sinha S., Brandis A., Kerr D. L., Wu W., Sekar A., Giri S., Chung Y., Drago-Garcia D., Danysh B. P., Lauriola M., Fiorentino M., Ardizzoni A., Oren M., Blakely C. M., Ezike J., Wiemann S., Parida L., Bivona T. G., Aqeilan R. I., Brugge J. S., Regev A., Getz G., Ruppin E. & Yarden Y. (2022),
Cancer Discovery. 12, 11, p. 2666-2683
-
Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis
Authors:
Zhang Y., Donaher J. L., Das S., Li X., Reinhardt F., Krall J. A., Lambert A. W., Thiru P., Keys H. R., Khan M., Hofree M., Wilson M. M., Yedier-Bayram O., Lack N. A., Onder T. T., Bagci-Onder T., Tyler M., Tirosh I., Regev A., Lees J. A. & Weinberg R. A. (2022),
Nature Cell Biology. 24, 4, p. 554-564
-
Blockade of the protease ADAM17 ameliorates experimental pancreatitis
Authors:
Saad M. I., Weng T., Lundy J., Gearing L. J., West A. C., Harpur C. M., Alanazi M., Hodges C., Croagh D., Kumar B., Sagi I., Rose-John S. & Jenkins B. J. (2022),
Proceedings of the National Academy of Sciences. 119, 42, e221374411
-
Brain metastases: Not all tumors are created equal
Authors:
Kirschenbaum D. & Amit I. (2022),
-
Sex Biases in Cancer and Autoimmune Disease Incidence Are Strongly Positively Correlated with Mitochondrial Gene Expression across Human Tissues
Authors:
Crawford D. R., Sinha S., Nair N. U., Ryan B. M., Barnholtz-Sloan J. S., Mount S. M., Erez A., Aldape K., Castle P. E., Rajagopal P. S., Day C., Schäffer A. A. & Ruppin E. (2022),
Cancers. 14, 23, 5885
-
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer
Authors:
Salaroglio I. C., Belisario D. C., Akman M., La Vecchia S., Godel M., Anobile D. P., Ortone G., Digiovanni S., Fontana S., Costamagna C., Rubinstein M., Kopecka J. & Riganti C. (2022),
Journal Of Experimental & Clinical Cancer Research. 41, 1, 243
-
Polysome-CAGE of TCL1-driven chronic lymphocytic leukemia revealed multiple N-terminally altered epigenetic regulators and a translation stress signature
Authors:
Ogran A., Havkin-Solomon T., Becker-Herman S., David K., Shachar I. & Dikstein R. (2022),
eLife. 11, e77714
-
S6K1 phosphorylates Cdk1 and MSH6 to regulate DNA repair
Authors:
Amar-Schwartz A., Ben Hur V., Jbara A., Cohen Y., Barnabas G. D., Arbib E., Siegfried Z., Mashahreh B., Hassouna F., Shilo A., Abu-Odeh M., Berger M., Wiener R., Aqeilan R., Geiger T. & Karni R. (2022),
eLife. 11
-
Spatial organization and early signaling of the B-cell receptor in CLL
-
Mouse Modeling Dissecting Macrophage–Breast Cancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and Breast Tumorigenesis
Authors:
Muller A., Kohler U. A., Trzebanski S., Vinik Y., Mohan Raju H. R., Girault J., Ben-Chetrit N., Maraver A., Jung S. & Lev S. (2022),
Advanced Science. 9, 9, 2105696
-
Intratumor heterogeneity and anti-tumor immunity shape one another bidirectionally
-
The microbiome and human cancer
-
Single Instillation of Hypertonic Saline Immediately Following Transurethral Resection of Bladder Tumor for Recurrence Prevention –A Phase I Study
Authors:
Modai J., Kovalyonok A., Scherz A., Preise D., Avda Y., Shpunt I., Sasson K., Jaber M., Peretz Y., Croock R., Shilo Y., Ikher S., Lindner U. & Leibovici D. (2021),
Bladder Cancer. 7, 2, p. 187-192
-
Albumin-EDTA-Vanadium Is a Powerful Anti-Proliferative Agent, Following Entrance into Glioma Cells via Caveolae-Mediated Endocytosis
Authors:
Cooper I., Ravid O., Rand D., Atrakchi D., Shemesh C., Bresler Y., Ben-Nissan G., Sharon M., Fridkin M. & Shechter Y. (2021),
Pharmaceutics. 13, 10, 1557
-
Identification of variable stages in murine pancreatic tumors by a multiparametric approach employing hyperpolarized 13C MRSI, 1H diffusivity and 1H T1 MRI
-
Improving deuterium metabolic imaging (DMI) signal‐to‐noise ratio by spectroscopic multi‐echo bSSFP: A pancreatic cancer investigation
-
TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment
Authors:
Maddalena M., Mallel G., Nataraj N. B., Shreberk-Shaked M., Hassin O., Mukherjee S., Arandkar S., Rotkopf R., Kapsack A., Lambiase G., Pellegrino B., Ben-Isaac E., Golani O., Addadi Y., Hajaj E., Eilam R., Straussman R., Yarden Y., Lotem M. & Oren M. (2021),
Proceedings of the National Academy of Sciences. 118, 23, e202563111
-
Conformational switches and redox properties of the colon cancer‐associated human lectin ZG16
-
Decoding cancer biology one cell at a time
-
Learned Super Resolution Ultrasound for Improved Breast Lesion Characterization
-
Melanoma models for the next generation of therapies
Authors:
Patton E. E., Mueller K. L., Adams D. J., Anandasabapathy N., Aplin A. E., Bertolotto C., Bosenberg M., Ceol C. J., Chi P., Herlyn M., Holmen S. L., Karreth F. A., Kaufman C. K., Khan S., Kobold S., Leucci E., Levy C., Lombard D. B., Lund A. W., Marie K. L., Marine J. C., Marais R., McMahon M., Robles-Espinoza C. D., Ronai Z. A., Samuels Y., Soengas M. S., Villanueva J., Weeraratna A. T., White R. M., Yeh I., Zhu J., Zon L. I., Hurlbert M. S. & Merlino G. (2021),
Cancer Cell. 39, 5, p. 610-631
-
Spatially organized multicellular immune hubs in human colorectal cancer
Authors:
Pelka K., Hofree M., Chen J. H., Sarkizova S., Pirl J. D., Jorgji V., Bejnood A., Dionne D., Ge W. H., Xu K. H., Chao S. X., Zollinger D. R., Lieb D. J., Reeves J. W., Fuhrman C. A., Hoang M. L., Delorey T., Nguyen L. T., Waldman J., Wakiro I., Klapholz M., Cohen O., Albers J., Smillie C. S., Cuoco M. S., Wu J., Su M., Yeung J., Vijaykumar B., Magnuson A. M., Asinovski N., Moll T., Goder-Reiser M. N., Applebaum A. S., Brais L. K., DelloStritto L. K., Denning S. L., Phillips S. T., Hill E. K., Meehan J. K., Frederick D. T., Sharova T., Kanodia A., Todres E. Z., Jané-Valbuena J., Biton M., Izar B., Lambden C. D., Clancy T. E., Bleday R., Melnitchouk N., Irani J., Kunitake H., Berger D. L., Srivastava A., Hornick J. L., Ogino S., Rotem A., Vigneau S., Johnson B. E., Corcoran R. B., Sharpe A. H., Kuchroo V. K., Ng K., Giannakis M., Nieman L. T., Boland G. M., Aguirre A. J., Anderson A. C., Rozenblatt-Rosen O., Regev A. & Hacohen N. (2021),
Cell. 184, 18, p. 4734-4752.e20
-
Breast cancer is marked by specific, Public T-cell receptor CDR3 regions shared by mice and humans
Authors:
Gordin M., Philip H., Zilberberg A., Gidoni M., Margalit R., Clouser C., Adams K., Vigneault F., Cohen I. R., Yaari G. & Efroni S. (2021),
PLoS Computational Biology. 17, 1, 1008486
-
Identification of bacteria-derived HLA-bound peptides in melanoma
Authors:
Kalaora S., Nagler A., Nejman D., Alon M., Barbolin C., Barnea E., Ketelaars S. L. C., Cheng K., Vervier K., Shental N., Bussi Y., Rotkopf R., Levy R., Benedek G., Trabish S., Dadosh T., Levin-Zaidman S., Geller L. T., Wang K., Greenberg P., Yagel G., Peri A., Fuks G., Bhardwaj N., Reuben A., Hermida L., Johnson S. B., Galloway-Peña J. R., Shropshire W. C., Bernatchez C., Haymaker C., Arora R., Roitman L., Eilam R., Weinberger A., Lotan-Pompan M., Lotem M., Levin Y., Lawley T. D., Adams D. J., Levesque M. P., Besser M. J., Schachter J., Golani O., Segal E., Ruppin E., Kvistborg P., Peterson S. N., Wargo J. A., Straussman R. & Samuels Y. (2021),
Nature (London). 592, 7852, p. 138-143
-
CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma
Authors:
Lewinsky H., Gunes E. G., David K., Radomir L., Kramer M. P., Pellegrino B., Perpinial M., Chen J., He T. F., Mansour A. G., Teng K. Y., Bhattacharya S., Caserta E., Troadec E., Lee P., Feng M., Keats J., Krishnan A., Rosenzweig M., Yu J., Caligiuri M. A., Cohen Y., Shevetz O., Becker-Herman S., Pichiorri F., Rosen S. & Shachar I. (2021),
JCI insight. 6, 4, 141683
-
Chromothripsis drives the evolution of gene amplification in cancer
Authors:
Shoshani O., Brunner S. F., Yaeger R., Ly P., Nechemia-Arbely Y., Kim D. H., Fang R., Castillon G. A., Yu M., Li J. S. Z., Sun Y., Ellisman M. H., Ren B., Campbell P. J. & Cleveland D. W. (2021),
Nature. 591, 7848, p. 137-141
-
Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells
Authors:
Rubinstein-Achiasaf L., Morein D., Ben-Yaakov H., Liubomirski Y., Meshel T., Elbaz E., Dorot O., Pichinuk E., Gershovits M., Weil M. & Ben-Baruch A. (2021),
Cancers. 13, 6, 1472
-
Proteomic profiling of tissue exosomes indicates continuous release of malignant exosomes in urinary bladder cancer patients, even with pathologically undetectable tumour
Authors:
Eldh M., Mints M., Hiltbrunner S., Ladjevardi S., Alamdari F., Johansson M., Jakubczyk T., Veerman R. E., Winqvist O., Sherif A. & Gabrielsson S. (2021),
Cancers. 13, 13, 3242
-
P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression
Authors:
Yeini E., Ofek P., Pozzi S., Albeck N., Ben-Shushan D., Tiram G., Golan S., Kleiner R., Sheinin R., Israeli Dangoor S., Reich-Zeliger S., Grossman R., Ram Z., Brem H., Hyde T. M., Magod P., Friedmann-Morvinski D., Madi A. & Satchi-Fainaro R. (2021),
Nature Communications. 12, 1912
-
The extracellular matrix protein agrin is essential for epicardial epithelial-to-mesenchymal transition during heart development
Authors:
Sun X., Malandraki-Miller S., Kennedy T., Bassat E., Klaourakis K., Zhao J., Gamen E., Vieira J. M., Tzahor E. & Riley P. R. (2021),
Development (Cambridge). 148, 9
-
CYP46A1-APOE axis at the choroid plexus is compromised in Alzheimer's disease but is amenable to rescue
Authors:
Tsitsou A., Suzzi S., Kenigsbuch M., Singer O., Strobelt R., Cahalon L., Arad M., Colaiuta S. P., Medina S., Kviatcovsky D. & Schwartz M. (2021),
-
Alternative splicing of the inhibitory immune checkpoint receptor SLAMF6 generates a dominant positive form, boosting T-cell effector functions
Authors:
Hajaj E., Zisman E., Tzaban S., Merims S., Cohen J., Klein S., Frankenburg S., Sade-Feldman M., Tabach Y., Yizhak K., Navon A., Stepensky P., Hacohen N., Peretz T., Veillette A., Karni R., Eisenberg G. & Lotem M. (2021),
Cancer Immunology Research. 9, 6, p. 637-650
-
Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles
Authors:
Tawil N., Bassawon R., Meehan B., Nehme A., Montermini L., Gayden T., De Jay N., Spinelli C., Chennakrishnaiah S., Choi D., Adnani L., Zeinieh M., Jabado N., Kleinman C. L., Witcher M., Riazalhosseini Y., Key N. S., Schiff D., Grover S. P., Mackman N., Couturier C. P., Petrecca K., Suvà M. L., Patel A., Tirosh I., Najafabadi H. & Rak J. (2021),
Blood advances. 5, 6, p. 1682-1694
-
The context-specific roles of urea cycle enzymes in tumorigenesis
-
Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma
Authors:
Hara T., Chanoch-Myers R., Mathewson N. D., Myskiw C., Atta L., Bussema L., Eichhorn S. W., Greenwald A. C., Kinker G. S., Rodman C., Gonzalez Castro L. N., Wakimoto H., Rozenblatt-Rosen O., Zhuang X., Fan J., Hunter T., Verma I. M., Wucherpfennig K. W., Regev A., Suvà M. L. & Tirosh I. (2021),
Cancer Cell. 39, 6, p. 779-792.e11
-
Diffusion is directional: Innovative diffusion tensor imaging to improve prostate cancer detection
Authors:
Shenhar C., Degani H., Ber Y., Baniel J., Tamir S., Benjaminov O., Rosen P., Furman-Haran E. & Margel D. (2021),
Diagnostics. 11, 3, 563
-
Biomolecular Recognition of the Glycan Neoantigen CA19-9 by Distinct Antibodies
Authors:
Borenstein-Katz A., Warszawski S., Amon R., Eilon M., Cohen-Dvashi H., Leviatan Ben-Arye S., Tasnima N., Yu H., Chen X., Padler-Karavani V., Fleishman S. J. & Diskin R. (2021),
Journal of Molecular Biology. 433, 15, 167099
-
The prospects of tumor chemosensitivity testing at the single-cell level
-
Multiplexed imaging analysis of the tumor-immune microenvironment reveals predictors of outcome in triple-negative breast cancer
-
TENT4A Non-Canonical Poly(A) Polymerase Regulates DNA-Damage Tolerance via Multiple Pathways That Are Mutated in Endometrial Cancer
Authors:
Swain U., Friedlander G., Sehrawat U., Sarusi-Portuguez A., Rotkopf R., Ebert C., Paz-Elizur T., Dikstein R., Carell T., Geacintov N. E. & Livneh Z. (2021),
International Journal of Molecular Sciences. 22, 13, 6957
-
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models
Authors:
Marrocco I., Romaniello D., Vaknin I., Drago‐Garcia D., Oren R., Uribe M. L., Belugali Nataraj N., Ghosh S., Eilam R., Salame T., Lindzen M. & Yarden Y. (2021),
EMBO Molecular Medicine. 13, 4, 13144
-
Anti-tumour immunity induces aberrant peptide presentation in melanoma
Authors:
Bartok O., Pataskar A., Nagel R., Laos M., Goldfarb E., Hayoun D., Levy R., Körner P., Kreuger I. Z. M., Champagne J., Zaal E. A., Bleijerveld O. B., Huang X., Kenski J., Wargo J., Brandis A., Levin Y., Mizrahi O., Alon M., Lebon S., Yang W., Nielsen M. M., Stern-Ginossar N., Altelaar M., Berkers C. R., Geiger T., Peeper D. S., Olweus J., Samuels Y. & Agami R. (2021),
Nature. 590, 7845, p. 332-337
-
Efficient acquisition of tens of thousands of short tandem repeats in single-cell whole-genome-amplified DNA
-
Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits
Authors:
Giacomelli C., Jung J., Wachter A., Ibing S., Will R., Uhlmann S., Mannsperger H., Sahin Ö., Yarden Y., Beißbarth T., Korf U., Körner C. & Wiemann S. (2021),
BMC Cancer. 21, 1296
-
Clump sequencing exposes the spatial expression programs of intestinal secretory cells
-
Proteomic patterns associated with response to breast cancer neoadjuvant treatment
Authors:
Shenoy A., Belugali Nataraj N., Perry G., Loayza Puch F., Nagel R., Marin I., Balint N., Bossel N., Pavlovsky A., Barshack I., Kaufman B., Agami R., Yarden Y., Dadiani M. & Geiger T. (2021),
Molecular Systems Biology. 16, 9, e9443
-
Reduced Lamin A/C Does Not Facilitate Cancer Cell Transendothelial Migration but Compromises Lung Metastasis
Authors:
Roncato F., Regev O., Feigelson S. W., Yadav S. K., Kaczmarczyk L., Levi N., Drago-Garcia D., Ovadia S., Kizner M., Addadi Y., Sabino J. C., Ovadya Y., de Almeida S. F., Feldmesser E., Gerlitz G. & Alon R. (2021),
Cancers. 13, 10, 2383
-
Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response
-
Immunotherapy for Triple-Negative Breast Cancer
-
Inhibition of ADAM17 impairs endothelial cell necroptosis and blocks metastasis
Authors:
Bolik J., Krause F., Stevanovic M., Gandraß M., Thomsen I., Schacht S., Rieser E., Müller M., Schumacher N., Fritsch J., Wichert R., Galun E., Bergmann J., Röder C., Schafmayer C., Egberts J., Becker-Pauly C., Saftig P., Lucius R., Schneider-Brachert W., Barikbin R., Adam D., Voss M., Hitzl W., Krüger A., Strilic B., Sagi I., Walczak H., Rose-John S. & Schmidt-Arras D. (2021),
Journal of Experimental Medicine. 219, 1, e20201039
-
Evolution of fibroblasts in the lung metastatic microenvironment is driven by stage-specific transcriptional plasticity
Authors:
Shani O., Raz Y., Monteran L., Scharff Y., Levi-Galibov O., Megides O., Shacham H., Cohen N., Silverbush D., Avivi C., Sharan R., Madi A., Scherz-Shouval R., Barshack I., Tsarfaty I. & Erez N. (2021),
eLife. 10, e60745
-
The key roles of cancer stem cell-derived extracellular vesicles
-
EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
-
Conformation-specific inhibitory anti-mmp-7 monoclonal antibody sensitizes pancreatic ductal adenocarcinoma cells to chemotherapeutic cell kill
Authors:
Mohan V., Gaffney J. P., Solomonov I., Levin M., Klepfish M., Akbareian S., Grünwald B., Dym O., Eisenstein M., Yu K. H., Kelsen D. P., Krüger A., Edwards D. R. & Sagi I. (2021),
Cancers. 13, 7, 1679
-
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
-
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo
Authors:
Dubiella C., Pinch B. J., Koikawa K., Zaidman D., Poon E., Manz T. D., Nabet B., He S., Resnick E., Rogel A., Langer E. M., Daniel C. J., Seo H., Chen Y., Adelmant G., Sharifzadeh S., Ficarro S. B., Martins da Costa B., Jamin Y., Zimmerman M. W., Lian X., Kibe S., Kozono S., Doctor Z. M., Browne C. M., Yang A., Stoler-Barak L., Shah R. B., Vangos N. E., Geffken E. A., Oren R., Koide E., Sidi S., Shulman Z., Wang C., Marto J. A., Dhe-Paganon S., Look T., Zhou X. Z., Lu K. P., Sears R. C., Chesler L., Gray N. S. & London N. (2021),
Nature Chemical Biology. 17, 9, p. 954-963
-
Clinical Proteomics of Metastatic Melanoma Reveals Profiles of Organ Specificity and Treatment Resistance
-
Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
Authors:
Mer A. S., Heath E. M., Madani Tonekaboni S. A., Dogan-Artun N., Nair S. K., Murison A., Garcia-Prat L., Shlush L., Hurren R., Voisin V., Bader G. D., Nislow C., Rantalainen M., Lehmann S., Gower M., Guidos C. J., Lupien M., Dick J. E., Minden M. D., Schimmer A. D. & Haibe-Kains B. (2021),
Nature Communications. 12, 1, 1054
-
Interacting evolutionary pressures drive mutation dynamics and health outcomes in aging blood
Authors:
Skead K., Houle A. A., Abelson S., Agbessi M., Bruat V., Lin B., Soave D., Shlush L., Wright S., Dick J., Morris Q. & Awadalla P. (2021),
Nature Communications. 12, 1, 4921
-
Roles for growth factors and mutations in metastatic dissemination
-
A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma
Authors:
Choi J. E., Sebastian C., Ferrer C. M., Lewis C. A., Sade-Feldman M., LaSalle T., Gonye A., Lopez B. G., Abdelmoula W. M., Regan M. S., Cetinbas M., Pascual G., Wojtkiewicz G. R., Silveira G. G., Boon R., Ross K. N., Tirosh I., Saladi S. V., Ellisen L. W., Sadreyev R. I., Benitah S. A., Agar N. Y., Hacohen N. & Mostoslavsky R. (2021),
Nature metabolism. 3, 2, p. 182-195
-
Single cell biology—a Keystone Symposia report
Authors:
Cable J., Elowitz M. B., Domingos A. I., Habib N., Itzkovitz S., Hamidzada H., Balzer M. S., Yanai I., Liberali P., Whited J., Streets A., Cai L., Stergachis A. B., Hong C. K. Y., Keren L., Guilliams M., Alon U., Shalek A. K., Hamel R., Pfau S. J., Raj A., Quake S. R., Zhang N. R., Fan J., Trapnell C., Wang B., Greenwald N. F., Vento-Tormo R., Santos S. D., Spencer S. L., Garcia H. G., Arekatla G., Gaiti F., Arbel-Goren R., Rulands S., Junker J. P., Klein A. M., Morris S. A., Murray J. I., Galloway K. E., Ratz M. & Romeike M. (2021),
Annals of the New York Academy of Sciences. 1506, 1, p. 74-97
-
Using a Recently Approved Tumor Mutational Burden Biomarker to Stratify Patients for Immunotherapy May Introduce a Sex Bias
Authors:
Sinha N., Sinha S., Cheng K., Madan S., Erez A., Ryan B. M., Schäffer A. A., Aldape K. & Ruppin E. (2021),
-
Metabolic decisions in development and disease—a Keystone Symposia report
Authors:
Cable J., Pourquié O., Wellen K. E., Finley L. W., Aulehla A., Gould A. P., Teleman A., Tu W. B., Garrett W. S., Miguel-Aliaga I., Perrimon N., Hooper L. V., Walhout A. J., Wei W., Alexandrov T., Erez A., Ralser M., Rabinowitz J. D., Hemalatha A., Gutiérrez-Pérez P., Chandel N. S., Rutter J., Locasale J. W., Landoni J. C. & Christofk H. (2021),
Annals of the New York Academy of Sciences. 1506, 1, p. 55-73
-
The evolution of leukaemia from pre‐leukaemic and leukaemic stem cells
-
Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer
Authors:
Mints M., Landin D., Näsman A., Mirzaie L., Ursu R. G., Zupancic M., Marklund L., Dalianis T., Munck-Wikland E. & Ramqvist T. (2021),
Scientific Reports. 11, 1, 1782
-
Avidity optimization of a MAGE-A1-specific TCR with somatic hypermutation
-
MT1 and MT2 melatonin receptors play opposite roles in brain cancer progression
Authors:
Kinker G. S., Ostrowski L. H., Ribeiro P. A., Chanoch R., Muxel S. M., Tirosh I., Spadoni G., Rivara S., Martins V. R., Santos T. G., Markus R. P. & Fernandes P. A. (2021),
Journal of Molecular Medicine. 2, p. 289-301
-
Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis
Authors:
Beyaz S., Chung C., Mou H., Bauer-Rowe K. E., Xifaras M. E., Ergin I., Dohnalova L., Biton M., Shekhar K., Eskiocak O., Papciak K., Ozler K., Almeqdadi M., Yueh B., Fein M., Annamalai D., Valle-Encinas E., Erdemir A., Dogum K., Shah V., Alici-Garipcan A., Meyer H. V., Özata D. M., Elinav E., Kucukural A., Kumar P., McAleer J. P., Fox J. G., Thaiss C. A., Regev A., Roper J., Orkin S. H. & Yilmaz Ö. H. (2021),
Cell Stem Cell. 28, 11, p. 1922-1935.e5
-
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Authors:
Pfister D., Núñez N. G., Pinyol R., Govaere O., Pinter M., Szydlowska M., Gupta R., Qiu M., Deczkowska A., Weiner A., Müller F., Sinha A., Friebel E., Engleitner T., Lenggenhager D., Moncsek A., Heide D., Stirm K., Kosla J., Kotsiliti E., Leone V., Dudek M., Yousuf S., Inverso D., Singh I., Teijeiro A., Castet F., Montironi C., Haber P. K., Tiniakos D., Bedossa P., Cockell S., Younes R., Vacca M., Marra F., Schattenberg J. M., Allison M., Bugianesi E., Ratziu V., Pressiani T., D’Alessio A., Personeni N., Rimassa L., Daly A. K., Scheiner B., Pomej K., Kirstein M. M., Vogel A., Peck-Radosavljevic M., Hucke F., Finkelmeier F., Waidmann O., Trojan J., Schulze K., Wege H., Koch S., Weinmann A., Bueter M., Rössler F., Siebenhüner A., De Dosso S., Mallm J. P., Umansky V., Jugold M., Luedde T., Schietinger A., Schirmacher P., Emu B., Augustin H. G., Billeter A., Müller-Stich B., Kikuchi H., Duda D. G., Kütting F., Waldschmidt D. T., Ebert M. P., Rahbari N., Mei H. E., Schulz A. R., Ringelhan M., Malek N., Spahn S., Bitzer M., Ruiz de Galarreta M., Lujambio A., Dufour J. F., Marron T. U., Kaseb A., Kudo M., Huang Y. H., Djouder N., Wolter K., Zender L., Marche P. N., Decaens T., Pinato D. J., Rad R., Mertens J. C., Weber A., Unger K., Meissner F., Roth S., Jilkova Z. M., Claassen M., Anstee Q. M., Amit I., Knolle P., Becher B., Llovet J. M. & Heikenwalder M. (2021),
Nature (London). 592, 7854, p. 450-456
-
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma
Authors:
Peri A., Greenstein E., Alon M., Pai J. A., Dingjan T., Reich-Zeliger S., Barnea E., Barbolin C., Levy R., Arnedo-Pac C., Kalaora S., Dassa B., Feldmesser E., Shang P., Greenberg P., Levin Y., Benedek G., Levesque M. P., Adams D. J., Lotem M., Wilmott J. S., Scolyer R. A., Jönsson G. B., Admon A., Rosenberg S. A., Cohen C. J., Niv M. Y., Lopez-Bigas N., Satpathy A. T., Friedman N. & Samuels Y. (2021),
Journal of Clinical Investigation. 131, 20, e129466
-
LFA-1 in T cell priming, differentiation, and effector functions
-
Cancer-associated fibroblasts promote aggressive gastric cancer phenotypes via heat shock factor 1-mediated secretion of extracellular vesicles
Authors:
Grunberg N., Pevsner-Fischer M., Goshen-Lago T., Diment J., Stein Y., Lavon H., Mayer S., Levi-Galibov O., Friedman G., Ofir-Birin Y., Syu L., Migliore C., Shimoni E., Stemmer S. M., Brenner B., Dlugosz A. A., Lyden D., Regev-Rudzki N., Ben-Aharon I. & Scherz-Shouval R. (2021),
Cancer Research. 81, 7, p. 1639-1653
-
ACK1 is dispensable for development, skin tumor formation, and breast cancer cell proliferation
-
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells
Authors:
Shorer Arbel Y., Katz B., Gabizon R., Shraga A., Bronstein Y., Kamdjou T., Globerson Levin A., Perry C., Avivi I., London N. & Herishanu Y. (2021),
Frontiers in Oncology. 11, 646971
-
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms
Authors:
Mather R. L., Parolia A., Carson S. E., Venalainen E., Roig-Carles D., Jaber M., Chu S., Alborelli I., Wu R., Lin D., Nabavi N., Jachetti E., Colombo M. P., Xue H., Pucci P., Ci X., Hawkes C., Li Y., Pandha H., Ulitsky I., Marconett C., Quagliata L., Jiang W., Romero I., Wang Y. & Crea F. (2021),
Molecular Oncology. 15, 7, p. 1921-1941
-
Astrocytes Downregulate Inflammation in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: Applicability to COVID-19
-
Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing
Authors:
Zada M., Wang S., Bornstein C., David E., Moshe A., Li B., Shlomi-loubaton S., Gatt M. E., Gur C., Lavi N., Ganzel C., Luttwak E., Chubar E., Rouvio O., Vaxman I., Pasvolsky O., Ballan M., Tadmor T., Nemets A., Jarchowcky-dolberg O., Shvetz O., Laiba M., Shpilberg O., Dally N., Avivi I., Weiner A. & Amit I. (2021),
Nature Medicine. 27, 3, p. 491-503
-
Albumin-Methotrexate Prodrug Analogues That Undergo Intracellular Reactivation Following Entrance into Cancerous Glioma Cells
-
Decoupling epithelial-mesenchymal transitions from stromal profiles by integrative expression analysis
-
Treatment results from a phase I study of WST11 phototherapy (VTP) for upper tract urothelial carcinoma
Authors:
Nogueira L., Tracey A., Alvim R. G., Reisz P., Sjoberg D. D., Demac Q., Benfante N., Nagar K., Thomas J., Cheng J., Kim K., Solit D. B., Scherz A. J. & Coleman J. (2021),
Journal of Clinical Oncology. 39, 6_suppl, p. 460-460
-
The Collagen-Modifying Enzyme PLOD2 Is Induced and Required during L1-Mediated Colon Cancer Progression
-
Accelerating AXL targeting for TNBC therapy
-
Putative Blood Somatic Mutations in Post-Traumatic Stress Disorder-Symptomatic Soldiers: High Impact of Cytoskeletal and Inflammatory Proteins
-
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
Authors:
Koikawa K., Kibe S., Suizu F., Sekino N., Kim N., Manz T. D., Pinch B. J., Akshinthala D., Verma A., Gaglia G., Nezu Y., Ke S., Qiu C., Ohuchida K., Oda Y., Lee T. H., Wegiel B., Clohessy J. G., London N., Santagata S., Wulf G. M., Hidalgo M., Muthuswamy S. K., Nakamura M., Gray N. S., Zhou X. Z. & Lu K. P. (2021),
Cell. 184, 18, p. 4753-4771.e27
-
IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy
Authors:
Jacob Berger A., Gigi E., Kupershmidt L., Meir Z., Gavert N., Zwang Y., Prior A., Gilad S., Harush U., Haviv I., Stemmer S. M., Blum G., Merquiol E., Mardamshina M., Kaminski Strauss S., Friedlander G., Bar J., Kamer I., Reizel Y., Geiger T., Pilpel Y., Levin Y., Tanay A., Barzel B., Reuveni H. & Straussman R. (2021),
Nature Cancer. 2, 10, p. 1055-1070
-
Neoadjuvant vascular-targeted photodynamic therapy improves survival and reduces recurrence and progression in a mouse model of urothelial cancer
Authors:
Rosenzweig B., Corradi R. B., Budhu S., Alvim R., Recabal P., La Rosa S., Somma A., Monette S., Scherz A., Kim K. & Coleman J. A. (2021),
Scientific Reports. 11, 1, 4842
-
Transient genomic instability drives tumorigenesis through accelerated clonal evolution
Authors:
Shoshani O., Bakker B., de Haan L., Tijhuis A., Wang Y., Kim D. H., Maldonado M., Demarest M., Artates J., Zhengyu O., Mark A., Wardenaar R., Sasik R., Spierings D., Vitre B., Fisch K., Foijer F. & Cleveland D. W. (2021),
Genes and Development. 35, 15-16, p. 1093-1109
-
Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining
Authors:
Feldman T., Bercovich A., Moskovitz Y., Chapal-Ilani N., Mitchell A., Medeiros J. J. F., Biezuner T., Kaushansky N., Minden M. D., Gupta V., Milyavsky M., Livneh Z., Tanay A. & Shlush L. I. (2021),
Nature Communications. 12, 1, 2455
-
Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review
Authors:
Kenner B., Chari S. T., Kelsen D., Klimstra D. S., Pandol S. J., Rosenthal M., Rustgi A. K., Taylor J. A., Yala A., Abul-Husn N., Andersen D. K., Bernstein D., Brunak S., Canto M. I., Eldar Y. C., Fishman E. K., Fleshman J., Go V. L. W., Holt J. M., Field B., Goldberg A., Hoos W., Iacobuzio-Donahue C., Li D., Lidgard G., Maitra A., Matrisian L. M., Poblete S., Rothschild L., Sander C., Schwartz L. H., Shalit U., Srivastava S. & Wolpin B. (2021),
Pancreas. 50, 3, p. 251-279
-
Meningeal lymphoid structures are activated under acute and chronic spinal cord pathologies
Authors:
Cohen M., Giladi A., Raposo C., Zada M., Li B., Ruckh J., Deczkowska A., Mohar B., Shechter R., Lichtenstein R. G., Amit I. & Schwartz M. (2021),
Life Science Alliance. 4, 1, 202000907
-
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation
Authors:
Canu V., Donzelli S., Sacconi A., Lo Sardo F., Pulito C., Bossel N., Di Benedetto A., Muti P., Botti C., Domany E., Bicciato S., Strano S., Yarden Y. & Blandino G. (2021),
Cell Death and Differentiation. 28, 5, p. 1493-1511
-
Proteogenomics of glioblastoma associates molecular patterns with survival
Authors:
Yanovich-Arad G., Ofek P., Yeini E., Mardamshina M., Danilevsky A., Shomron N., Grossman R., Satchi-Fainaro R. & Geiger T. (2021),
Cell reports (Cambridge). 34, 9, 108787
-
DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation
Authors:
Batra R. N., Lifshitz A., Vidakovic A. T., Chin S., Sati-Batra A., Sammut S., Provenzano E., Ali H. R., Dariush A., Bruna A., Murphy L., Purushotham A., Ellis I., Green A., Garrett-Bakelman F. E., Mason C., Melnick A., Aparicio S. A. J. R., Rueda O. M., Caldas C. & Tanay A. (2021),
Nature Communications. 12, 1, 5406
-
Immunoediting role for major vault protein in apoptotic signaling induced by bacterial N-acyl homoserine lactones
Authors:
Rayo J., Gregor R., Jacob N. T., Dandela R., Dubinsky L., Yashkin A., Aranovich A., Thangaraj M., Ernst O., Barash E., Malitsky S., Florea B. I., Krom B. P., Wiemer E. A. C., Kickhoefer V. A., Rome L. H., Mathison J. C., Kaufmann G. F., Overkleeft H. S., Cravatt B. F., Zor T., Janda K. D., Ulevitch R. J., Kravchenko V. V. & Meijler M. M. (2021),
Proceedings of the National Academy of Sciences - PNAS. 118, 12, e201252911
-
Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anti-cancer activities in lung adenocarcinoma
-
Microbiome and cancer
-
Tumor heterogeneity
-
Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ)
-
MEK inhibition reverses aberrant signaling in melanoma cells through reorganization of NRas and BRAF in self nano-clusters
-
Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts
Authors:
Quinn J. J., Jones M. G., Okimoto R. A., Nanjo S., Chan M. M., Yosef N., Bivona T. G. & Weissman J. S. (2021),
Science. 371, 6532, abc1944
-
Microtubule destabilization is a critical checkpoint of chemotaxis and transendothelial migration in melanoma cells but not in T cells
-
P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas
Authors:
Rousso-Noori L., Mastandrea I., Talmor S., Waks T., Globerson Levin A., Haugas M., Teesalu T., Alvarez-Vallina L., Eshhar Z. & Friedmann-Morvinski D. (2021),
Nature Communications. 12, 1, 3615
-
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
Authors:
Mathewson N. D., Ashenberg O., Tirosh I., Gritsch S., Perez E. M., Marx S., Jerby-Arnon L., Chanoch-Myers R., Hara T., Richman A. R., Ito Y., Pyrdol J., Friedrich M., Schumann K., Poitras M. J., Gokhale P. C., Gonzalez Castro L. N., Shore M. E., Hebert C. M., Shaw B., Cahill H. L., Drummond M., Zhang W., Olawoyin O., Wakimoto H., Rozenblatt-Rosen O., Brastianos P. K., Liu X. S., Jones P. S., Cahill D. P., Frosch M. P., Louis D. N., Freeman G. J., Ligon K. L., Marson A., Chiocca E. A., Reardon D. A., Regev A., Suvà M. L. & Wucherpfennig K. W. (2021),
Cell. 184, 5, p. 1281-1298
-
SCIRT lncRNA Restrains Tumorigenesis by Opposing Transcriptional Programs of Tumor-Initiating Cells
Authors:
Zagorac S., de Giorgio A., Dabrowska A., Kalisz M., Casas-Vila N., Cathcart P., Yiu A., Ottaviani S., Degani N., Lombardo Y., Tweedie A., Nissan T., Vance K. W., Ulitsky I., Stebbing J. & Castellano L. (2021),
Cancer Research. 81, 3, p. 580-593
-
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Authors:
Alameda D., Goicoechea I., Vicari M., Arriazu E., Nevone A., Rodríguez S., Lasa M., Puig N., Cedena M., Alignani D., Garate S., Lara-Astiaso D., Vilas-Zornoza A., Sarvide S., Ocio E. M., Lecumberri R., Garcia de Coca A., Labrador J., Gonzalez M., Palomera L., Gironella M., Cabañas V., Casanova M., Oriol A., Krsnik I., Pérez-Montaña A., de la Rubia J., de la Puerta J., de Arriba F., Fazio V. M., Martinez-Lopez J., Lahuerta J., Mateos M., Odero M. D., Prosper F., Weiner A., Amit I., Nuvolone M., San-Miguel J. F. F. & Paiva B. (2021),
Blood. 138, 17, p. 1583-1589
-
β2-Integrin Adhesion Regulates Dendritic Cell Epigenetic and Transcriptional Landscapes to Restrict Dendritic Cell Maturation and Tumor Rejection
Authors:
Guenther C., Faisal I., Fusciello M., Sokolova M., Harjunpää H., Ilander M., Tallberg R., Vartiainen M. K., Alon R., Gonzalez-Granado J., Cerullo V. & Fagerholm S. C. (2021),
Cancer Immunology Research. 9, 11, p. 1354-1369
-
PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR
Authors:
Ghosh S., Nataraj N. B., Noronha A., Patkar S., Sekar A., Mukherjee S., Winograd-Katz S., Kramarski L., Verma A., Lindzen M., Garcia D. D., Green J., Eisenberg G., Gil-Henn H., Basu A., Lender Y., Weiss S., Oren M., Lotem M., Geiger B., Ruppin E. & Yarden Y. (2021),
Cell Reports. 35, 8, 109181
-
Intratumoral heterogeneity in cancer progression and response to immunotherapy
-
Retrospective cell lineage reconstruction in humans by using short tandem repeats
Authors:
Tao L., Raz O., Marx Z., Ghosh M. S., Huber S., Greindl-Junghans J., Biezuner T., Amir S., Milo L., Adar R., Levy R., Onn A., Chapal-Ilani N., Berman V., Ben Arie A., Rom G., Oron B., Halaban R., Czyz Z. T., Werner-Klein M., Klein C. A. & Shapiro E. (2021),
Cell Reports Methods. 1, 3, 100054
-
Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53
Authors:
Lindzen M., Ghosh S., Noronha A., Drago D., Nataraj N. B., Leitner O., Carvalho S., Zmora E., Sapoznik S., Shany K. B., Levanon K., Aderka D., Ramírez B. S., Dahlhoff M., McNeish I. & Yarden Y. (2021),
Oncogene. 40, 21, p. 3665-3679
-
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Authors:
Spencer C. N., McQuade J. L., Gopalakrishnan V., McCulloch J. A., Vetizou M., Cogdill A. P., Khan M. A. W., Zhang X., White M. G., Peterson C. B., Wong M. C., Morad G., Rodgers T., Badger J. H., Helmink B. A., Andrews M. C., Rodrigues R. R., Morgun A., Kim Y. S., Roszik J., Hoffman K. L., Zheng J., Zhou Y., Medik Y. B., Kahn L. M., Johnson S., Hudgens C. W., Wani K., Gaudreau P., Harris A. L., Jamal M. A., Baruch E. N., Perez-Guijarro E., Day C., Merlino G., Pazdrak B., Lochmann B. S., Szczepaniak-Sloane R. A., Arora R., Anderson J., Zobniw C. M., Posada E., Sirmans E., Simon J., Haydu L. E., Burton E. M., Wang L., Dang M., Clise-Dwyer K., Schneider S., Chapman T., Anang N. A. S., Duncan S., Toker J., Malke J. C., Glitza I. C., Amaria R. N., Tawbi H. A., Diab A., Wong M. K., Patel S. P., Woodman S. E., Davies M. A., Ross M. I., Gershenwald J. E., Lee J. E., Hwu P., Jensen V., Samuels Y., Straussman R., Ajami N. J., Nelson K. C., Nezi L., Petrosino J. F., Futreal P. A., Lazar A. J., Hu J., Jenq R. R., Tetzlaff M. T., Yan Y., Garrett W. S., Huttenhower C., Sharma P., Watowich S. S., Allison J. P., Cohen L., Trinchieri G., Daniel C. R. & Wargo J. A. (2021),
Science. 374, 6575, p. 1632-1640
-
Systematic detection of m6A-modified transcripts at single-molecule and single-cell resolution
Authors:
Kim K. L., van Galen P., Hovestadt V., Rahme G. J., Andreishcheva E. N., Shinde A., Gaskell E., Jones D. R., Shema E. & Bernstein B. E. (2021),
Cell Reports Methods. 1, 5, 100061
-
Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models
-
Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression
Authors:
Barnabas G. D., Lee J. S., Shami T., Harel M., Beck L., Selitrennik M., Jerby-Arnon L., Erez N., Ruppin E. & Geiger T. (2021),
Cancer research (Chicago, Ill.). 81, 6, p. 1443-1456
-
Effect of ibrutinib on the ifn response of chronic lymphocytic leukemia cells
-
Stromal Expression of the Core Clock Gene Period 2 Is Essential for Tumor Initiation and Metastatic Colonization
-
Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation
Authors:
Wu Y., Chou T., Young L., Hsieh F., Pan H., Mo S., Brown S. B., Chen R., Kimchi A. & Lai M. (2020),
Cell Death & Disease. 11, 305
-
The microbiome and cytosolic innate immune receptors
-
Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma
Authors:
Weidner P., Soehn M., Schroeder T., Helm L., Hauber V., Gutting T., Betge J., Roecken C., Rohrbacher F. N., Pattabiraman V. R., Bode J. W., Seger R., Saar D., Nunes-Alves A., Wade R. C., Ebert M. P. A. & Burgermeister E. (2020),
Oncogenesis. 9, 6, 59
-
Regulation of eIF2α by RNF4 Promotes Melanoma Tumorigenesis and Therapy Resistance
Authors:
Avitan-Hersh E., Feng Y., Oknin Vaisman A., Abu Ahmad Y., Zohar Y., Zhang T., Lee J. S., Lazar I., Sheikh Khalil S., Feiler Y., Kluger H., Kahana C., Brown K., Ruppin E., Ronai Z. A. & Orian A. (2020),
Journal of Investigative Dermatology. 12, p. 2466-2477
-
Modeling Multiplexed Images with Spatial-LDA Reveals Novel Tissue Microenvironments
-
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
Authors:
Kalaora S., Lee J. S., Barnea E., Levy R., Greenberg P., Alon M., Yagel G., Bar Eli G., Oren R., Peri A., Patkar S., Bitton L., Rosenberg S. A., Lotem M., Levin Y., Admon A., Ruppin E. & Samuels Y. (2020),
Nature Communications. 11, 1, 896
-
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
Authors:
Kinker G. S., Greenwald A. C., Tal R., Orlova Z., Cuoco M. S., McFarland J. M., Warren A., Rodman C., Roth J. A., Bender S. A., Kumar B., Rocco J. W., Fernandes P. A., Mader C. C., Keren-Shaul H., Plotnikov A., Barr H., Tsherniak A., Rozenblatt-Rosen O., Krizhanovsky V., Puram S. V., Regev A. & Tirosh I. (2020),
Nature Genetics. 52, 11, p. 1208-1218
-
Genomic retargeting of p53 and CTCF is associated with transcriptional changes during oncogenic HRas-induced transformation
Authors:
Schwartz M., Portugez A. S., Attia B. Z., Tannenbaum M., Cohen L., Loza O., Chase E., Turman Y., Kaplan T., Salah Z. & Hakim O. (2020),
Communications Biology. 3, 1, 696
-
A single cell atlas of the human liver tumor microenvironment
Authors:
Massalha H., Bahar Halpern K., Abu-Gazala S., Jana T., Massasa E. E., Moor A. E., Buchauer L., Rozenberg M., Pikarsky E., Amit I., Zamir G. & Itzkovitz S. (2020),
Molecular Systems Biology. 16, 12, e9682
-
Induction and characterization of pancreatic cancer in a transgenic pig model
Authors:
Edward Boas F., Nurili F., Bendet A., Cheleuitte-Nieves C., Basturk O., Askan G., Michel A. O., Monette S., Ziv E., Sofocleous C. T., Maxwell A. W., Schook L. B., Solomon S. B., Kelsen D. P., Scherz A. & Yarmohammadi H. (2020),
PLoS ONE. 15, 9, e0239391
-
Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor-Thr(701) phosphorylation
Authors:
Gaviraghi M., Rabellino A., Andolfo A., Brand M., Brombin C., Bagnato P., De Feudis G., Raimondi A., Locatelli A., Tosoni D., Mazza D., Gianni L., Tonon G., Yarden Y., Tacchetti C. & Daniele T. (2020),
Scientific Reports. 10, 16906
-
Mutant p53 oncogenicity: dominant-negative or gain-of-function?
-
Developments in Vascular-Targeted Photodynamic Therapy for Urologic Malignancies
-
The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma
Authors:
Gamaev L., Mizrahi L., Friehmann T., Rosenberg N., Pappo O., Olam D., Zeira E., Bahar Halpern, K., Caruso S., Zucman-Rossi J., Axelrod J. H., Galun E. & Goldenberg D. S. (2020),
Oncogene. 40, 1, p. 127-139
-
Predicting and affecting response to cancer therapy based on pathway-level biomarkers
Authors:
Ben-Hamo R., Berger A. J., Gavert N., Miller M., Pines G., Oren R., Pikarsky E., Benes C. H., Neuman T., Zwang Y., Efroni S., Getz G. & Straussman R. (2020),
Nature Communications. 11, 1, 3296
-
Genome-wide association study identifies 16 genomic regions associated with circulating cytokines at birth
-
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor
Authors:
Romaniello D., Marrocco I., Nataraj N. B., Ferrer I., Drago-Garcia D., Vaknin I., Oren R., Lindzen M., Ghosh S., Kreitman M., Kittel J. C., Gaborit N., Baez G. B., Sanchez B., Eilam R., Pikarsky E., Paz-Ares L. & Yarden Y. (2020),
Cancers. 12, 9, p. 1-20, 2394
-
A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanoma
Authors:
Nagler A., Vredevoogd D. W., Alon M., Cheng P. F., Trabish S., Kalaora S., Arafeh R., Goldin V., Levesque M. P., Peeper D. S. & Samuels Y. (2020),
Pigment Cell and Melanoma Research. 33, 2, p. 334-344
-
Interleukin 10 Restores Lipopolysaccharide-Induced Alterations in Synaptic Plasticity Probed by Repetitive Magnetic Stimulation
Authors:
Lenz M., Eichler A., Kruse P., Strehl A., Rodriguez-Rozada S., Goren I., Yogev N., Frank S., Waisman A., Deller T., Jung S., Maggio N. & Vlachos A. (2020),
Frontiers in Immunology. 11, 614509
-
Reduction in MLKL-mediated endosomal trafficking enhances the TRAIL-DR4/5 signal to increase cancer cell death
-
Mitochondrial carrier homolog 2 is necessary for AML survival
Authors:
Khan D. H., Mullokandov M., Wu Y., Voisin V., Gronda M. V., Hurren R., Wang X., MacLean N., Jeyaraju D. V., Jitkova Y., Xu G. W., Laister R. C., Seneviratne A., Blatman Z., Ketala T., Bader G. D., Marhon S. A., Carvalho D. D. D., Minden M. D., Gross A. & Schimmer A. D. (2020),
Blood. 136, 1, p. 81-92
-
A framework for advancing our understanding of cancer-associated fibroblasts
Authors:
Sahai E., Astsaturov I., Cukierman E., DeNardo D. G., Egeblad M., Evans R. M., Fearon D., Greten F. R., Hingorani S. R., Hunter T., Hynes R. O., Jain R. K., Janowitz T., Jorgensen C., Kimmelman A. C., Kolonin M. G., Maki R. G., Powers R. S., Pure E., Ramirez D. C., Scherz-Shouval R., Sherman M. H., Stewart S., Tlsty T. D., Tuveson D. A., Watt F. M., Weaver V., Weeraratna A. T. & Werb Z. (2020),
Nature Reviews Cancer. 20, 3, p. 174-186
-
A single-cell landscape of high-grade serous ovarian cancer
Authors:
Izar B., Tirosh I., Stover E. H., Wakiro I., Cuoco M. S., Alter I., Rodman C., Leeson R., Su M., Shah P., Iwanicki M., Walker S. R., Kanodia A., Melms J. C., Mei S., Lin J., Porter C. B. M., Slyper M., Waldman J., Jerby-Arnon L., Ashenberg O., Brinker T. J., Mills C., Rogava M., Vigneau S., Sorger P. K., Garraway L. A., Konstantinopoulos P. A., Liu J. F., Matulonis U., Johnson B. E., Rozenblatt-Rosen O., Rotem A. & Regev A. (2020),
Nature Medicine. 26, 8, p. 1271-1279
-
Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain
Authors:
Donninelli G., Saraf-Sinik I., Mazziotti V., Capone A., Grasso M. G., Battistini L., Reynolds R., Magliozzi R. & Volpe E. (2020),
Journal of Neuroinflammation. 17, 1, 149
-
Rational design of universal immunotherapy for TfR1-tropic arenaviruses
Authors:
Cohen-Dvashi H., Amon R., Agans K. N., Cross R. W., Borenstein-Katz A., Mateo M., Baize S., Padler-Karavani V., Geisbert T. W. & Diskin R. (2020),
Nature Communications. 11, 1, 67
-
Immune related proteins and tumor infiltrating CD8+lymphocytes in hypopharyngeal cancer in relation to human papillomavirus (HPV) and clinical outcome
Authors:
Landin D., Ahrlund-Richter A., Mirzaie L., Mints M., Nasman A., Kolev A., Marklund L., Dalianis T., Munck-Wikland E. & Ramqvist T. (2020),
Head and Neck. 42, 11, p. 3206-3217
-
Pleiotropic tumor suppressor functions of WWOX antagonize metastasis
Authors:
Khawaled S., Nigita G., Distefano R., Oster S., Suh S., Smith Y., Khalaileh A., Peng Y., Croce C. M., Geiger T., Seewaldt V. L. & Aqeilan R. I. (2020),
Signal Transduction and Targeted Therapy. 5, 1, 43
-
NF-κB-miR-155 axis activation mediates ovulation-induced oncogenic effects in fallopian tube epithelium
Authors:
Brand H., Barnabas G. D., Sapoznik S., Bahar-Shany K., Pozniak Y., Yung Y., Hourvitz A., Geiger T., Jacob-Hirsch J. & Levanon K. (2020),
Carcinogenesis (New York). 41, 12, p. 1703-1712
-
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts
Authors:
Kim K., Hu W., Audenet F., Almassi N., Hanrahan A. J., Murray K., Bagrodia A., Wong N., Clinton T. N., Dason S., Mohan V., Jebiwott S., Nagar K., Gao J., Penson A., Hughes C., Gordon B., Chen Z., Dong Y., Watson P. A., Alvim R., Elzein A., Gao S. P., Cocco E., Santin A. D., Ostrovnaya I., Hsieh J. J., Sagi I., Pietzak E. J., Hakimi A. A., Rosenberg J. E., Iyer G., Vargas H. A., Scaltriti M., Al-Ahmadie H., Solit D. B. & Coleman J. A. (2020),
Nature Communications. 11, 1, 1975
-
Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations
-
Single-cell analysis of clonal maintenance of transcriptional and epigenetic states in cancer cells
-
Immunomodulatory Properties of Leishmania Extracellular Vesicles During Host-Parasite Interaction: Differential Activation of TLRs and NF-kappa B Translocation by Dermotropic and Viscerotropic Species
-
The Glioma Stem Cell Model in the Era of Single-Cell Genomics
-
Inter-Tumor Heterogeneity-Melanomas Respond Differently to GM-CSF-Mediated Activation
Authors:
Moshe A., Izraely S., Sagi-Assif O., Malka S., Ben-Menachem S., Meshel T., Pasmanik-Chor M., Hoon D. S. & Witz I. P. (2020),
Cells. 9, 7, 1683
-
Microbiome genomics for cancer prediction
-
Breast Cancer-Derived Microparticles Reduce Cancer Cell Adhesion, an Effect Augmented by Chemotherapy
Authors:
Shechter D., Harel M., Mukherjee A., Sagredo L. M., Loven D., Prinz E., Avraham S., Orian-Rousseau V., Geiger T., Shaked Y. & Wolfenson H. (2020),
Cells (Basel, Switzerland). 9, 10, 2263
-
Time-resolved profiling reveals ATF3 as a novel mediator of endocrine resistance in breast cancer
Authors:
Borgoni S., Sofyalı E., Soleimani M., Wilhelm H., Müller-Decker K., Will R., Noronha A., Beumers L., Verschure P. J., Yarden Y., Magnani L., van Kampen A. H., Moerland P. D. & Wiemann S. (2020),
Cancers. 12, 10, p. 1-19, 2918
-
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
Authors:
Rosenblum D., Gutkin A., Kedmi R., Ramishetti S., Veiga N., Jacobi A. M., Schubert M. S., Friedmann-Morvinski D., Cohen Z. R., Behlke M. A., Lieberman J. & Peer D. (2020),
Science advances. 6, 47, eabc9450
-
Effect of IV Administration of a Gadolinium-Based Contrast Agent on Breast Diffusion-Tensor Imaging
-
Nanobodies Targeting Prostate-specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer
Authors:
Rosenfeld L., Sananes A., Zur Y., Cohen S., Dhara K., Gelkop S., Ben Zeev E., Shahar A., Lobel L., Akabayov B., Arbely E. & Papo N. (2020),
Journal of Medicinal Chemistry. 63, 14, p. 7601-7615
-
Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models
Authors:
Feldman T., Grossman-Haham I., Elkis Y., Vilela P., Moskovits N., Barshack I., Salame T. M., Fass D. & Ilani T. (2020),
Oncotarget. 11, 4, p. 386-398
-
Emerging roles of ECM remodeling processes in cancer
-
Cardiac remodeling secondary to chronic volume overload is attenuated by a novel MMP9/2 blocking antibody
Authors:
Cohen L., Sagi I., Bigelman E., Solomonov I., Aloshin A., Ben-Shoshan J., Rozenbaum Z., Keren G. & Entin-Meer M. (2020),
PLoS ONE. 15, 4, e0231202
-
Immunological Features of Non-neuronal Brain Cells: Implications for Alzheimer's Disease Immunotherapy
-
A Unified Linear Viscoelastic Model of the Cell Nucleus Defines the Mechanical Contributions of Lamins and Chromatin
Authors:
Wintner O., Hirsch-Attas N., Schlossberg M., Brofman F., Friedman R., Kupervaser M., Kitsberg D. & Buxboim A. (2020),
Advanced Science. 7, 8, 1901222
-
The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Authors:
Nejman D., Livyatan I., Fuks G., Gavert N., Zwang Y., Geller L. T., Rotter-Maskowitz A., Weiser R., Mallel G., Gigi E., Meltser A., Douglas G. M., Kamer I., Gopalakrishnan V., Dadosh T., Levin-Zaidman S., Avnet S., Atlan T., Cooper Z. A., Arora R., Cogdill A. P., Khan M. A. W., Ologun G., Bussi Y., Weinberger A., Lotan-Pompan M., Golani O., Perry G., Rokah M., Bahar-Shany K., Rozeman E. A., Blank C. U., Ronai A., Shaoul R., Amit A., Dorfman T., Kremer R., Cohen Z. R., Harnof S., Siegal T., Yehuda-Shnaidman E., Gal-Yam E. N., Shapira H., Baldini N., Langille M. G. I., Ben-Nun A., Kaufman B., Nissan A., Golan T., Dadiani M., Levanon K., Bar J., Yust-Katz S., Barshack I., Peeper D. S., Raz D. J., Segal E., Wargo J. A., Sandbank J., Shental N. & Straussman R. (2020),
Science. 368, 6494, p. 973-980
-
The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy
-
Interleukin-10 Prevents Pathological Microglia Hyperactivation following Peripheral Endotoxin Challenge
Authors:
Shemer A., Scheyltjens I., Frumer G. R., Kim J., Grozovski J., Ayanaw S., Dassa B., Van Hove H., Chappell-Maor L., Boura-Halfon S., Leshkowitz D., Mueller W., Maggio N., Movahedi K. & Jung S. (2020),
Immunity. 53, 5, p. 1033-1049.e7
-
IL-16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity
Authors:
Krantz D., Mints M., Winerdal M., Riklund K., Rutishauser D., Zubarev R., Zirakhzadeh A. A., Alamdari F., Johansson M., Sherif A. & Winqvist O. (2020),
Scandinavian Journal of Immunology. 92, 6, e12926
-
Diffusion-weighted breast MRI of malignancies with submillimeter resolution and immunity to artifacts by spatiotemporal encoding at 3T
-
Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma
-
Increased circulatory IL-6 during 8-week fluoxetine treatment is a risk factor for suicidal behaviors in youth
-
Wnt/β-catenin target genes in colon cancer metastasis: The special case of l1cam
-
Diffusivity in breast malignancies analyzed for b > 1000 s/mm
2
at 1 mm in‐plane resolutions: Insight from Gaussian and
non‐Gaussian
behaviors
-
Single-cell genomic approaches for developing the next generation of immunotherapies
-
Lipid Transfer Proteins and Membrane Contact Sites in Human Cancer
-
Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature
Authors:
Tavor S., Shalit T., Chapal Ilani N., Moskovitz Y., Livnat N., Groner Y., Barr H., Minden M. D., Plotnikov A., Deininger M. W., Kaushansky N. & Shlush L. I. (2020),
Haematologica. 105, 12, p. 2795-2804
-
Bystander IFN-gamma activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment
Authors:
Thibaut R., Bost P., Milo I., Cazaux M., Lemaitre F., Garcia Z., Amit I., Breart B., Cornuot C., Schwikowski B. & Bousso P. (2020),
Nature Cancer. 1, 3, p. 302-314
-
Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia
Authors:
Mathew N. R., Vinnakota J. M., Apostolova P., Erny D., Hamarsheh S., Andrieux G., Kim J., Hanke K., Goldmann T., Chappell-Maor L., El-Khawanky N., Ihorst G., Schmidt D., Duyster J., Finke J., Blank T., Boerries M., Blazar B. R., Jung S., Prinz M. & Zeiser R. (2020),
The Journal of Clinical Investigation. 130, 3, p. 1315-1329
-
A 20-Year Journey from Axonal Injury to Neurodegenerative Diseases and the Prospect of Immunotherapy for Combating Alzheimer's Disease
-
Intravital imaging of vascular anomalies and extracellular matrix remodeling in orthotopic pancreatic tumors
-
High-resolution optoacoustic imaging of tissue responses to vascular-targeted therapies
Authors:
Haedicke K., Agemy L., Omar M., Berezhnoi A., Roberts S., Longo-Machado C., Skubal M., Nagar K., Hsu H., Kim K., Reiner T., Coleman J., Ntziachristos V., Scherz A. & Grimm J. (2020),
Nature Biomedical Engineering. 4, 3, p. 286-297
-
A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer
Authors:
Shreberk-Shaked M., Dassa B., Sinha S., Di Agostino S., Azuri I., Mukherjee S., Aylon Y., Blandino G., Ruppin E. & Oren M. (2020),
Cancer Research. 80, 19, p. 4145-4157
-
High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier Function
Authors:
Grosheva I., Zheng D., Levy M., Polansky O., Lichtenstein A., Golani O., Dori-Bachash M., Moresi C., Shapiro H., Del Mare-Roumani S., Valdes-Mas R., He Y., Karbi H., Chen M., Harmelin A., Straussman R., Yissachar N., Elinav E. & Geiger B. (2020),
Gastroenterology. 159, 5, p. 1807-1823
-
Identification of a potent and selective covalent Pin1 inhibitor
Authors:
Pinch B. J., Doctor Z. M., Nabet B., Browne C. M., Seo H., Mohardt M. L., Kozono S., Lian X., Manz T. D., Chun Y., Kibe S., Zaidman D., Daitchman D., Yeoh Z. C., Vangos N. E., Geffken E. A., Tan L., Ficarro S. B., London N., Marto J. A., Buratowski S., Dhe-Paganon S., Zhou X. Z., Lu K. P. & Gray N. S. (2020),
Nature Chemical Biology. 16, 9, p. 979-987
-
Directed evolution of therapeutic antibodies targeting glycosylation in cancer
Authors:
Amon R., Rosenfeld R., Perlmutter S., Grant O. C., Yehuda S., Borenstein-Katz A., Alcalay R., Marshanski T., Yu H., Diskin R., Woods R. J., Chen X. & Padler-Karavani V. (2020),
Cancers. 12, 10, 2824
-
DNA Repair Biomarker for Lung Cancer Risk and its Correlation With Airway Cells Gene Expression
Authors:
Paz-Elizur T., Leitner-Dagan Y., Meyer K. B., Markus B., Giorgi F. M., O'Reilly M., Kim H., Evgy Y., Fluss R., Freedman L. S., Rintoul R. C., Ponder B. & Livneh Z. (2020),
Jnci cancer spectrum. 4, 1, pkz067
-
The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
Authors:
Kadosh E., Snir-Alkalay I., Venkatachalam A., May S., Lasry A., Elyada E., Zinger A., Shaham M., Vaalani G., Mernberger M., Stiewe T., Pikarsky E., Oren M. & Ben-Neriah Y. (2020),
Nature. 7827, p. 133-+
-
Introducing PIONEER: a project to harness big data in prostate cancer research
-
The potential anti-inflammatory and anti-nociceptive effects of rat hemopressin (PVNFKFLSH) in experimental arthritis
Authors:
Camargo L. L., Denadai-Souza A., Yshii L. M., Lima C., Teixeira S. A., Cerqueira A. R., Gewehr M. C., Fernandes E. S., Schenka A. A., Muscará M. N., Ferro E. S. & Costa S. K. (2020),
European Journal of Pharmacology. 173636
-
Nasopharyngeal carcinoma joins the single-cell party
Authors:
Mints M. & Tirosh I. (2020),
-
Trypanosoma cruzi-Infected Human Macrophages Shed Proinflammatory Extracellular Vesicles That Enhance Host-Cell Invasion via Toll-Like Receptor 2
Authors:
Cronemberger-Andrade A., Xander P., Soares R. P., Pessoa N. L., Campos M. A., Ellis C. C., Grajeda B., Ofir-Birin Y., Almeida I. C., Regev-Rudzki N. & Torrecilhas A. C. (2020),
Frontiers in Cellular and Infection Microbiology. 10, 99
-
Characterization of the human tumor microbiome reveals tumor-type specific intra-cellular bacteria
-
beta-Catenin safeguards the ground state of mouse pluripotency by strengthening the robustness of the transcriptional apparatus
Authors:
Zhang M., Lai Y., Krupalnik V., Guo P., Guo X., Zhou J., Xu Y., Yu Z., Liu L., Jiang A., Li W., Ma G., Li N., Fu X., Lv Y., Jiang M., Tariq M., Kanwal S., Liu H., Xu X., Zhang H., Huang Y., Wang L., Chen S., Babarinde I. A., Luo Z., Wang D., Zhou T., Ward C., He M., Ibanez D. P., Li Y., Zhou J., Yuan J., Feng Y., Arumugam K., Di Vicino U., Bao X., Wu G., Schambach A., Wang H., Sun H., Gao F., Qin B., Hutchins A. P., Doble B. W., Hartmann C., Cosma M. P., Qin Y., Xu G., Chen R., Volpe G., Chen L., Hanna J. H. & Esteban M. A. (2020),
Science Advances. 6, 29, 1593
-
Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features
Authors:
Benor G., Fuks G., Chin S., Rueda O. M., Mukherjee S., Arandkar S., Aylon Y., Caldas C., Domany E. & Oren M. (2020),
Molecular Oncology. 14, 8, p. 1640-1652
-
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance
Authors:
Lamballe F., Ahmad F., Vinik Y., Castellanet O., Daian F., Muller A., Kohler U. A., Bailly A., Josselin E., Castellano R., Cayrou C., Charafe-Jauffret E., Mills G. B., Geli V., Borg J., Lev S. & Maina F. (2020),
Advanced Science. 3, 2003049
-
Mapping cell phenotypes in breast cancer
-
Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells
Authors:
Levite M., Zelig D., Friedman A., Ilouz N., Eilam R., Bromberg Z., Lasu A. A. R., Arbel-Alon S., Edvardson S., Tarshish M., Riek L. P., Lako R. L., Reubinoff B., Lebendiker M., Yaish D., Stavsky A. & Galun E. (2020),
Journal of Autoimmunity. 112, 102462
-
Across the Globe: Proteogenomic Landscapes of Lung Cancer
Authors:
Yanovich-Arad G. & Geiger T. (2020),
-
Publisher Correction: Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome (BMC Biology, (2020), 18, 1, (163), 10.1186/s12915-020-00893-2)
Authors:
Shaashua L., Eckerling A., Israeli B., Yanovich G., Rosenne E., Fichman-Horn S., Zvi I. B., Sorski L., Haldar R., Satchi-Fainaro R., Geiger T., Sloan E. K. & Ben-Eliyahu S. (2020),
-
Metabolic alterations in the tumor microenvironment and their role in oncogenesis
-
Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma
Authors:
Mur E. B., Bernardo S., Papon L., Mancini M., Fabbrizio E., Goussard M., Ferrer I., Giry A., Quantin X., Pujol J., Calvayrac O., Moll H. P., Glasson Y., Pirot N., Turtoi A., Canamero M., Wong K., Yarden Y., Casanova E., Soria J., Colinge J., Siebel C. W., Mazieres J., Favre G., Paz-Ares L. & Maraver A. (2020),
Journal of Clinical Investigation. 130, 2, p. 612-624
-
Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer
Authors:
Katzenelenbogen Y., Sheban F., Yalin A., Yofe I., Svetlichnyy D., Jaitin D. A., Bornstein C., Moshe A., Keren-Shaul H., Cohen M., Wang S., Li B., David E., Salame T., Weiner A. & Amit I. (2020),
Cell. 182, 4, p. 872-885.e19
-
Targeting Metabolic Plasticity and flexibility Dynamics for Cancer Therapy
-
Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual Specificity
Authors:
Levin A. G., Slobodkin M. R., Waks T., Horn G., Ninio-Many L., Unger N. D., Ohayon Y., Suliman S., Cohen Y., Tartakovsky B., Naparstek E., Avivi I. & Eshhar Z. (2020),
Cancer Immunology Research. 8, 12, p. 1485-1495
-
NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration
Authors:
Cui C., Liu Y., Gerloff D., Rohde C., Pauli C., Koehn M., Misiak D., Oellerich T., Schwartz S., Schmidt L., Wiewrodt R., Marra A., Hillejan L., Bartel F., Wickenhauser C., Huettelmaier S., Goellner S., Zhou F., Edemir B. & Mueller-Tidow C. (2020),
Oncogene. 40, 5, p. 909-921
-
The Animal Lectin Galectin-8 Promotes Cytokine Expression and Metastatic Tumor Growth in Mice
-
Deconstructing tumor heterogeneity: The stromal perspective
Authors:
Vickman R. E., Faget D. V., Beachy P., Beebe D., Bhowmick N. A., Cukierman E., Deng W., Granneman J. G., Hildesheim J., Kalluri R., Lau K. S., Lengyel E., Lundeberg J., Moscat J., Nelson P. S., Pietras K., Politi K., Puré E., Scherz-Shouval R., Sherman M. H., Tuveson D., Weeraratna A. T., White R. M., Wong M. H., Woodhouse E. C., Zheng Y., Hayward S. W. & Stewart S. A. (2020),
Oncotarget. 11, 40, p. 3621-3632
-
Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome
Authors:
Shaashua L., Eckerling A., Israeli B., Yanovich G., Rosenne E., Fichman-Horn S., Ben Zvi I., Sorski L., Haldar R., Satchi-Fainaro R., Geiger T., Sloan E. K. & Ben-Eliyahu S. (2020),
BMC Biology. 18, 1, 163
-
HSF1 and Molecular Chaperones in Biology and Cancer
Authors:
Mendillo M. L., Pincus D. & Scherz-Shouval R. (2020),
-
Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment
-
Dissecting cellular crosstalk by sequencing physically interacting cells
Authors:
Giladi A., Cohen M., Medaglia C., Baran Y., Li B., Zada M., Bost P., Blecher-Gonen R., Salame T., Mayer J. U., David E., Ronchese F., Tanay A. & Amit I. (2020),
Nature Biotechnology. 38, 5, p. 629-637
-
Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action
Authors:
McFarland J. M., Paolella B. R., Warren A., Geiger-Schuller K., Shibue T., Rothberg M., Kuksenko O., Colgan W. N., Jones A., Chambers E., Dionne D., Bender S., Wolpin B. M., Ghandi M., Tirosh I., Rozenblatt-Rosen O., Roth J. A., Golub T. R., Regev A., Aguirre A. J., Vazquez F. & Tsherniak A. (2020),
Nature Communications. 11, 1, 4296
-
Novel Proteome Extraction Method Illustrates a Conserved Immunological Signature of MSI-H Colorectal Tumors.
-
Tumour heterogeneity and the evolutionary trade-offs of cancer
-
Efficient targeted degradation via reversible and irreversible covalent PROTACs
Authors:
Gabizon R., Shraga A., Gehrtz P., Livnah E., Shorer Y., Gurwicz N., Avram L., Unger T., Aharoni H., Albeck S., Brandis A., Shulman Z., Katz B., Herishanu Y. & London N. (2020),
Journal of the American Chemical Society. 142, 27, p. 11734-11742
-
PRMT1 inhibition induces differentiation of colon cancer cells
Authors:
Plotnikov A., Kozer N., Cohen G., Carvalho S., Duberstein S., Almog O., Solmesky L. J., Shurrush K. A., Babaev I., Benjamin S., Gilad S., Kupervaser M., Levin Y., Gershovits M., Ben-Avraham D. & Barr H. M. (2020),
Scientific Reports. 10, 1, 20030
-
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
Authors:
Chen Y., Yin J., Li W., Li H., Chen D., Zhang C., Lv J., Wang Y., Li X., Li J., Zhang P., Li Y., He Q., Yang X., Lei Y., Tang L., Zhou G., Mao Y., Wei C., Xiong K., Zhang H., Zhu S., Hou Y., Sun Y., Dean M., Amit I., Wu K., Kuang D., Li G., Liu N. & Ma J. (2020),
Cell Research. 30, 11, p. 1024-1042
-
Intravital visualization of interactions of murine Peyer's patch-resident dendritic cells with M cells
-
Cellular Origins of the Lymphatic Endothelium: Implications for Cancer Lymphangiogenesis: Implications for Cancer Lymphangiogenesis
-
Fluorescent Silica Nanoparticles to Label Metastatic Tumor Cells in Mineralized Bone Microenvironments
Authors:
Chiou A. E., Hinckley J. A., Khaitan R., Varsano N., Wang J., Malarkey H. F., Hernandez C. J., Williams R. M., Estroff L. A., Weiner S., Addadi L., Wiesner U. B. & Fischbach C. (2020),
Small. 2001432
-
Bone marrow dendritic cells support the survival of chronic lymphocytic leukemia cells in a CD84 dependent manner
Authors:
Barak A. F., Lewinsky H., Perpinial M., Huber V., Radomir L., Kramer M. P., Sever L., Wolf Y., Shapiro M., Herishanu Y., Jung S., Becker-Herman S. & Shachar I. (2020),
Oncogene. 39, 9, p. 1997-2008
-
Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencing
Authors:
Abelson S., Zeng A. G., Nofech-Mozes I., Wang T. T., Ng S. W., Minden M. D., Pugh T. J., Awadalla P., Shlush L. I., Murphy T., Chan S. M., Dick J. E. & Bratman S. V. (2020),
Science advances. 6, 50, 3722
-
Donor cell leukemia: reappearance of gene mutations in donor cells - more than an incidental phenomenon?
Authors:
Shahar Gabay T., Chapal-Ilani N., Moskovitz Y., Biezuner T., Oron B., Brilon Y., Fridman-Dror A., Sabah R., Balicer R., Tanay A., Mendelson-Cohen N., Dann E. J., Fineman R., Kaushansky N., Yehudai-Reshef S., Zuckerman T. & Shlush L. I. (2020),
Haematologica. 105, 12, p. 2861-2863
-
Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response
Authors:
Vinik Y., Ortega F. G., Mills G. B., Lu Y., Jurkowicz M., Halperin S., Aharoni M., Gutman M. & Lev S. (2020),
Science advances. 6, 40, eaba5714
-
Theileria parasites subvert E2F signaling to stimulate leukocyte proliferation
Authors:
Tretina K., Haidar M., Madsen-Bouterse S. A., Sakura T., Mfarrej S., Fry L., Chaussepied M., Pain A., Knowles D. P., Nene V. M., Ginsberg D., Daubenberger C. A., Bishop R. P., Langsley G. & Silva J. C. (2020),
Scientific Reports. 10, 1, 3982
-
Hitting KRAS When It’s Down
-
Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
-
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression
Authors:
Parhi L., Alon-Maimon T., Sol A., Nejman D., Shhadeh A., Fainsod-Levi T., Yajuk O., Isaacson B., Abed J., Maalouf N., Nissan A., Sandbank J., Yehuda-Shnaidman E., Ponath F., Vogel J., Mandelboim O., Granot Z., Straussman R. & Bachrach G. (2020),
Nature Communications. 11, 1, 3259
-
The Role of HSF1 and the Chaperone Network in the Tumor Microenvironment
-
PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problem
Authors:
Sadeqi Azer E., Rashidi Mehrabadi F., Malikić S., Li X. C., Bartok O., Litchfield K., Levy R., Samuels Y., Schäffer A. A., Gertz E. M., Day C. P., Pérez-Guijarro E., Marie K., Lee M. P., Merlino G., Ergun F. & Sahinalp S. C. (2020),
Bioinformatics (Oxford, England). 36, suppl 1, p. i169-i176
-
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
Authors:
Hoshino A., Kim H. S., Bojmar L., Gyan K. E., Cioffi M., Hernandez J., Zambirinis C. P., Rodrigues G., Molina H., Heissel S., Mark M. T., Steiner L., Benito-Martin A., Lucotti S., Di Giannatale A., Offer K., Nakajima M., Williams C., Nogués L., Pelissier Vatter F. A., Hashimoto A., Davies A. E., Freitas D., Kenific C. M., Ararso Y., Buehring W., Lauritzen P., Ogitani Y., Sugiura K., Takahashi N., Alečković M., Bailey K. A., Jolissant J. S., Wang H., Harris A., Schaeffer L. M., García-Santos G., Posner Z., Balachandran V. P., Khakoo Y., Raju G. P., Scherz A., Sagi I., Scherz-Shouval R., Yarden Y., Oren M., Malladi M., Petriccione M., De Braganca K. C., Donzelli M., Fischer C., Vitolano S., Wright G. P., Ganshaw L., Marrano M., Ahmed A., DeStefano J., Danzer E., Roehrl M. H. A., Lacayo N. J., Vincent T. C., Weiser M. R., Brady M. S., Meyers P. A., Wexler L. H., Ambati S. R., Chou A. J., Slotkin E. K., Modak S., Roberts S. S., Basu E. M., Diolaiti D., Krantz B. A., Cardoso F., Simpson A. L., Berger M., Rudin C. M., Simeone D. M., Jain M., Ghajar C. M., Batra S. K., Stanger B. Z., Bui J., Brown K. A., Rajasekhar V. K., Healey J. H., de Sousa M., Kramer K., Sheth S., Baisch J., Pascual V., Heaton T. E., La Quaglia M. P., Pisapia D. J., Schwartz R., Zhang H., Liu Y., Shukla A., Blavier L., DeClerck Y. A., LaBarge M., Bissell M. J., Caffrey T. C., Grandgenett P. M., Hollingsworth M. A., Bromberg J., Costa-Silva B., Peinado H., Kang Y., Garcia B. A., O'Reilly E. M., Kelsen D., Trippett T. M., Jones D. R., Matei I. R., Jarnagin W. R. & Lyden D. (2020),
Cell. 182, 4, p. 1044-1061.e18
-
Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4(+) and PDPN+ CAFs to clinical outcome
Authors:
Friedman G., Levi-Galibov O., David E., Bornstein C., Giladi A., Dadiani M., Mayo A., Halperin C., Pevsner-Fischer M., Lavon H., Mayer S., Nevo R., Stein Y., Balint-Lahat N., Barshack I., Ali H. R., Caldas C., Nili-Gal-Yam E., Alon U., Amit I. & Scherz-Shouval R. (2020),
Nature Cancer. 1, p. 692-708
-
Tackling the Many Facets of Glioblastoma Heterogeneity
-
Nuclear P38: Roles in Physiological and Pathological Processes and Regulation of Nuclear Translocation
-
Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors
Authors:
Keshet R., Lee J. S., Adler L., Iraqi M., Ariav Y., Lim L. Q. J., Lerner S., Rabinovich S., Oren R., Katzir R., Tishler H. W., Stettner N., Goldman O., Landesman H., Galai S., Kuperman Y., Kuznetsov Y., Brandis A., Mehlman T., Malitsky S., Itkin M., Koehler S. E., Zhao Y., Talsania K., Shen T., Peled N., Ulitsky I., Porgador A., Ruppin E. & Erez A. (2020),
Nature Cancer. 1, 9, p. 894-908
-
Recent insights into the role of L1CAM in cancer initiation and progression
-
Super-resolution Ultrasound Imaging
Authors:
Christensen-Jeffries K., Couture O., Dayton P. A., Eldar Y. C., Hynynen K., Kiessling F., O'Reilly M., Pinton I. G. F., Schmitz G., Tang M., Tanter M. & Van Sloun R. J. G. (2020),
Ultrasound in Medicine and Biology. 46, 4, p. 865-891
-
Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging
Authors:
Hiltbrunner S., Mints M., Eldh M., Rosenblatt R., Holmström B., Alamdari F., Johansson M., Veerman R. E., Winqvist O., Sherif A. & Gabrielsson S. (2020),
Scientific Reports. 10, 1, p. 5960-5960, 5960
-
Leptin modulates gene expression in the heart and cardiomyocytes towards mitigating ischemia-induced damage
Authors:
Abd Alkhaleq H., Kornowski R., Waldman M., Levy E., Zemel R., Nudelman V., Shainberg A., Miskin R. & Hochhauser E. (2020),
Experimental Cell Research. 397, 2, 112373
-
Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer
Authors:
Levi-Galibov O., Lavon H., Wassermann-Dozorets R., Pevsner-Fischer M., Mayer S., Wershof E., Stein Y., Brown L. E., Zhang W., Friedman G., Nevo R., Golani O., Katz L. H., Yaeger R., Laish I., Porco J. A., Sahai E., Shouval D. S., Kelsen D. & Scherz-Shouval R. (2020),
Nature Communications. 11, 6245
-
miR-17-92 and miR-106b-25 clusters regulate beta cell mitotic checkpoint and insulin secretion in mice
Authors:
Mandelbaum A. D., Kredo-Russo S., Aronowitz D., Myers N., Yanowski E., Klochendler A., Swisa A., Dor Y. & Hornstein E. (2019),
Diabetologia. 62, 9, p. 1653-1666
-
Cooperativity between stromal cytokines drives the invasive migration of human breast cancer cells
-
Author Correction: Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells (Scientific Reports, (2017), 7, 1, (16345), 10.1038/s41598-017-16558-0)
Authors:
Arafeh R., Flores K., Keren-Paz A., Maik-Rachline G., Gutkind N., Rosenberg S., Seger R. & Samuels Y. (2019),
-
Prediction of PD-L1 inhibition effects for HIV-infected individuals
-
A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival
Authors:
Sharbi-Yunger A., Grees M., Cafri G., Bassan D., Eichmuller S. B., Tzehoval E., Utikal J., Umansky V. & Eisenbach L. (2019),
International Journal of Cancer. 144, 4, p. 909-921
-
Tumor diversity and the trade-off between universal cancer tasks
-
Imaging of Red-Shifted Light From Bioluminescent Tumors Using Fluorescence by Unbound Excitation From Luminescence
Authors:
Sonego F., Bouccara S., Pons T., Lequeux N., Danckaert A., Tinevez J., Alam I. S., Shorte S. L. & Tournebize R. (2019),
Frontiers in Bioengineering and Biotechnology. 7, APR, p. 73, 73
-
Adipocytes sensitize melanoma cells to environmental TGF-beta cues by repressing the expression of miR-211
Authors:
Golan T., Parikh R., Jacob E., Vaknine H., Zemser-Werner V., Hershkovitz D., Malcov H., Leibou S., Reichman H., Sheinboim D., Percik R., Amar S., Brenner R., Greenberger S., Kung A., Khaled M. & Levy C. (2019),
Science Signaling. 12, 591, 6847
-
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies
Authors:
Maron R., Schechter B., Nataraj N. B., Ghosh S., Romaniello D., Marrocco I., Noronha A., Carvalho S., Yarden Y. & Sela M. (2019),
Biochemical and Biophysical Research Communications. 513, 1, p. 219-225
-
Cancer exome-based identification of tumor neo-antigens using mass spectrometry
-
Immunohistochemical quantification of partial-EMT in oral cavity squamous cell carcinoma primary tumors is associated with nodal metastasis
Authors:
Parikh A. S., Puram S. V., Faquin W. C., Richmon J. D., Emerick K. S., Deschler D. G., Varvares M. A., Tirosh I., Bernstein B. E. & Lin D. T. (2019),
Oral Oncology. 99, 104458
-
SLAMF9 regulates pDC homeostasis and function in health and disease
Authors:
Sever L., Radomir L., Strim K., Weiner A., Shchottlender N., Lewinsky H., Barak A. F., Friedlander G., Ben-Dor S., Becker-Herman S. & Shachar I. (2019),
Proceedings of the National Academy of Sciences of the United States of America. 116, 33, p. 16489-16496
-
Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2
-
Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities
Authors:
Sana G., Madigan J. P., Gartner J. J., Fourrez M., Lin J., Qutob N., Narayan J., Shukla S., Ambudkar S. V., Xia D., Rosenberg S. A., Gottesman M. M., Samuels Y. & Gillet J. (2019),
Journal of Investigative Dermatology. 139, 9, p. 1985-1992
-
SLAMF receptors on normal and malignant B cells
-
The cancer microbiome
-
Single-Cell RNA Sequencing in Cancer: Lessons Learned and Emerging Challenges
-
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer
Authors:
Kubli S. P., Bassi C., Roux C., Wakeham A., Gobl C., Zhou W., Jafari S. M., Snow B., Jones L., Palomero L., Thu K. L., Cassetta L., Soong D., Berger T., Ramachandran P., Baniasadi S. P., Duncan G., Lindzen M., Yarden Y., Herranz C., Lazaro C., Chu M. F., Haight J., Tinto P., Silvester J., Cescon D. W., Petit A., Pettersson S., Pollard J. W., Mak T. W., Pujana M. A., Cappello P. & Gorrini C. (2019),
Proceedings of the National Academy of Sciences. 116, 9, p. 3604-3613
-
Deciphering Human Tumor Biology by Single-Cell Expression Profiling
-
PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model
Authors:
Rosenzweig N., Dvir-Szternfeld R., Tsitsou-Kampeli A., Keren-Shaul H., Ben-Yehuda H., Weill-Raynal P., Cahalon L., Kertser A., Baruch K., Amit I., Weiner A. & Schwartz M. (2019),
Nature Communications. 10, 465
-
The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of Phospholipids
Authors:
Seneviratne A. K., Xu M., Henao J. J. A., Fajardo V. A., Hao Z., Voisin V., Xu G. W., Hurren R., Kim S., MacLean N., Wang X., Gronda M., Jeyaraju D., Jitkova Y., Ketela T., Mullokandov M., Sharon D., Thomas G., Chouinard-Watkins R., Hawley J. R., Schafer C., Yau H. L., Khuchua Z., Arnan A., Al-awar R., Gross A., Claypoo S. M., Bazinet R., Lupien M., Chan S., De Carvalho D. D., Minden M. D., Bader G. D., Stark K. D., LeBlanc P. & Schimmer A. D. (2019),
Cell Stem Cell. 24, 4, p. 621-636
-
Arginine refolds, stabilizes, and restores function of mutant pVHL proteins in animal model of the VHL cancer syndrome
-
KLF4 sensitizes the colon cancer cell HCT-15 to cisplatin by altering the expression of HMGB1 and hTERT
-
Kinetic modeling of DUSP regulation in herceptin-resistant HER2-positive breast cancer
-
In vivo effects of temperature on the heart and pyloric rhythms in the crab Cancer borealis
-
RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction
Authors:
Ptasinska A., Pickin A., Assi S. A., Chin P. S., Ames L., Avellino R., Groeschel S., Delwel R., Cockerill P. N., Osborne C. S. & Bonifer C. (2019),
Cell Reports. 28, 12, p. 3022-3031.e7
-
Liver and Steroid Hormones - Can a Touch of p53 Make a Difference?
-
Genome-wide miRNA methylome analysis in oral cancer: possible biomarkers associated with patient survival
Authors:
Roy R., Chatterjee A., Das D., Ray A., Singh R., Chattopadhyay E., De Sarkar N., Eccles M., Pal M., Maitra A. & Roy B. (2019),
Epigenomics. 11, 5, p. 473-487
-
Transient p53-Mediated Regenerative Senescence in the Injured Heart
Authors:
Sarig R., Rimmer R., Bassat E., Zhang L., Umansky K. B., Lendengolts D., Perlmoter G., Yaniv K. & Tzahor E. (2019),
-
Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018): RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (Scientific Reports, (2018), 8, 1, (653), 10.1038/s41598-017-18851-4)
Authors:
Qutob N., Masuho I., Alon M., Emmanuel R., Cohen I., Di Pizio A., Madore J., Elkahloun A., Ziv T., Levy R., Gartner J. J., Hill V. K., Lin J. C., Hevroni Y., Greenberg P., Brodezki A., Rosenberg S. A., Kosloff M., Hayward N. K., Admon A., Niv M. Y., Scolyer R. A., Martemyanov K. A. & Samuels Y. (2019),
-
Hepatitis C virus core protein interacts with cellular metastasis suppressor Nm23-H1 and promotes cell migration and invasion
-
Corrigendum to 'p53 balances between tissue hierarchy and anarchy'
Authors:
Koifman G., Aloni-Grinstein R. & Rotter V. (2019),
-
Modelling the role of dual specificity phosphatases in herceptin resistant breast cancer cell lines
-
Increased expression of cathepsin D is required for L1-mediated colon cancer progression
-
The role of the microbiome in NAFLD and NASH
-
N-Acetyl-L-Cysteine Supplement in Early Life or Adulthood Reduces Progression of Diabetes in Nonobese Diabetic Mice
-
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma
Authors:
Li H., van der Leun A. M., Yofe I., Lubling Y., Gelbard-Solodkin D., van Akkooi A. C. J., van den Braber M., Rozeman E. A., Haanen J. B. A. G., Blank C. U., Horlings H. M., David E., Baran Y., Bercovich A., Lifshitz A., Schumacher T. N., Tanay A. & Amit I. (2019),
Cell. 176, 4, p. 775-789.e18
-
Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types
Authors:
Ben-Hamo R., Zilberberg A., Cohen H., Bahar-Shany K., Wachtel C., Korach J., Aviel-Ronen S., Barshack I., Barash D., Levanon K. & Efroni S. (2019),
npj Precision Oncology. 3, p. 12, 12
-
Myosin IIA and formin dependent mechanosensitivity of filopodia adhesion
Authors:
Alieva N. O., Efremov A. K., Hu S., Oh D., Chen Z., Natarajan M., Ong H. T., Jegou A., Romet-Lemonne G., Groves J. T., Sheetz M. P., Yan J. & Bershadsky A. D. (2019),
Nature Communications. 10, 3593
-
Molecular pathways of senescence regulate placental structure and function
Authors:
Gal H., Lysenko M., Stroganov S., Vadai E., Youssef S. A., Tzadikevitch-Geffen K., Rotkopf R., Biron-Shental T., de Bruin A., Neeman M. & Krizhanovsky V. (2019),
EMBO Journal. 38, 18, 100849
-
Simultaneous Integration of Multi-omics Data Improves the Identification of Cancer Driver Modules
-
Reduced CTL motility and activity in avascular tumor areas
Authors:
Manaster Y., Shipony Z., Hutzler A., Kolesnikov M., Avivi C., Shalmon B., Barshack I., Besser M. J., Feferman T. & Shakhar G. (2019),
Cancer Immunology Immunotherapy. 68, 8, p. 1287-1301
-
The transcriptional profile of circulating myeloid derived suppressor cells correlates with tumor development and progression in mouse
Authors:
Nachmany I., Bogoch Y., Friedlander-Malik G., Amar O., Bondar E., Zohar N., Hantisteanu S., Fainaru O., Lubezky N., Klausner J. M. & Pencovich N. (2019),
Genes and Immunity. 20, 7, p. 589-598
-
IKK epsilon regulates the breast cancer stem cell phenotype
-
c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression
Authors:
Sim W. J., Iyengar P. V., Lama D., Lui S. K. L., Ng H. C., Haviv-Shapira L., Domany E., Kappei D., Tan T. Z., Saie A., Jaynes P. W., Verma C. S., Kumar A. P., Rouanne M., Ha H. K., Radulescu C., ten Dijke P., Eichhorn P. J. A. & Thiery J. P. (2019),
Nature Communications. 10, 4349
-
The landscape of tiered regulation of breast cancer cell metabolism
Authors:
Katzir R., Polat I. H., Harel M., Katz S., Foguet C., Selivanov V. A., Sabatier P., Cascante M., Geiger T. & Ruppin E. (2019),
Scientific Reports. 9, 1, 17760
-
The ADAM17 Protease Promotes Tobacco Smoke Carcinogen-induced Lung Tumourigenesis
-
The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis
Authors:
Croci S., Bonacini M., Muratore F., Caruso A., Fontana A., Boiardi L., Soriano A., Cavazza A., Cimino L., Belloni L., Perry O., Fridkin M., Parmeggiani M., Blank M., Shoenfeld Y. & Salvarani C. (2019),
Journal of Autoimmunity. 98, p. 113-121
-
Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissues
Authors:
Persi E., Prandi D., Wolf Y. I., Pozniak Y., Barnabas G. D., Levanon K., Barshack I., Barbieri C., Gasperini P., Beltran H., Faltas B. M., Rubin M. A., Geiger T., Koonin E. V., Demichelis F. & Horn D. (2019),
Proceedings of the National Academy of Sciences - PNAS. 116, 34, p. 16987-16996
-
Proteomic analysis reveals greater abundance of complement and inflammatory proteins in subcutaneous adipose tissue from postpartum cows treated with sodium salicylate
Authors:
Takiya C. S., Montgomery S. R., Mamedova L. K., Kra G., Nemes-Navon N., Levin Y., Fleming S. D., Bradford B. J. & Zachut M. (2019),
Journal of Proteomics. 204, 103399
-
A cancer associated somatic mutation in LC3B attenuates its binding to E1-like ATG7 protein and subsequent lipidation
Authors:
Nuta G. C., Gilad Y., Gershoni M., Sznajderman A., Schlesinger T., Bialik S., Eisenstein M., Pietrokovski S. & Kimchi A. (2019),
Autophagy. 15, 3, p. 438-452
-
Accelerated Hypofractionated Radiation Therapy for Elderly Frail Bladder Cancer Patients Unfit for Surgery or Chemotherapy
Authors:
Hammer L., Laufer M., Dotan Z., Leibowitz-Amit R., Berger R., Felder S., Weiss I., Lawrence Y. R. & Symon Z. (2019),
American Journal Of Clinical Oncology-Cancer Clinical Trials. 42, 2, p. 179-183
-
Cross-Talk between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells
-
Daily light and darkness onset and circadian rhythms metabolically synchronize hematopoietic stem cell differentiation and maintenance: The role of bone marrow norepinephrine, tumor necrosis factor, and melatonin cycles
-
The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment
-
Optimizing T-cell receptor avidity with somatic hypermutation
-
Cancer immunotherapy: The dawn of antibody cocktails
-
Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis
-
Melanoma-derived extracellular vesicles instigate proinflammatory signaling in the metastatic microenvironment
Authors:
Lahav T. G., Adler O., Zait Y., Shani O., Amer M., Doron H., Abramovitz L., Yofe I., Cohen N. & Erez N. (2019),
International Journal of Cancer. 145, 9, p. 2521-2534
-
Nonmuscle myosin IIA and IIB differentially modulate migration and alter gene expression in primary mouse tumorigenic cells
Authors:
Halder D., Saha S., Singh R. K., Ghosh I., Mallick D., Dey S. K., Ghosh A., Das B. B., Ghosh S. & Jana S. S. (2019),
Molecular Biology of the Cell. 30, 12, p. 1463-1476
-
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators
Authors:
Conniot J., Scomparin A., Peres C., Yeini E., Pozzi S., Matos A., Kleiner R., Moura L. I. F., Zupancic E., Viana A. S., Doron H., Gois P. M. P., Erez N., Jung S., Satchi-Fainaro R. & Florindo H. F. (2019),
Nature Nanotechnology. 14, 9, p. 891-901
-
p53: not just a tumor suppressor
-
Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
-
ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer
Authors:
Saad M. I., Alhayyani S., McLeod L., Yu L., Alanazi M., Deswaerte V., Tang K., Jarde T., Smith J. A., Prodanovic Z., Tate M. D., Balic J. J., Watkins D. N., Cain J. E., Bozinovski S., Algar E., Kohmoto T., Ebi H., Ferlin W., Garbers C., Ruwanpura S., Sagi I., Rose-John S. & Jenkins B. J. (2019),
EMBO Molecular Medicine. 11, 4, 9976
-
RASA2 and NF1; two-negative regulators of Ras with complementary functions in melanoma
Authors:
Arafeh R., Di Pizio A., Elkahloun A. G., Dym O., Niv M. Y. & Samuels Y. (2019),
-
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors
Authors:
Jachimowicz R. D., Beleggia F., Isensee J., Velpula B. B., Goergens J., Bustos M. A., Doll M. A., Shenoy A., Checa-Rodriguez C., Wiederstein J. L., Baranes-Bachar K., Bartenhagen C., Hertwig F., Teper N., Nishi T., Schmitt A., Distelmaier F., Lüdecke H., Albrecht B., Krüger M., Schumacher B., Geiger T., Hoon D. S., Huertas P., Fischer M., Hucho T., Peifer M., Ziv Y., Reinhardt H. C., Wieczorek D. & Shiloh Y. (2019),
Cell. 176, 3, p. 505-519.e22
-
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer
Authors:
Shee K., Jiang A., Varn F. S., Liu S., Traphagen N. A., Owens P., Ma C. X., Hoog J., Cheng C., Golub T. R., Straussman R. & Miller T. W. (2019),
FASEB Journal. 33, 2, p. 1644-1657
-
Histamine releasing factor and elongation factor 1 alpha secreted via malaria parasites extracellular vesicles promote immune evasion by inhibiting specific T cell responses
Authors:
Demarta-Gatsi C., Rivkin A., Di Bartolo V., Peronet R., Ding S., Commere P., Guillonneau F., Bellalou J., Brule S., Abou Karam P., Cohen S. R., Lagache T., Janse C. J., Regev-Rudzki N. & Mecheri S. (2019),
Cellular Microbiology. 21, 7, e13021
-
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Authors:
Neftel C., Laffy J., Filbin M. G., Hara T., Shore M. E., Rahme G. J., Richman A. R., Silverbush D., Shaw M. L., Hebert C. M., Dewitt J., Gritsch S., Perez E. M., Castro L. N. G., Lan X., Druck N., Rodman C., Dionne D., Kaplan A., Bertalan M. S., Small J., Pelton K., Becker S., Bonal D., Quang-De Nguyen, Servis R. L., Fung J. M., Mylvaganam R., Mayr L., Gojo J., Haberler C., Geyeregger R., Czech T., Slavc I., Nahed B., Curry W. T., Carter B. S., Wakimoto H., Brastianos P. K., Batchelor T. T., Stemmer-Rachamimov A., Martinez-Lage M., Frosch M. P., Stamenkovic I., Riggi N., Rheinbay E., Monje M., Rozenblatt-Rosen O., Cahill D. P., Patel A. P., Hunter T., Verma I. M., Ligon K. L., Louis D. N., Regev A., Bernstein B. E., Tirosh I. & Suva M. L. (2019),
Cell. 178, 4, p. 835-849.e21
-
ISG15 induction is required during L1-mediated colon cancer progression and metastasis
-
Single-cell sequencing and its applications in head and neck cancer
-
Microvesicle proteomic profiling of uterine liquid biopsy for ovarian cancer early detection
Authors:
Barnabas G. D., Bahar-Shany K., Sapoznik S., Helpman L., Kadan Y., Beiner M., Weitzner O., Arbib N., Korach J., Perri T., Katz G., Blecher A., Brandt B., Friedman E., Stockheim D., Jakobson-Setton A., Eitan R., Armon S., Brand H., Zadok O., Aviel-Ronen S., Harel M., Geiger T. & Levanon K. (2019),
Molecular and Cellular Proteomics. 18, 5, p. 865-875
-
Evolutionary trajectory of leukemic clones and its clinical implications
-
Nuclear ERK: Mechanism of Translocation, Substrates, and Role in Cancer
-
Magnesium transporter 1 (MAGT1) deficiency causes selective defects in N-linked glycosylation and expression of immune-response genes
Authors:
Matsuda-Lennikov M., Biancalana M., Zou J., Ravell J. C., Zheng L., Kanellopoulou C., Jiang P., Notarangelo G., Jing H., Masutani E., Oler A. J., Olano L. R., Schulz B. L. & Lenardo M. J. (2019),
Journal of Biological Chemistry. 294, 37, p. 13638-13656
-
Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer A Review
-
Specific inhibition of splicing factor activity by decoy RNA oligonucleotides
Authors:
Denichenko P., Mogilevsky M., Clery A., Welte T., Biran J., Shimshon O., Barnabas G. D., Danan-Gotthold M., Kumar S., Yavin E., Levanon E. Y., Allain F. H., Geiger T., Levkowitz G. & Karni R. (2019),
Nature Communications. 10, 1590
-
Effectiveness of the combination of vascular targeted photodynamic therapy and anti-cytotoxic T-lymphocyte-associated antigen 4 in a preclinical mouse model of urothelial carcinoma
Authors:
Corradi R. B., LaRosa S., Jebiwott S., Murray K. S., Rosenzweig B., Somma A. J., Gomez R. S., Scherz A., Kim K. & Coleman J. A. (2019),
International Journal of Urology. 26, 3, p. 414-422
-
New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?
-
Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients
Authors:
Gofrit O. N., Klein B. Y., Cohen I. R., Ben-Hur T., Greenblatt C. L. & Bercovier H. (2019),
PLoS ONE. 14, 11, 0224433
-
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
Authors:
Wolf Y., Bartok O., Patkar S., Eli G. B., Cohen S., Litchfield K., Levy R., Jiménez-Sánchez A., Trabish S., Lee J. S., Karathia H., Barnea E., Day C., Cinnamon E., Stein I., Solomon A., Bitton L., Pérez-Guijarro E., Dubovik T., Shen-Orr S. S., Miller M. L., Merlino G., Levin Y., Pikarsky E., Eisenbach L., Admon A., Swanton C., Ruppin E. & Samuels Y. (2019),
Cell. 179, 1, p. 219-235
-
PIK3CA in cancer: The past 30 years
-
Scaling laws indicate distinct nucleation mechanisms of holes in the nuclear lamina
-
Transmissible inflammation-induced colorectal cancer in inflammasome-deficient mice
-
Exosomes as a storehouse of tissue remodeling proteases and mediators of cancer progression
-
Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c(+) CD1lb(+) Grl(+) myeloid-derived dendritic cells
-
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy
Authors:
Owyong M., Chou J., van den Bijgaart R. J., Kong N., Efe G., Maynard C., Talmi-Frank D., Solomonov I., Koopman C., Hadler-Olsen E., Headley M., Lin C., Wang C., Sagi I., Werb Z. & Plaks V. (2019),
Life Science Alliance. 2, 6, e201800226
-
Cancer-Associated Eukaryotic Translation Initiation Factor 1A Mutants Impair Rps3 and Rps10 Binding and Enhance Scanning of Cell Cycle Genes
-
STAT3 Post-Translational Modifications Drive Cellular Signaling Pathways in Prostate Cancer Cells
Authors:
Cocchiola R., Rubini E., Altieri F., Chichiarelli S., Paglia G., Romaniello D., Carissimi S., Giorgi A., Giamogante F., Macone A., Perugia G., Gurtner A. & Eufemi M. (2019),
International Journal of Molecular Sciences. 20, 8, 1815
-
MicroRNAs Affect Complement Regulator Expression and Mitochondrial Activity to Modulate Cell Resistance to Complement-Dependent Cytotoxicity
-
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Authors:
Keskin D. B., Anandappa A. J., Sun J., Tirosh I., Mathewson N. D., Li S., Oliveira G., Giobbie-Hurder A., Felt K., Gjini E., Shukla S. A., Hu Z., Li L., Le P. M., Allesoe R. L., Richman A. R., Kowalczyk M. S., Abdelrahman S., Geduldig J. E., Charbonneau S., Pelton K., Iorgulescu J. B., Elagina L., Zhang W., Olive O., McCluskey C., Olsen L. R., Stevens J., Lane W. J., Salazar A. M., Daley H., Wen P. Y., Chiocca E. A., Harden M., Lennon N. J., Gabriel S., Getz G., Lander E. S., Regev A., Ritz J., Neuberg D., Rodig S. J., Ligon K. L., Suva M. L., Wucherpfennig K. W., Hacohen N., Fritsch E. F., Livak K. J., Ott P. A., Wu C. J. & Reardon D. A. (2019),
Nature. 565, 7738, p. 234-239
-
The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer
Authors:
De Mattos-Arruda L., Sammut S., Ross E. M., Bashford-Rogers R., Greenstein E., Markus H., Morganella S., Teng Y., Maruvka Y., Pereira B., Rueda O. M., Chin S., Contente-Cuomo T., Mayor R., Arias A., Ali H. R., Cope W., Tiezzi D., Dariush A., Amarante T. D., Reshef D., Ciriaco N., Martinez-Saez E., Peg V., Ramon y Cajal S., Cortes J., Vassiliou G., Getz G., Nik-Zainal S., Murtaza M., Friedman N., Markowetz F., Seoane J. & Caldas C. (2019),
Cell Reports. 27, 9, p. 2690-2708
-
Potential immunotherapy for Alzheimer disease and age-related dementia
-
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Authors:
Riquelme E., Zhang Y., Zhang L., Montiel M., Zoltan M., Dong W., Quesada P., Sahin I., Chandra V., San Lucas A., Scheet P., Xu H., Hanash S. M., Feng L., Burks J. K., Do K., Peterson C. B., Nejman D., Tzeng C. D., Kim M. P., Sears C. L., Ajami N., Petrosino J., Wood L. D., Maitra A., Straussman R., Katz M., White J. R., Jenq R., Wargo J. & McAllister F. (2019),
Cell. 178, 4, p. 795-806, e1-e12
-
The HERV-K accessory protein Np9 controls viability and migration of teratocarcinoma cells
Authors:
Chan S. M., Sapir T., Park S., Rual J., Contreras-Galindo R., Reiner O. & Markovitz D. M. (2019),
PLoS ONE. 14, 2, 0212970
-
Fast dose fractionation using ultra-short laser accelerated proton pulses can increase cancer cell mortality, which relies on functional PARP1 protein
Authors:
Bayart E., Flacco A., Delmas O., Pommarel L., Levy D., Cayallone M., Megnin-Chanet F., Deutsch E. & Malka V. A. (2019),
Scientific Reports. 9, 1, 10132
-
Biological implications of clonal hematopoiesis
-
Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer
Authors:
Lebdai S., Gigoux M., Alvim R., Somma A., Nagar K., Azzouzi A. R., Cussenot O., Merghoub T., Wolchok J. D., Scherz A., Kim K. & Coleman J. (2019),
OncoImmunology. 8, 6, e1581528
-
Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer
Authors:
Hooda J., Novak M., Salomon M. P., Matsuba C., Ramos R. I., MacDuffie E., Song M., Hirsch M. S., Lester J., Parkash V., Karlan B. Y., Oren M., Hoon D. S. & Drapkin R. (2019),
Cancer Research. 79, 4, p. 760-772
-
Mutant p53-a potential player in shaping the tumor-stroma crosstalk
-
Self-assembled micellar clusters based on Triton-X-family surfactants for enhanced solubilization, encapsulation, proteins permeability control, and anticancer drug delivery
Authors:
Solomonov A. V., Marfin Y. S., Rumyantsev E. V., Ragozin E., Zahavi T. S., Gellerman G., Tesler A. B., Muench F., Kumagai A. & Miyawaki A. (2019),
Materials Science & Engineering: C-Materials For Biological Applications. 99, p. 794-804
-
RUNX represses Pmp22 to drive neurofibromagenesis
Authors:
Hall A., Choi K., Liu W., Rose J., Zhao C., Yu Y., Na Y., Cai Y., Coover R. A., Lin Y., Dombi E., Kim M., Levanon D., Groner Y., Boscolo E., Pan D., Liu P. P., Lu Q. R., Ratner N., Huang G. & Wu J. (2019),
Science Advances. 5, 4, 8389
-
p53 balances between tissue hierarchy and anarchy
-
Facing the future: challenges and opportunities in adoptive T cell therapy in cancer
Authors:
Magalhaes I., Carvalho-Queiroz C., Hartana C. A., Kaiser A., Lukic A., Mints M., Nilsson O., Grönlund H., Mattsson J. & Berglund S. (2019),
Expert Opinion on Biological Therapy. 19, 8, p. 811-827
-
Oxidative stress and therapeutic development in lung cancer
-
The integrated stress response promotes B7H6 expression
Authors:
Obiedat A., Charpak-Amikam Y., Tai-Schmiedel J., Seidel E., Mahameed M., Avril T., Stern-Ginossar N., Springuel L., Bolsee J., Gilham D. E., Dipta P., Shmuel M., Chevet E., Mandelboim O. & Tirosh B. (2019),
Journal of Molecular Medicine. 98, 1, p. 135-148
-
Veto cells for safer nonmyeloablative haploidentical HSCT and CAR T cell therapy
-
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
Authors:
Harel M., Ortenberg R., Varanasi S. K., Mangalhara K. C., Mardamshina M., Markovits E., Baruch E. N., Tripple V., Arama-Chayoth M., Greenberg E., Shenoy A., Ayasun R., Knafo N., Xu S., Anafi L., Yanovich-Arad G., Barnabas G. D., Ashkenazi S., Besser M. J., Schachter J., Bosenberg M., Shadel G. S., Barshack I., Kaech S. M., Markel G. & Geiger T. (2019),
Cell. 179, 1, p. 236-250.e18
-
Characterization of inv(3) cell line OCI-AML-20 with stroma-dependent CD34 expression
Authors:
Luciani G. M., Xie L., Dilworth D., Tierens A., Moskovitz Y., Murison A., Szewczyk M. M., Mitchell A., Lupien M., Shlush L., Dick J. E., Arrowsmith C. H., Barsyte-Lovejoy D. & Minden M. D. (2019),
Experimental Hematology. 69, p. 27-36
-
Can immunization with Bacillus Calmette-Guerin (BCG) protect against Alzheimer's disease?
-
Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas
Authors:
Dietz S., Lifshitz A., Kazdal D., Harms A., Endris V., Winter H., Stenzinger A., Warth A., Sill M., Tanay A. & Sueltmann H. (2019),
International Journal of Cancer. 144, 5, p. 1061-1072
-
Hydrophobic Organic Components of Ambient Fine Particulate Matter (PM 2.5) Associated with Inflammatory Cellular Response.
Authors:
Jiang X., Xu F., Qiu X., Shi X., Pardo M., Shang Y., Wang J., Rudich Y. & Zhu T. (2019),
Environmental Science & Technology. 53, 17, p. 10479-10486
-
Acid-Induced Downregulation of ASS1 Contributes to the Maintenance of Intracellular pH in Cancer
Authors:
Silberman A., Goldman O., Assayag O. B., Jacob A., Rabinovich S., Adler L., Lee J. S., Keshet R., Sarver A., Frug J., Stettner N., Galai S., Persi E., Halpern K. B., Zaltsman-Amir Y., Pode-Shakked B., Eilam R., Anikster Y., Nagamani S. C. S., Ulitsky I., Ruppin E. & Erez A. (2019),
Cancer Research. 79, 3, p. 518-533
-
Prediction of ultra-high-order antibiotic combinations based on pairwise interactions
-
Data on peptidyl platform-based anticancer drug synthesis and triton-x-based micellar clusters (MCs) self-assembly peculiarities for enhanced solubilization, encapsulation of hydrophobic compounds and their interaction with HeLa cells
Authors:
Solomonov A. V., Marfin Y. S., Rumyantsev E. V., Ragozin E., Zahavi T. S., Gellerman G., Tesler A. B., Muench F., Kumagai A. & Miyawaki A. (2019),
Data in Brief. 25, 104052
-
Phenotypic Screen Identifies JAK2 as a Major Regulator of FAT10 Expression
-
Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy
Authors:
Lonetto G., Koifman G., Silberman A., Attery A., Solomon H., Levin-Zaidman S., Goldfinger N., Porat Z., Erez A. & Rotter V. (2019),
Cell Death and Differentiation. 26, 9, p. 1566-1581
-
p53 and the Viral Connection: Back into the Future
Authors:
Aloni-Grinstein R., Charni-Natan M., Solomon H. & Rotter V. (2018),
Cancers. 10, 6, 178
-
Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma
Authors:
Ledergor G., Weiner A., Zada M., Wang S., Cohen Y. C., Gatt M. E., Snir N., Magen H., Koren-Michowitz M., Herzog-Tzarfati K., Keren-Shaul H., Bornstein C., Rotkopf R., Yofe I., David E., Yellapantula V., Kay S., Salai M., Ben Yehuda D., Nagler A., Shvidel L., Orr-Urtreger A., Halpern K. B., Itzkovitz S., Landgren O., San-Miguel J., Paiva B., Keats J. J., Papaemmanuil E., Avivi I., Barbash G. I., Tanay A. & Amit I. (2018),
Nature Medicine. 24, 12, p. 1867-1876
-
P53 shades of Hippo
-
The nuclear translocation of the kinases p38 and JNK promotes inflammation-induced cancer
-
Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results
-
Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers
Authors:
Solomon H., Dinowitz N., Pateras I. S., Cooks T., Shetzer Y., Molchadsky A., Charni M., Rabani S., Koifman G., Tarcic O., Porat Z., Kogan-Sakin I., Goldfinger N., Oren M., Harris C. C., Gorgoulis V. G. & Rotter V. (2018),
Oncogene. 37, 12, p. 1669-1684
-
Does cancer strive to minimize the cost of gene expression?
-
Regulation of dual specificity phosphatases in breast cancer during initial treatment with Herceptin: a Boolean model analysis
-
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma
Authors:
Yu Y., Schleich K., Yue B., Ji S., Lohneis P., Kemper K., Silvis M. S., Qutob N., van Rooijen E., Werner-Klein M., Li L., Dhawan D., Meierjohann S., Reimann M., Elkahloun A., Treitschke S., Dörken B., Speck C., Mallette F. A., Zon L. I., Holmen S. L., Peeper D. S., Samuels Y., Schmitt C. A. & Lee S. (2018),
Cancer Cell. 33, 2, p. 322-336.e8
-
mRNA-seq whole transcriptome profiling of fresh frozen versus archived fixed tissues
Authors:
Ben-Moshe N. B., Gilad S., Perry G., Benjamin S., Balint-Lahat N., Pavlovsky A., Halperin S., Markus B., Yosepovich A., Barshack I., Gal-Yam E. N., Domany E., Kaufman B. & Dadiani M. (2018),
BMC Genomics. 19, 1, 419
-
Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy
Authors:
Bar-Shir A., Alon L., Korrer M. J., Lim H. S., Yadav N. N., Kato Y., Pathak A. P., Bulte J. W. M. & Gilad A. A. (2018),
Magnetic Resonance in Medicine. 79, 2, p. 1010-1019
-
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq
Authors:
Filbin M. G., Tirosh I., Hovestadt V., Shaw M. L., Escalante L. E., Mathewson N. D., Neftel C., Frank N., Pelton K., Hebert C., Haberler C., Yizhak K., Gojo J., Egervari K., Mount C., van Galen P., Bonal D. M., Quang-De Nguyen, Beck A., Sinai C., Czech T., Dorfer C., Goumnerova L., Lavarino C., Carcaboso A. M., Mora J., Mylvaganam R., Luo C. C., Peyrl A., Popovic M., Azizi A., Batchelor T. T., Frosch M. P., Martinez-Lage M., Kieran M. W., Bandopadhayay P., Beroukhim R., Fritsch G., Getz G., Rozenblatt-Rosen O., Wucherpfennig K. W., Louis D. N., Monje M., Slavc I., Ligon K. L., Golub T. R., Regev A., Bernstein B. E. & Suva M. L. (2018),
Science. 360, 6386, p. 331-335
-
The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies
-
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies
Authors:
Roncato F., Rruga F., Porcu E., Casarin E., Ronca R., Maccarinelli F., Realdon N., Basso G., Alon R., Viola G. & Morpurgo M. (2018),
Nature Communications. 9, 1, 4070
-
A combined computational-experimental approach to define the structural origin of antibody recognition of sialyl-Tn, a tumor-associated carbohydrate antigen
Authors:
Amon R., Grant O. C., Ben-Arye S. L., Makeneni S., Nivedha A. K., Marshanski T., Norn C., Yu H., Glushka J. N., Fleishman S. J., Chen X., Woods R. J. & Padler-Karavani V. (2018),
Scientific Reports. 8, 10786
-
Mutated MITF-E87R in Melanoma Enhances Tumor Progression via S100A4
Authors:
Nordlinger A., Dror S., Elkahloun A., Del Rio J., Stubbs E., Golan T., Malcov H., Pricket T. D., Cronin J. C., Parikh S., Labes S., Thomas L., Yankovitz G., Tabach Y., Levy C., Samuels Y. & Khaled M. (2018),
Journal of Investigative Dermatology. 138, 10, p. 2216-2223
-
Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer
-
A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment
Authors:
Griveau A., Seano G., Shelton S. J., Kupp R., Jahangiri A., Obernier K., Krishnan S., Lindberg O. R., Yuen T. J., Tien A., Sabo J. K., Wang N., Chen I., Kloepper J., Larrouquere L., Ghosh M., Tirosh I., Huillard E., Alvarez-Buylla A., Oldham M. C., Persson A. I., Weiss W. A., Batchelor T. T., Stemmer-Rachamimov A., Suva M. L., Phillips J. J., Aghi M. K., Mehta S., Jain R. K. & Rowitch D. H. (2018),
Cancer Cell. 33, 5, p. 874-889
-
Rapid labelling and covalent inhibition of intracellular native proteins using ligand-directed N-acyl-N-alkyl sulfonamide
-
Direct Real-Time Monitoring of Prodrug Activation by Chemiluminescence
-
Intratumoral bacteria may elicit chemoresistance by metabolizing anticancer agents
-
Induction of Nitric-Oxide Metabolism in Enterocytes Alleviates Colitis and Inflammation-Associated Colon Cancer
Authors:
Stettner N., Rosen C., Bernshtein B., Gur-Cohen S., Frug J., Silberman A., Sarver A., Carmel-Neiderman N. N., Eilam R., Biton I., Pevsner-Fischer M., Zmora N., Brandis A., Halpern K. B., Mazkereth R., di Bernardo D., Brunetti-Pierri N., Premkumar M. H., Dank G., Nagamani S. C. S., Jung S., Harmelin A. & Erez A. (2018),
Cell Reports. 23, 7, p. 1962-1976
-
Expansion and Antitumor Cytotoxicity of T-Cells Are Augmented by Substrate-Bound CCL21 and Intercellular Adhesion Molecule 1
-
Stepping out of the shadows: Oncogenic and tumor-promoting protein tyrosine phosphatases
-
International conference on Cell Death in Cancer and Toxicology 2018 (CDCT-2018)
-
Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification
-
Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer
Authors:
Shee K., Yang W., Hinds J. W., Hampsch R. A., Varn F. S., Traphagen N. A., Patel K., Cheng C., Jenkins N. P., Kettenbach A. N., Demidenko E., Owens P., Faber A. C., Golub T. R., Straussman R. & Miller T. W. (2018),
Journal of Experimental Medicine. 215, 3, p. 895-910
-
Quiescin sulfhydryl oxidase 1 (QSOX1) glycosite mutation perturbs secretion but not Golgi localization
-
Single-Cell Genomics: A Stepping Stone for Future Immunology Discoveries
-
The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic Implications
Authors:
Iglesias-Gato D., Thysell E., Tyanova S., Crnalic S., Santos A., Lima T. S., Geiger T., Cox J., Widmark A., Bergh A., Mann M., Flores-Morales A. & Wikström P. (2018),
Clinical Cancer Research. 24, 21, p. 5433-5444
-
Senescence and Telomere Homeostasis Might Be Involved in Placenta Percreta-Preliminary Investigation
-
NKp46 Receptor-Mediated Interferon-gamma Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis
Authors:
Glasner A., Levi A., Enk J., Isaacson B., Viukov S., Orlanski S., Scope A., Neuman T., Enk C. D., Hanna J. H., Sexl V., Jonjic S., Seliger B., Zitvogel L. & Mandelboim O. (2018),
Immunity. 48, 1, p. 107-+
-
Analysis of enzymatic activity of matrix metalloproteinase (MMP) by collagen zymography in Melanoma
-
Mining Plants for Bacterial Quorum Sensing Modulators
-
SUSHI: Sparsity-Based Ultrasound Super-Resolution Hemodynamic Imaging
-
Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness
-
Fresh water, marine and terrestrial cyanobacteria display distinct allergen characteristics
Authors:
Lang-Yona N., Kunert A. T., Vogel L., Kampf C. J., Bellinghausen I., Saloga J., Schink A., Ziegler K., Lucas K., Schuppan D., Poeschl U., Weber B. & Froelich-Nowoisky J. (2018),
Science of the Total Environment. 612, p. 767-774
-
The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patients
-
Ex-vivo organ culture as potential prioritization tool for breast cancer targeted therapy
Authors:
Grinshpun A., Gavert N., Granit R. Z., Masuri H., Ben-Porath I., Breuer S., Zick A., Rosenberg S., Maoz M., Granit A., Pikarsky E., Straussman R., Peretz T. & Sonnenblick A. (2018),
Cancer Biology and Therapy. 19, 8, p. 645-648
-
Harnessing synthetic lethality to predict the response to cancer treatment
Authors:
Lee J. S., Das A., Jerby-Arnon L., Arafeh R., Auslander N., Davidson M., McGarry L., James D., Amzallag A., Park S. G., Cheng K., Robinson W., Atias D., Stossel C., Buzhor E., Stein G., Waterfall J. J., Meltzer P. S., Golan T., Hannenhalli S., Gottlieb E., Benes C. H., Samuels Y., Shanks E. & Ruppin E. (2018),
Nature Communications. 9, 2546
-
Cell-cell adhesion: linking Wnt/β-catenin signaling with partial EMT and stemness traits in tumorigenesis
-
New Insights into the Role of DNA Shape on Its Recognition by p53 Proteins
-
Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis
Authors:
Girbl T., Lenn T., Perez L., Rolas L., Barkaway A., Thiriot A., del Fresno C., Lynam E., Hub E., Thelen M., Graham G., Alon R., Sancho D., von Andrian U. H., Voisin M., Rot A. & Nourshargh S. (2018),
Immunity. 49, 6, p. 1062-1076
-
Systemic antitumor immunity by PD-1/PD-L1 inhibition is potentiated by vascular-targeted photodynamic therapy of primary tumors
Authors:
O'Shaughnessy M. J., Murray K. S., La Rosa S. P., Budhu S., Merghoub T., Somma A., Monette S., Kim K., Corradi R. B., Scherz A. & Coleman J. A. (2018),
Clinical Cancer Research. 24, 3, p. 592-599
-
Phagocyte-extracellular matrix crosstalk empowers tumor development and dissemination
-
Prediction of acute myeloid leukaemia risk in healthy individuals
Authors:
Abelson S., Collord G., Ng S. W. K., Weissbrod O., Mendelson Cohen N., Niemeyer E., Barda N., Zuzarte P. C., Heisler L., Sundaravadanam Y., Luben R., Hayat S., Wang T. T., Zhao Z., Cirlan I., Pugh T. J., Soave D., Ng K., Latimer C., Hardy C., Raine K., Jones D., Hoult D., Britten A., McPherson J. D., Johansson M., Mbabaali F., Eagles J., Miller J. K., Pasternack D., Timms L., Krzyzanowski P., Awadalla P., Costa R., Segal E., Bratman S. V., Beer P., Behjati S., Martincorena I., Wang J. C. Y., Bowles K. M., Quirós J. R., Karakatsani A., La Vecchia C., Trichopoulou A., Salamanca-Fernández E., Huerta J. M., Barricarte A., Travis R. C., Tumino R., Masala G., Boeing H., Panico S., Kaaks R., Krämer A., Sieri S., Riboli E., Vineis P., Foll M., McKay J., Polidoro S., Sala N., Khaw K., Vermeulen R., Campbell P. J., Papaemmanuil E., Minden M. D., Tanay A., Balicer R. D., Wareham N. J., Gerstung M., Dick J. E., Brennan P., Vassiliou G. S. & Shlush L. I. (2018),
Nature. 559, 7714, p. 400-404
-
Medical Cannabis Use by Hodgkin Lymphoma Patients: Experience of a Single Center
Authors:
Sarid N., Zada M., Lev-Ran S., Yashphe E., Givon I., Barzilai M., Perry C., Avivi I. & Wolf I. (2018),
Acta Haematologica. 140, 4, p. 194-202
-
Pigment Epithelium-Derived Factor and its Phosphomimetic Mutant Induce JNK-Dependent Apoptosis and P38-Mediated Migration Arrest
-
CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
Authors:
Alon M., Arafeh R., Lee J. S., Madan S., Kalaora S., Nagler A., Abgarian T., Greenberg P., Ruppin E. & Samuels Y. (2018),
Oncotarget. 9, 58, p. 31264-31277
-
Refinement of the endogenous epitope tagging technology allows the identification of a novel NRAS binding partner in melanoma
Authors:
Alon M., Emmanuel R., Qutob N., Bakhman A., Peshti V., Brodezki A., Bassan D., Kosloff M. & Samuels Y. (2018),
Pigment Cell and Melanoma Research. 31, 5, p. 641-648
-
Single cell RNA-seq highlights a role for a partial EMT in head and neck cancer
-
Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016
Authors:
Al Malki M. M., Jones R., Ma Q., Lee D., Reisner Y., Miller J. S., Lang P., Hongeng S., Hari P., Strober S., Yu J., Maziarz R., Mavilio D., Roy D., Bonini C., Champlin R. E., Fuchs E. J. & Ciurea S. O. (2018),
Biology of Blood and Marrow Transplantation. 24, 5, p. 895-908
-
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures
Authors:
Lee J. S., Adler L., Karathia H., Carmel N., Rabinovich S., Auslander N., Keshet R., Stettner N., Silberman A., Agemy L., Helbling D., Eilam R., Sun Q., Brandis A., Malitsky S., Itkin M., Weiss H., Pinto S., Kalaora S., Levy R., Barnea E., Admon A., Dimmock D., Stern-Ginossar N., Scherz A., Nagamani S. C. S., Unda M., Wilson D. M., Elhasid R., Carracedo A., Samuels Y., Hannenhalli S., Ruppin E. & Erez A. (2018),
Cell. 174, 6, p. 1559-1570
-
Dual role of E-cadherin in the regulation of invasive collective migration of mammary carcinoma cells
-
PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma
Authors:
Ghannam-Shahbari D., Jacob E., Kakun R. R., Wasserman T., Korsensky L., Sternfeld O., Kagan J., Bublik D. R., Aviel-Ronen S., Levanon K., Sabo E., Larisch S., Oren M., Hershkovitz D. & Perets R. (2018),
Oncogene. 37, 17, p. 2213-2224
-
An exploratory study of adolescent response to fluoxetine using psychological and biological predictors
Authors:
Zohar A. H., Eilat T., Amitai M., Taler M., Bari R., Chen A., Apter A., Weizman A. & Fennig S. (2018),
PeerJ. 6, 4240
-
Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity
-
A sorafenib-sparing effect in the treatment of thyroid carcinoma cells attained by co-treatment with a novel isoflavone derivative and 1,25 dihydroxyvitamin D3
-
Molecular mechanisms underlying the role of galectin-8 as a regulator of cancer growth and metastasis
Authors:
Vinik Y., Shatz-Azoulay H. & Zick Y. (2018),
-
Nonredundant, highly connected microRNAs control functionality in breast cancer networks
-
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
Authors:
Kalaora S., Wolf Y., Feferman T., Barnea E., Greenstein E., Reshef D., Tirosh I., Reuben A., Patkar S., Levy R., Quinkhardt J., Omokoko T., Qutob N., Golani O., Zhang J., Mao X., Song X., Bernatchez C., Haymaker C., Forget M., Creasy C., Greenberg P., Carter B. W., Cooper Z. A., Rosenberg S. A., Lotem M., Sahin U., Shakhar G., Ruppin E., Wargo J. A., Friedman N., Admon A. & Samuels Y. (2018),
Cancer Discovery. 8, 11, p. 1366-1375
-
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways
Authors:
Romaniello D., Mazzeo L., Mancini M., Marrocco I., Noronha A., Kreitman M., Srivastava S., Ghosh S., Lindzen M., Salame T. M., Onn A., Bar J. & Yarden Y. (2018),
Clinical Cancer Research. 24, 22, p. 5610-5621
-
Rewiring urea cycle metabolism in cancer to support anabolism
-
IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer
Authors:
Zhang Y., Wester L., He J., Geiger T., Moerkens M., Siddappa R., Helmijr J. A., Timmermans M. M., Look M. P., van Deurzen C. H. M., Martens J. W. M., Pont C., de Graauw M., Danen E. H. J., Berns E. M. J. J., Meerman J. H. N., Jansen M. P. H. M. & van de Water B. (2018),
Oncogene. 37, 14, p. 1869-1884
-
A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation
Authors:
Kotler E., Shani O., Goldfeld G., Lotan-Pompan M., Tarcic O., Gershoni A., Hopf T. A., Marks D. S., Oren M. & Segal E. (2018),
Molecular Cell. 71, 1, p. 178-190.e8
-
Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia
Authors:
Gutjahr J. C., Szenes E., Tschech L., Asslaber D., Schlederer M., Roos S., Yu X., Girbl T., Sternberg C., Egle A., Aberger F., Alon R., Kenner L., Greil R., Orian-Rousseau V. & Hartmann T. N. (2018),
Blood. 131, 12, p. 1337-1349
-
A biological-computational human cell lineage discovery platform based on duplex molecular inversion probes
Authors:
Tao L., Raz O., Marx Z., Biezuner T., Amir S., Milo L., Adar R., Onn A., Chapal-Ilani N., Berman V., Levy R., Oron B., Halaban R. & Shapiro E. (2018),
BioRxiv.
-
Differentiation Between Vasogenic Edema and Infiltrative Tumor in Patients With High-Grade Gliomas Using Texture Patch-Based Analysis
-
Loss of C/EBP-beta LIP drives cisplatin resistance in malignant pleural mesothelioma
Authors:
Kopecka J., Salaroglio I. C., Righi L., Libener R., Orecchia S., Grosso F., Milosevic V., Ananthanarayanan P., Ricci L., Capelletto E., Pradotto M., Napoli F., Di Maio M., Novello S., Rubinstein M., Scagliotti G. V. & Riganti C. (2018),
Lung Cancer. 120, p. 34-45
-
p53 in Bronchial Club Cells Facilitates Chronic Lung Inflammation by Promoting Senescence
Authors:
Sagiv A., Bar-Shai A., Levi N., Hatzav M., Zada L., Ovadya Y., Roitman L., Manella G., Regev O., Majewska J., Vadai E., Eilam R., Feigelson S. W., Tsoory M., Tauc M., Alon R. & Krizhanovsky V. (2018),
Cell Reports. 22, 13, p. 3468-3479
-
Androgen deprivation therapy potentiates the efficacy of vascular targeted photodynamic therapy of prostate cancer xenografts
Authors:
Kim K., Watson P. A., Lebdai S., Jebiwott S., Somma A. J., Rosa S. L., Mehta D., Murray K. S., Lilja H., Ulmert D., Monette S., Scherz A. & Coleman J. A. (2018),
Clinical Cancer Research. 24, 10, p. 2408-2416
-
Functional characterization of the p53 "mutome"
-
A modular platform for targeted RNAi therapeutics
Authors:
Kedmi R., Veiga N., Ramishetti S., Goldsmith M., Rosenblum D., Dammes N., Hazan-Halevy I., Nahary L., Leviatan-Ben-Arye S., Harlev M., Behlke M., Benhar I., Lieberman J. & Peer D. (2018),
Nature Nanotechnology. 13, p. 214-219
-
Efficient Therapeutic Protein Expression Using Retroviral Replicating Vector with 2A Peptide in Cancer Models
Authors:
Hofacre A., Yagiz K., Mendoza D., Lopez Espinoza F., Munday A. W., Burrascano C., Singer O., Gruber H. E., Jolly D. J. & Lin A. H. (2018),
Human Gene Therapy. 29, 4, p. 437-451
-
A Mutant p53-Dependent Embryonic Stem Cell Gene Signature Is Associated with Augmented Tumorigenesis of Stem Cells
Authors:
Koifman G., Shetzer Y., Eizenberger S., Solomon H., Rotkopf R., Molchadsky A., Lonetto G., Goldfinger N. & Rotter V. (2018),
Cancer Research. 78, 20, p. 5833-5847
-
LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state
Authors:
Furth N., Pateras I. S., Rotkopf R., Vlachou V., Rivkin I., Schmitt I., Bakaev D., Gershoni A., Ainbinder E., Leshkowitz D., Johnson R. L., Gorgoulis V. G., Oren M. & Aylon Y. (2018),
Life science alliance. 1, 5, 201800171
-
ICAMs Are Not Obligatory for Functional Immune Synapses between Naive CD4 T Cells and Lymph Node DCs
Authors:
Feigelson S. W., Solomon A., Biram A., Hatzav M., Lichtenstein M., Regev O., Kozlovski S., Varol D., Curato C., Leshkowitz D., Jung S., Shulman Z. & Alon R. (2018),
Cell Reports. 22, 4, p. 849-859
-
Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition
Authors:
Schneidman-Duhovny D., Khuri N., Dong G. Q., Winter M. B., Shifrut E., Friedman N., Craik C. S., Pratt K. P., Paz P., Aswad F. & Sali A. (2018),
PLoS ONE. 13, 11, 0206654
-
Caspases maintain tissue integrity by an apoptosis-independent inhibition of cell migration and invasion
Authors:
Gorelick-Ashkenazi A., Weiss R., Sapozhnikov L., Florentin A., Tarayrah-Ibraheim L., Dweik D., Yacobi-Sharon K. & Arama E. (2018),
Nature Communications. 9, 1, 2806
-
Small Molecules Co-targeting CKI alpha and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models
Authors:
Minzel W., Venkatachalam A., Fink A., Hung E., Brachya G., Burstain I., Shaham M., Rivlin A., Omer I., Zinger A., Elias S., Winter E., Erdman P. E., Sullivan R. W., Fung L., Mercurio F., Li D., Vacca J., Kaushansky N., Shlush L., Oren M., Levine R., Pikarsky E., Snir-Alkalay I. & Ben-Neriah Y. (2018),
Cell. 175, 1, p. 171-185
-
Increasing intratumor C/EBP- LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer
Authors:
Salaroglio I. C., Gazzano E., Abdullrahman A., Mungo E., Castella B., Abd-elrahman G. E. F. A., Massaia M., Donadelli M., Rubinstein M., Riganti C. & Kopecka J. (2018),
Journal Of Experimental & Clinical Cancer Research. 37, 1, 286
-
The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota
-
The immune system profoundly restricts intratumor genetic heterogeneity
-
Delivery of ROS Generating Anthraquinones Using Reduction-Responsive Peptide-Based Nanoparticles
-
Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis
Authors:
Blank M., Bashi T., Lachnish J., Ben-Ami-Shor D., Shovman O., Fridkin M., Eisenstein M., Volkov A., Barshack I. & Shoenfeld Y. (2018),
PLoS ONE. 13, 8, 0200615
-
MRI radiomics analysis of molecular alterations in low-grade gliomas
Authors:
Shofty B., Artzi M., Ben Bashat D., Liberman G., Haim O., Kashanian A., Bokstein F., Blumenthal D. T., Ram Z. & Shahar T. (2018),
Computer-Assisted Radiology and Surgery. 13, 4, p. 563-571
-
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors
Authors:
Mancini M., Gal H., Gaborit N., Mazzeo L., Romaniello D., Salame T. M., Lindzen M., Mahlknecht G., Enuka Y., Burton D. G. A., Roth L., Noronha A., Marrocco I., Adreka D., Altstadter R. E., Bousquet E., Downward J., Maraver A., Krizhanovsky V. & Yarden Y. (2018),
EMBO Molecular Medicine. 10, 2, p. 294-308
-
Soluble SLAMF6 Receptor Induces Strong CD8 + T-cell Effector Function and Improves Anti-Melanoma Activity In Vivo
Authors:
Eisenberg G., Engelstein R., Geiger-Maor A., Hajaj E., Merims S., Frankenburg S., Uzana R., Rutenberg A., Machlenkin A., Frei G., Peretz T. & Lotem M. (2018),
Cancer Immunology Research. 6, 2, p. 127-138
-
Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer
Authors:
Zupancic E., Curato C., Kim J., Yeini E., Porat Z., Viana A. S., Globerson-Levin A., Waks T., Eshhar Z., Moreira J. N., Satchi-Fainaro R., Eisenbach L., Jung S. & Florindo H. F. (2018),
Nanomedicine: Nanotechnology, Biology, and Medicine. 14, 3, p. 835-847
-
A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies
Authors:
Bahr C., von Paleske L., Slu V. V. U., Emeseiro S. R., Takayama N., Ng S. W., Murison A., Langenfeld K., Petretich M., Scognamiglio R., Zeisberger P., Benk A. S., Amit I., Zandstra P. W., Lupien M., Dick J. E., Trumpp A. & Spitz F. (2018),
Nature. 553, 7689, p. 515-+
-
The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression
-
Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
Authors:
Martin D., Degese M. S., Vitale-Cross L., Iglesias-Bartolome R., Valera J. L. C., Wang Z., Feng X., Yeerna H., Vadmal V., Moroishi T., Thorne R. F., Zaida M., Siegele B., Cheong S. C., Molinolo A. A., Samuels Y., Tamayo P., Guan K. L., Lippman S. M., Lyons J. G. & Gutkind J. S. (2018),
Nature Communications. 9, 1, 2372
-
Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models
Authors:
Grees M., Sharbi-Yunger A., Evangelou C., Baumann D., Cafri G., Tzehoval E., Eichmueller S. B., Offringa R., Utikal J., Eisenbach L. & Umansky V. (2018),
OncoImmunology. 7, 7, 1445457
-
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
Authors:
Keren L., Bosse M., Marquez D., Angoshtari R., Jain S., Varma S., Yang S., Kurian A., Van Valen D., West R., Bendall S. C. & Angelo M. (2018),
Cell. 174, 6, p. 1373-1387
-
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma
Authors:
Jethwa A., Slabicki M., Huellein J., Jentzsch M., Dala V., Rabe S., Wagner L., Walther T., Klapper W., Bohnenberger H., Rettel M., Lu J., Smits A. H., Stein F., Savitski M. M., Huber W., Aylon Y., Oren M. & Zenz T. (2018),
Blood. 131, 25, p. 2789-2802
-
Autophagy differentially regulates TNF receptor Fn14 by distinct mammalian Atg8 proteins
-
Arginine and the metabolic regulation of nitric oxide synthesis in cancer
-
Intratumor heterogeneity in epigenetic patterns
-
The oncogenic fusion protein CBFB-SMMHC downregulates CD48 to evade NK cell recognition
Authors:
Kahlon S., Shreibman D., Unger T., Ben-Yehuda D. & Elias S. (2018),
-
A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach
Authors:
Haran M., Mirkin V., Braester A., Harpaz N., Shevetz O., Shtreiter M., Greenberg S., Mordich O., Amram O., Binsky-Ehrenreich I., Marom A., Shachar I., Herishanu Y., Ruchlemer R., Berrebi A., Valinsky L., Shtalrid M. & Shvidel L. (2018),
-
LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF
-
The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice
Authors:
Rotem E., Faingold O., Charni M., Klug Y. A., Harari D., Shmuel-Galia L., Nudelman A., Rotter V. & Shai Y. (2018),
PLoS Pathogens. 14, 5, e1007044
-
Laplacian pyramid based data fusion for high resolution dynamic MRI
Authors:
Pollack-Zuckerman L., Weizman L., Eldar Y. C., Ben Bashat D., Arzi M. & Irani M. (2018),
-
Brain investigations of rodent disease models by chemical exchange saturation transfer at 21.1T
-
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors
Authors:
Roth L., Srivastava S., Lindzen M., Sas-Chen A., Sheffer M., Lauriola M., Enuka Y., Noronha A., Mancini M., Lavi S., Tarcic G., Pines G., Nevo N., Heyman O., Ziv T., Rueda O. M., Gnocchi D., Pikarski E., Admon A., Caldas C. & Yarden Y. (2018),
Science Signaling. 11, 515, 0949
-
Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner
-
RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells
Authors:
Qutob N., Masuho I., Alon M., Emmanuel R., Cohen I., Di Pizio A., Madore J., Elkahloun A., Ziv T., Levy R., Gartner J. J., Hill V. K., Lin J. C., Hevroni Y., Greenberg P., Brodezki A., Rosenberg S. A., Kosloff M., Hayward N. K., Admon A., Niv M. Y., Scolyer R. A., Martemyanov K. A. & Samuels Y. (2018),
Scientific Reports. 8, 1, 653
-
MiRNA-513a-5p inhibits progesterone receptor expression and constitutes a risk factor for breast cancer: The hOrmone and Diet in the ETiology of breast cancer prospective study
Authors:
Muti P., Donzelli S., Sacconi A., Hossain A., Ganci F., Frixa T., Sieri S., Krogh V., Berrino F., Biagioni F., Strano S., Beyene J., Yarden Y. & Blandino G. (2018),
Carcinogenesis. 39, 2, p. 98-108
-
Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability
Authors:
Galanos P., Pappas G., Polyzos A., Kotsinas A., Svolaki I., Giakoumakis N. N., Glytsou C., Pateras I. S., Swain U., Souliotis V. L., Georgakilas A. G., Geacintov N., Scorrano L., Lukas C., Lukas J., Livneh Z., Lygerou Z., Chowdhury D., Sorensen C. S., Bartek J. & Gorgoulis V. G. (2018),
Genome Biology. 19, 1, 37
-
CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia
Authors:
Lewinsky H., Barak A. F., Huber V., Kramer M. P., Radomir L., Sever L., Orr I., Mirkin V., Dezorella N., Shapiro M., Cohen Y., Shvidel L., Seiffert M., Herishanu Y., Becker-Herman S. & Shachar I. (2018),
Journal of Clinical Investigation. 128, 12, p. 5465-5478
-
PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein
-
Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features
Authors:
Arandkar S., Furth N., Elisha Y., Belugali Nataraj N., van der Kuip H., Yarden Y., Aulitzky W., Ulitsky I., Geiger B. & Oren M. (2018),
Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 115, 25, p. 6410-6415
-
WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice
Authors:
Neuschmelting V., Kim K., Malekzadeh-Najafabadi J., Jebiwott S., Prakash J., Scherz A., Coleman J. A., Kircher M. F. & Ntziachristos V. (2018),
Theranostics. 8, 3, p. 723-734
-
Cancer research in the era of immunogenomics
-
The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia
-
Degradation of Bcl-2 by XIAP and ARTS Promotes Apoptosis
Authors:
Edison N., Curtz Y., Paland N., Mamriev D., Chorubczyk N., Haviv-Reingewertz T., Kfir N., Morgenstern D., Kupervaser M., Kagan J., Kim H. T. & Larisch S. (2017),
Cell Reports. 21, 2, p. 442-454
-
Dynamic proteomics reveals bimodal protein dynamics of cancer cells in response to HSP90 inhibitor
-
Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in mice
Authors:
Bogoch Y., Friedlander-Malik G., Lupu L., Bondar E., Zohar N., Langier S., Ram Z., Nachmany I., Klausner J. M. & Pencovich N. (2017),
Tumor Biology. 39, 4
-
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Authors:
Geller L. T., Barzily-Rokni M., Danino T., Jonas O. H., Shental N., Nejman D., Gavert N., Zwang Y., Cooper Z. A., Shee K., Thaiss C. A., Reuben A., Livny J., Avraham R., Frederick D. T., Ligorio M., Chatman K., Johnston S. E., Mosher C. M., Brandis A., Fuks G., Gurbatri C., Gopalakrishnan V., Kim M., Hurd M. W., Katz M., Fleming J., Maitra A., Smith D. A., Skalak M., Bu J., Michaud M., Trauger S. A., Barshack I., Golan T., Sandbank J., Flaherty K. T., Mandinova A., Garrett W. S., Thayer S. P., Ferrone C. R., Huttenhower C., Bhatia S. N., Gevers D., Wargo J. A., Golub T. R. & Straussman R. (2017),
Science. 357, 6356, p. 1156-1160
-
Runx3 in Immunity, Inflammation and Cancer
Authors:
Lotem J., Levanon D., Negreanu V., Bauer O., Hantisteanu S., Dicken J. & Groner Y. (2017),
RUNX PROTEINS IN DEVELOPMENT AND CANCER. VanWijnen A., Neil JC., Speck NA., Liu P., Groner Y. & Ito Y. (eds.). p. 369-393 (trueAdvances in Experimental Medicine and Biology).
-
Diverse p53/DNA binding modes expand the repertoire of p53 response elements
Authors:
Vyas P., Beno I., Xi Z., Stein Y., Golovenko D., Kessler N., Rotter V., Shakked Z. & Haran T. E. (2017),
Proceedings of the National Academy of Sciences of the United States of America. 114, 40, p. 10624-10629
-
Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation
Authors:
Wolf Y., Shemer A., Polonsky M., Gross-Vered M., Mildner A., Yona S., David E., Kim K., Goldmann T., Amit I., Heikenwalder M., Nedospasov S., Prinz M., Friedman N. & Jung S. (2017),
Journal of Experimental Medicine. 214, 4, p. 905-917
-
A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10
-
Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression
Authors:
Glasner A., Isaacson B., Viukov S., Neuman T., Friedman N., Mandelboim M., Sexl V., Hanna J. H. & Mandelboim O. (2017),
Scientific Reports. 7, 1, 13090
-
Real Time Laser Speckle Imaging Monitoring Vascular Targeted Photodynamic Therapy
-
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development
Authors:
Boege Y., Malehmir M., Healy M. E., Bettermann K., Lorentzen A., Vucur M., Ahuja A. K., Bohm F., Mertens J. C., Shimizu Y., Frick L., Remouchamps C., Mutreja K., Kaehne T., Sundaravinayagam D., Wolf M. J., Rehrauer H., Koppe C., Speicher T., Padrissa-Altes S., Maire R., Schattenberg J. R. M., Jeong J., Liu L., Zwirner S., Boger R., Hueser N., Davis R. J., Mullhaupt B., Moch H., Schulze-Bergkamen H., Clavien P., Werner S., Borsig L., Luther S. A., Jost P. J., Weinlich R., Unger K., Behrens A., Hillert L., Dillon C., Di Virgilio V. M., Wallach D., Dejardin E., Zender L., Naumann M., Walczak H., Green D. R., Lopes M., Lavrik I., Luedde T., Heikenwalder M. & Weber A. (2017),
Cancer Cell. 32, 3, p. 342-359.e10
-
p53 is essential for DNA methylation homeostasis in naive embryonic stem cells, and its loss promotes clonal heterogeneity
Authors:
Tovy A., Spiro A., McCarthy R., Shipony Z., Aylon Y., Allton K., Ainbinder E., Furth N., Tanay A., Barton M. & Oren M. (2017),
GENES & DEVELOPMENT. 31, 10, p. 959-972
-
Light-Stimulated Generation of Free Radicals by Quinones-Chelators
Authors:
Markova I. D., Polyakov N. E., Selyutina O. Y., Fedenok L. G., Fedotov K. Y., Slepneva I. A., Leshina T. V., Pokrovsky A. G., Vasilieva N. V. & Weiner L. M. (2017),
Zeitschrift Fur Physikalische Chemie-International Journal Of Research In Physical Chemistry & Chemical Physics. 231, 2, p. 369-389
-
CD84 mediates CLL-microenvironment interactions
Authors:
Marom A., Barak A. F., Kramer M. P., Lewinsky H., Binsky-Ehrenreich I., Cohen S., Tsitsou-Kampeli A., Kalchenko V. (., Kuznetsov Y., Mirkin V., Dezorella N., Shapiro M., Schwartzberg P. L., Cohen Y., Shvidel L., Haran M., Becker Herman S., Herishanu Y. & Shachar I. (2017),
Oncogene. 36, 5, p. 628-638
-
Contrast enhanced ultrasound imaging can predict vascular-targeted photodynamic therapy induced tumor necrosis in small animals
-
Non-canonical NF kappa B mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB: p50 NF kappa B pathway
-
Matrix Mechanosensing: From Scaling Concepts in 'Omics Data to Mechanisms in the Nucleus, Regeneration, and Cancer
-
The short and the long: non-coding RNAs and growth factors in cancer progression
-
Biological and clinical consequences of NPM1 mutations in AML
-
P53 on the crossroad between regeneration and cancer
-
The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation
-
Familial chronic lymphocytic leukemia in Israel: A disproportionate distribution among Ashkenazi Jews
-
Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues
Authors:
Chai C., Rivkin M., Berkovits L., Simerzin A., Zorde-Khvalevsky E., Rosenberg N., Klein S., Yaish D., Durst R., Shpitzen S., Udi S., Tam J., Heeren J., Worthmann A., Schramm C., Kluwe J., Ravid R., Hornstein E., Giladi H. & Galun E. (2017),
Gastroenterology. 153, 5, p. 1404-1415
-
Can immunotherapy treat neurodegeneration?
Authors:
Schwartz M. (2017),
-
From Prokaryotes to Cancer: Glutamine Flux in Multicellular Units
-
Fast Vascular Ultrasound Imaging With Enhanced Spatial Resolution and Background Rejection
-
Tumor Suppression by p53: Bring in the Hippo!
Authors:
Aylon Y. & Oren M. (2017),
-
Next-Generation Proteomics and Its Application to Clinical Breast Cancer Research
-
Activation of Signaling Cascades by Weak Extremely Low Frequency Electromagnetic Fields
-
Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells
-
Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors
-
The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element
Authors:
Marín-Béjar O., Mas A. M., González J., Martinez D., Athie A., Morales X., Galduroz M., Raimondi I., Grossi E., Guo S., Rouzaut A., Ulitsky I. & Huarte M. (2017),
GENOME BIOLOGY. 18, 1, 202
-
Von Hippel-Lindau and hereditary pheochromocytoma/paraganglioma syndromes: Clinical features, genetics, and surveillance recommendations in childhood
Authors:
Rednam S. P., Erez A., Druker H., Janeway K. A., Kamihara J., Kohlmann W. K., Nathanson K. L., States L. J., Tomlinson G. E., Villani A., Voss S. D., Schiffman J. D. & Wasserman J. D. (2017),
Clinical Cancer Research. 23, 12, p. e68-e75
-
Integrating multiple fitting regression and Bayes decision for cancer diagnosis with transcriptomic data from tumor-educated blood platelets
-
Herpesviruses shape tumour microenvironment through exosomal transfer of viral microRNAs
-
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway
-
The microbiome in anti-cancer therapy
-
FXYD5 (dysadherin) may mediate metastatic progression through regulation of the beta-Na+-K+-ATPase subunit in the 4T1 mouse breast cancer model
-
Lymphocyte activation gene 3: A novel therapeutic target in chronic lymphocytic leukemia
Authors:
Shapiro M., Herishanu Y., Ben-Zion-Katz, Dezorella N., Sun C., Kay S., Polliack A., Avivi I., Wiestner A. & Perry C. (2017),
Haematologica. 102, 5, p. 874-882
-
Classification of high-grade glioma into tumor and nontumor components using support vector machine
-
Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival
Authors:
Bublik D. R., Bursac S., Sheffer M., Orsolic I., Shalit T., Tarcic O., Kotler E., Mouhadeb O., Hoffman Y., Fuchs G., Levin Y., Volarevic S. & Oren M. (2017),
Proceedings of the National Academy of Sciences of the United States of America. 114, 4, p. E496-E505
-
McPAS-TCR: A manually curated catalogue of pathology-associated T cell receptor sequences
-
SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress
Authors:
Zipin-Roitman A., Aqaqe N., Yassin M., Biechonski S., Amar M., van Delft D. M. F., Gan O. I., McDermott S. P., Buzina A., Ketela T., Shlush L. I., Xie S., Voisin V., Moffat J., Minden M. D., Dick J. E. & Milyavsky M. (2017),
Oncotarget. 8, 10, p. 16712-16727
-
Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1
Authors:
Evans D. G. R., Salvador H., Chang V. Y., Erez A., Voss S. D., Schneider K. W., Scott H. S., Plon S. E. & Tabori U. (2017),
Clinical Cancer Research. 23, 12, p. e46-e53
-
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Authors:
Lavin Y., Kobayashi S., Leader A., Amir E. D., Elefant N., Bigenwald C., Remark R., Sweeney R., Becker C. D., Levine J. H., Meinhof K., Chow A., Kim-Shulze S., Wolf A., Medaglia C., Li H., Rytlewski J. A., Emerson R. O., Solovyov A., Greenbaum B. D., Sanders C., Vignali M., Beasley M. B., Flores R., Gnjatic S., Pe'er D., Rahman A., Amit I. & Merad M. (2017),
Cell. 169, 4, p. 750-765.e17
-
Pyruvate dehydrogenase has a major role in mast cell function, and its activity is regulated by mitochondrial microphthalmia transcription factor
Authors:
Sharkia I., Hadad Erlich T., Landolina N., Assayag M., Motzik A., Rachmin I., Kay G., Porat Z., Tshori S., Berkman N., Levi-Schaffer F. & Razin E. (2017),
Journal of Allergy and Clinical Immunology. 140, 1, p. 204-214.e8
-
BCAT1 restricts alpha KG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
Authors:
Raffel S., Falcone M., Kneisel N., Hansson J., Wang W., Lutz C., Bullinger L., Poschet G., Nonnenmacher Y., Barnert A., Bahr C., Zeisberger P., Przybylla A., Sohn M., Toenjes M., Erez A., Adler L., Jensen P., Scholl C., Froehling S., Cocciardi S., Wuchter P., Thiede C., Floercken A., Westermann J., Ehninger G., Lichter P., Hiller K., Hell R., Herrmann C., Ho A. D., Krijgsveld J., Radlwimmer B. & Trumpp A. (2017),
Nature. 551, 7680, p. 384-388
-
Increased potency of a bi-specific TL1A-ADAM17 (TACE) inhibitor by cell surface targeting
-
p53-dependent programmed necrosis controls germ cell homeostasis during spermatogenesis
Authors:
Napoletano F., Gibert B., Yacobi-Sharon K., Vincent S., Favrot C., Mehlen P., Girard V., Teil M., Chatelain G., Walter L., Arama E. & Mollereau B. (2017),
PLoS Genetics. 13, 9, e1007024
-
Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells
Authors:
Arafeh R., Flores K., Keren-Paz A., Maik-Rachline G., Gutkind N., Rosenberg S., Seger R. & Samuels Y. (2017),
Scientific Reports. 7, 16345
-
A recombinant fungal compound induces anti-proliferative and pro-apoptotic effects on colon cancer cells
Authors:
Nimri L., Spivak O., Tal D., Schälling D., Peri I., Graeve L., Salame T. M., Yarden O., Hadar Y. & Schwartz B. (2017),
Oncotarget. 8, 17, p. 28854-28864
-
Death by over-eating: The Gaucher disease associated gene GBA1, identified in a screen for mediators of autophagic cell death, is necessary for developmental cell death in Drosophila midgut
-
Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases
Authors:
Rachman-Tzemah C., Zaffryar-Eilot S., Grossman M., Ribero D., Timaner M., Mäki J. M., Myllyharju J., Bertolini F., Hershkovitz D., Sagi I., Hasson P. & Shaked Y. (2017),
Cell Reports. 19, 4, p. 774-784
-
Reduced changes in protein compared to mRNA levels across non-proliferating tissues
Authors:
Perl K., Ushakov K., Pozniak Y., Yizhar-Barnea O., Bhonker Y., Shivatzki S., Geiger T., Avraham K. B. & Shamir R. (2017),
BMC Genomics. 18, 1, 305
-
miR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis
-
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome
Authors:
Schwartzman O., Savino A. M., Gombert M., Palmi C., Cario G., Schrappe M., Eckert C., von Stackelberg A., Huang J., Hameiri-Grossman M., Avigad S., te Kronnie G., Geron I., Birger Y., Rein A., Zarfati G., Fischer U., Mukamel Z., Stanulla M., Biondi A., Cazzaniga G., Vetere A., Wagner B. K., Chen Z., Chen S., Tanay A., Borkhardt A. & Izraeli S. (2017),
Proceedings Of The National Academy Of Sciences Of The United States Of America-Physical Sciences. 114, 20, p. E4030-E4039
-
Synonymous Somatic Variants in Human Cancer Are Not Infamous: A Plea for Full Disclosure in Databases and Publications
-
Jaspine B induces nonapoptotic cell death in gastric cancer cells independently of its inhibition of ceramide synthase
-
Tracing the origins of relapse in acute myeloid leukaemia to stem cells
Authors:
Shlush L. I., Mitchell A., Heisler L., Abelson S., Ng S. W. K., Trotman-Grant A., Medeiros J. J. F., Rao-Bhatia A., Jaciw-Zurakowsky I., Marke R., McLeod J. L., Doedens M., Bader G., Voisin V., Xu C., McPherson J. D., Hudson T. J., Wang J. C. Y., Minden M. D. & Dick J. E. (2017),
Nature. 547, 7661, p. 104-108
-
Bombesin antagonist-based radiotherapy of prostate cancer combined with WST-11 vascular targeted photodynamic therapy
Authors:
Kim K., Zhang H., La Rosa R. S., Jebiwott S., Desai P., Kimm S., Scherz A., O'Donoghue J. A., Weber W. A. & Coleman J. A. (2017),
Clinical Cancer Research. 23, 13, p. 3343-3351
-
Spontaneous Activation of Antigen-presenting Cells by Genes Encoding Truncated Homo-Oligomerizing Derivatives of CD40
-
Post-translational regulation of p53 function through 20S proteasome-mediated cleavage
Authors:
Solomon H., Brauning B., Fainer I., Ben-Nissan G., Rabani S., Goldfinger N., Moscovitz O., Shakked Z., Rotter V. & Sharon M. (2017),
Cell Death and Differentiation. 24, p. 2187-2198
-
Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease
Authors:
Golan T., Stossel C., Schvimer M., Atias D., Halperin S., Buzhor E., Raitses Gurevich G. M., Cohen K., Pri-Chen S., Wilson J., Denroche R. E., Lungu I., Bartlett J. M. S., Mbabaali F., Yarden Y., Nataraj N. B., Gallinger S. & Berger R. (2017),
Oncotarget. 8, 25, p. 40778-40790
-
Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 2 and related disorders
-
The cancer paradigms of mammalian regeneration: Can mammals regenerate as amphibians?
-
TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein response
Authors:
Isaac R., Goldstein I., Furth N., Zilber N., Streim S., Boura-Halfon S., Elhanany E., Rotter V., Oren M. & Zick Y. (2017),
Cell Death and Differentiation. 24, 1, p. 132-143
-
AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia
Authors:
Zhou F., Liu Y., Rohde C., Pauli C., Gerloff D., Koehn M., Misiak D., Baeumer N., Cui C., Goellner S., Oellerich T., Serve H., Garcia-Cuellar M., Slany R., Maciejewski J. P., Przychodzen B., Seliger B., Klein H., Bartenhagen C., Berdel W. E., Dugas M., Taketo M. M., Farouq D., Schwartz S., Regev A., Hebert J., Sauvageau G., Pabst C., Huettelmaier S. & Mueller-Tidow C. (2017),
Nature Cell Biology. 19, 7, p. 844-855
-
T cell receptor repertoires of mice and humans are clustered in similarity networks around conserved public CDR3 sequences
Authors:
Madi A., Poran A., Shifrut E., Reich-Zeliger S., Greenstein E., Zaretsky I., Arnon T., Van Laethem L. F., Singer A., Lu J., Sun P. D., Cohen I. R. & Friedman N. (2017),
eLife. 6, e22057
-
The Leo Sachs’ legacy: A pioneer’s journey through hematopoiesis
-
Genetic and Functional Analysis of GRIN2A in Tumor Samples
-
Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression
Authors:
Fiziev P., Akdemir K. C., Miller J. P., Keung E. Z., Samant N. S., Sharma S., Natale C. A., Terranova C. J., Maitituoheti M., Amin S. B., Martinez-Ledesma E., Dhamdhere M., Axelrad J. B., Shah A., Cheng C. S., Mahadeshwar H., Seth S., Barton M. C., Protopopov A., Tsai K. Y., Davies M. A., Garcia B. A., Amit I., Chin L., Ernst J. & Rai K. (2017),
Cell Reports. 19, 4, p. 875-889
-
Diverse continuum of CD4+ T-cell states is determined by hierarchical additive integration of cytokine signals
-
Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function
-
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
Authors:
Arce Vargas F., Furness A. J., Solomon I., Joshi K., Mekkaoui L., Lesko M. H., Miranda Rota E., Dahan R., Georgiou A., Sledzinska A., Ben Aissa A., Franz D., Werner Sunderland M., Wong Y. N. S., Henry J. Y., O'Brien T., Nicol D., Challacombe B., Beers S. A. & Spain L. (2017),
Immunity. 46, 4, p. 577-586
-
Recommendations for surveillance for children with leukemia-predisposing conditions
Authors:
Porter C. C., Druley T. E., Erez A., Kuiper R. P., Onel K., Schiffman J. D., Schneider K. W., Scollon S. R., Scott H. S., Strong L. C., Walsh M. F. & Nichols K. E. (2017),
Clinical Cancer Research. 23, 11, p. e14-e22
-
RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer
Authors:
Tarcic O., Granit R. Z., Pateras I. S., Masury H., Maly B., Zwang Y., Yarden Y., Gorgoulis V. G., Pikarsky E., Ben-Porath I. & Oren M. (2017),
Cell Death and Differentiation. 24, 4, p. 694-704
-
Receptor Protein Tyrosine Phosphatase alpha-Mediated Enhancement of Rheumatoid Synovial Fibroblast Signaling and Promotion of Arthritis in Mice
Authors:
Stanford S. M., Svensson M. N. D., Sacchetti C., Pilo C. A., Wu D. J., Kiosses W. B., Hellvard A., Bergum B., Muench G. R. A., Elly C., Liu Y., den Hertog J., Elson A., Sap J., Mydel P., Boyle D. L., Corr M., Firestein G. S. & Bottini N. (2016),
Arthritis & Rheumatology. 68, 2, p. 359-369
-
TMPRSS2-ERG fusion protein regulates insulin-like growth factor-1 receptor (IGF1R) gene expression in prostate cancer: Involvement of transcription factor Sp1
-
Co-targeting of Adenosine Signaling Pathways for Immunotherapy: Potentiation by Fc Receptor Engagement
Authors:
Dahan R. & Ravetch J. V. (2016),
-
Measurement of lymphocyte aggregation by flow cytometry-physiological implications in chronic lymphocytic leukemia
Authors:
Dezorella N., Kay S., Baron S., Shapiro M., Porat Z., Deutsch V., Herishanu Y. & Katz B. (2016),
Cytometry. Part B, Clinical cytometry. 90, 3, p. 257-266
-
Wnt signaling in cancer stem cells and colon cancer metastasis
-
MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells
-
p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression
-
The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders
Authors:
Amitai M., Taler M., Carmel M., Michaelovsky E., Eilat T., Yablonski M., Orpaz N., Chen A., Apter A., Weizman A. & Fennig S. (2016),
Journal of Child and Adolescent Psychopharmacology. 26, 8, p. 727-732
-
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
-
NKG2D ligands mediate immunosurveillance of senescent cells
Authors:
Sagiv A., Burton D., Moshayev Z., Vadai E., Wensveen F., Ben-Dor S., Golani O., Polic B. & Krizhanovsky V. (2016),
AGING-US. 8, 2, p. 328-344
-
Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
Authors:
Rodgers D. T., Mazagova M., Hampton E. N., Cao Y., Ramadoss N. S., Hardy I. R., Schulman A., Du J., Wang F., Singer O., Ma J., Nunez V., Shen J., Woods A. K., Wright T. M., Schultz P. G., Kim C. H. & Young T. S. (2016),
Proceedings of the National Academy of Sciences of the United States of America. 113, 4, p. E459-E468
-
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
Authors:
Georgoudaki A. M., Prokopec K. E., Boura V. F., Hellqvist E., Sohn S., Östling J., Dahan R., Harris R. A., Rantalainen M., Klevebring D., Sund M., Brage S. E., Fuxe J., Rolny C., Li F., Ravetch J. V. & Karlsson M. C. (2016),
Cell Reports. 15, 9, p. 2000-2011
-
LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer
Authors:
Sas-Chen A., Aure M. R., Leibovich L., Carvalho S., Enuka Y., Korner C., Polycarpou-Schwarz M., Lavi S., Nevo N., Kuznetsov Y., Yuan J., Azuaje F., Ulitsky I., Diederichs S., Wiemann S., Yakhini Z., Kristensen V. N., Borresen-Dale A. & Yarden Y. (2016),
EMBO Molecular Medicine. 8, 9, p. 1052-1064
-
The relationship between the nucleolus and cancer: Current evidence and emerging paradigms
-
Tumor macrophages are pivotal constructors of tumor collagenous matrix
Authors:
Afik R., Zigmond E., Vugman M., Klepfish M., Shimshoni E., Pasmanik-Chor M., Shenoy A., Bassat E., Halpern Z., Geiger T., Sagi I. & Varol C. (2016),
Journal of Experimental Medicine. 213, 11, p. 2315-2331
-
The Hippo pathway, p53 and cholesterol
-
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
Authors:
Yosef R., Pilpel N., Tokarsky-Amiel R., Biran A., Ovadya Y., Cohen S., Vadai E., Dassa L., Shahar E., Condiotti R., Ben-Porath I. & Krizhanovsky V. (2016),
Nature Communications. 7, 11190
-
Oncogenic mutant p53 gain of function nourishes the vicious cycle of tumor development and cancer stem-cell formation
-
System-wide Clinical Proteomics of Breast Cancer Reveals Global Remodeling of Tissue Homeostasis
Authors:
Pozniak Y., Balint-Lahat N., Rudolph J. D., Lindskog C., Katzir R., Avivi C., Pontén F., Ruppin E., Barshack I. & Geiger T. (2016),
Cell Systems. 2, 3, p. 172-184
-
FXYD5 Protein Has a Pro-inflammatory Role in Epithelial Cells
-
Analysis of subcellular RNA fractions revealed a transcription- independent effect of tumor necrosis factor alpha on splicing, mediated by Spt5
-
Adipose-induced retroperitoneal soft tissue sarcoma tumorigenesis: A potential crosstalk between sarcoma and fat cells
Authors:
Loewenstein S., Lubezky N., Nizri E., Zemel M., Levin Y., Savidor A., Sher O., Klausner J. & Lahat G. (2016),
Molecular Cancer Research. 14, 12, p. 1254-1265
-
The cybernetics of TNF: Old views and newer ones
-
mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model
-
Mutational and network level mechanisms underlying resistance to anti-cancer kinase inhibitors
-
Interfering with the Dimerization of the ERBB Receptors by Transmembrane Domain-Derived Peptides Inhibits Tumorigenic Growth in Vitro and in Vivo
-
Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells
-
Identification of a Functional Risk Variant for Pemphigus Vulgaris in the ST18 Gene
Authors:
Vodo D., Sarig O., Geller S., Ben-Asher E., Olender T., Bochner R., Goldberg I., Nosgorodsky J., Alkelai A., Tatarskyy P., Peled A., Baum S., Barzilai A., Ibrahim S. M., Zillikens D., Lancet D. & Sprecher E. (2016),
PLoS Genetics. 12, 5, e1006008
-
The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation
Authors:
Aylon Y., Gershoni A., Rotkopf R., Biton I. E., Porat Z., Koh A. P., Sun X., Lee Y., Fiel M., Hoshida Y., Friedman S. L., Johnson R. L. & Oren M. (2016),
GENES & DEVELOPMENT. 30, 7, p. 786-797
-
ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
Authors:
Dittrich C., Kosty M., Jezdic S., Pyle D., Berardi R., Bergh J., El-Saghir N., Lotz J. P., Österlund P., Pavlidis N., Purkalne G., Awada A., Banerjee S., Bhatia S., Bogaerts J., Buckner J., Cardoso F., Casali P., Chu E., Close J. L., Coiffier B., Connolly R., Coupland S., De Petris L., De Santis M., De Vries E. G., Dizon D. S., Duff J., Duska L. R., Eniu A., Ernstoff M., Felip E., Fey M. F., Gilbert J., Girard N., Glaudemans A. W., Gopalan P. K., Grothey A., Hahn S. M., Hanna D., Herold C., Herrstedt J., Homicsko K., Jones D. V., Jost L., Keilholz U., Khan S., Kiss A., Köhne C. H., Kunstfeld R., Lenz H. J., Lichtman S., Licitra L., Lion T., Litière S., Liu L., Loehrer P. J., Markham M. J., Markman B., Mayerhoefer M., Meran J. G., Michielin O., Moser E. C., Mountzios G., Moynihan T., Nielsen T., Ohe Y., Öberg K., Palumbo A., Peccatori F. A., Pfeilstöcker M., Raut C., Remick S. C., Robson M., Rutkowski P., Salgado R., Schapira L., Schernhammer E., Schlumberger M., Schmoll H. J., Schnipper L., Sessa C., Shapiro C. L., Steele J., Sternberg C. N., Stiefel F., Strasser F., Stupp R., Sullivan R., Tabernero J., Travado L., Verheij M., Voest E., Vokes E., Von Roenn J., Weber J. S., Wildiers H. & Yarden Y. (2016),
ESMO Open. 1, 5, e000097
-
P53 mutations promote proteasomal activity
Authors:
Oren M. & Kotler E. (2016),
-
Dynamics inside the cancer cell attractor reveal cell heterogeneity, limits of stability, and escape
-
Non-alcoholic fatty liver and the gut microbiota
-
Widespread parainflammation in human cancer
Authors:
Aran D., Lasry A., Zinger A., Biton M., Pikarsky E., Hellman A., Butte A. J. & Ben-Neriah Y. (2016),
Genome Biology. 17, 1, 145
-
Estrogen receptor-targeted contrast agents for molecular magnetic resonance imaging of breast cancer hormonal status
-
A metabolic link between the urea cycle and cancer cell proliferation
-
Tumor cell invasion can be blocked by modulators of collagen fibril alignment that control assembly of the extracellular matrix
Authors:
Grossman M., Ben-Chetrit N., Zhuravlev A., Afik R., Bassat E., Solomonov I., Yarden Y. & Sagi I. (2016),
Cancer Res.. 76, 14, 052206
-
Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in Swine
Authors:
Murray K. S., Winter A. G., Corradi R. B., LaRosa S., Jebiwott S., Somma A., Takaki H., Srimathveeravalli G., Lepherd M., Monette S., Kim K., Scherz A. & Coleman J. A. (2016),
Journal of Urology. 196, 1, p. 236-243
-
Tumor Necrosis Factor Alpha (TNFalpha)
-
Overcoming a species-specificity barrier in development of an inhibitory antibody targeting a modulator of tumor stroma
-
Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation
Authors:
Charni M., Molchadsky A., Goldstein I., Solomon H., Tal P., Goldfinger N., Yang P., Porat Z., Lozano G. & Rotter V. (2016),
Cell Death and Differentiation. 23, 3, p. 509-520
-
Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma
-
The involvement of mutant Rac1 in the formation of invadopodia in cultured melanoma cells
-
The evolution of T-cell depletion in haploidentical stem-cell transplantation
-
Microglia Replenished OHSC: A Culture System to Study In Vivo Like Adult Microglia
Authors:
Masuch A., van der Pijl d. P. R., Fuener L., Wolf Y., Eggen B., Boddeke E., Biber K., Dalimot J., Bergmueller E., Jung S., Voortman S., Winterhager E., Brandau S., Garbi N., Kurrer M., Eriksson U., Gunzer M. & Hasenberg M. (2016),
GLIA. 64, 8, p. 1285-1297
-
Breast MRI: Malignant Cystosarcoma Phyllodes Tumor Exhibits Unique Anisotropic Diffusion
-
Optimization of DCE-MRI protocol for the assessment of patients with brain tumors
-
Immunotherapy of cancer: From monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18
-
Post-translational modification profiling - A novel tool for mapping the protein modification landscape in cancer
-
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors
Authors:
Carvalho S., Lindzen M., Lauriola M., Shirazi N., Sinha S., Abdul-Hai A., Levanon K., Korach J., Barshack I., Cohen Y., Onn A., Mills G. & Yarden Y. (2016),
Oncogene. 35, 4, p. 438-447
-
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
Authors:
Lotem M., Merims S., Frank S., Hamburger T., Nissan A., Kadouri L., Cohen J., Straussman R., Eisenberg G., Frankenburg S., Carmon E., Alaiyan B., Shneibaum S., Ayyildiz Z. O., Isbilen M., Senses K. M., Ron I., Steinberg H., Smith Y., Shiloni E., Gure A. O. & Peretz T. (2016),
Journal of Immunology Research. 2016, 8121985
-
Genetic and pharmacological modulation of Akt1 for improving ovarian graft revascularization in a mouse model
Authors:
Cohen Y., Dafni H., Avni R., Fellus L., Bochner F., Rotkopf R., Raz T., Benjamin L. E., Walsh K. & Neeman M. (2016),
Biology of Reproduction. 94, 1, 14
-
Extracellular matrix and tissue regeneration
-
Harnessing the natural inhibitory domain to control TNF alpha Converting Enzyme (TACE) activity in vivo
-
Serum thioredoxin reductase is highly increased in mice with hepatocellular carcinoma and its activity is restrained by several mechanisms
-
RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer
Authors:
Tarcic O., Pateras I. S., Cooks T., Shema E., Kanterman J., Ashkenazi H., Boocholez H., Hubert A., Rotkopf R., Baniyash M., Pikarsky E., Gorgoulis V. G. & Oren M. (2016),
Cell Reports. 14, 6, p. 1462-1476
-
Targeting mutant p53 for cancer therapy
-
Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
-
Tumour suppressor death-associated protein kinase targets cytoplasmic HIF-1α for Th17 suppression
Authors:
Chou T. F., Chuang Y. T., Hsieh W. C., Chang P. Y., Liu H. Y., Mo S. T., Hsu T. S., Miaw S. C., Chen R. H., Kimchi A. & Lai M. Z. (2016),
Nature Communications. 7, 11904
-
Intrinsic superoxide dismutase activity of MnO nanoparticles enhances the magnetic resonance imaging contrast
Authors:
Ragg R., Schilmann A. M., Korschelt K., Wieseotte C., Kluenker M., Viel M., Voelker L., Preiss S., Herzberger J., Frey H., Heinze K., Bluemler P., Tahir M. N., Natalio F. & Tremel W. (2016),
Journal of Materials Chemistry B. 4, 46, p. 7423-7428
-
Genetic manipulation of iron biomineralization enhances MR relaxivity in a ferritin-M6A chimeric complex
Authors:
Radoul M., Lewin L., Cohen B., Oren R., Popov S., Davidov G., Vandsburger M. H., Harmelin A., Bitton R., Greneche J., Neeman M. & Zarivach R. (2016),
Scientific Reports. 6, 26550
-
Androgen deprivation therapy potentiates the efficacy of vascular targeted photodynamic therapy of prostate cancer xenografts
Authors:
Kim K., Watson P. A., Jebiwott S., Somma A. J., La Rosa R. S. P., Mehta D., Murray K. S., Lilja H., Ulmert D., Scherz A. & Coleman J. A. (2016),
Cancer Research. 76, 2016
-
Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy
-
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors
Authors:
Gelfo V., Rodia M. T., Pucci M., Dall'Ora M., Santi S., Solmi R., Roth L., Lindzen M., Bonafe M., Bertotti A., Caramelli E., Lollini P., Trusolino L., Yarden Y., D'Uva G. & Lauriola M. (2016),
Oncotarget. 7, 44, p. 72167-72183
-
Mutational scanning reveals the determinants of protein insertion and association energetics in the plasma membrane
-
Coronary vasculature patterning requires a novel endothelial ErbB2 holoreceptor
Authors:
Aghajanian H., Cho Y. K., Manderfield L. J., Herling M. R., Gupta M., Ho V. C., Li L., Degenhardt K., Aharonov A., Tzahor E. & Epstein J. A. (2016),
Nature Communications. 7, 12038
-
MicroRNAs: Non-coding fine tuners of receptor tyrosine kinase signalling in cancer
-
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
Authors:
Notta F., Chan-Seng-Yue M., Lemire M., Li Y., Wilson G. W., Connor A. A., Denroche R. E., Liang S. B., Brown A. M., Kim J. C., Wang T., Simpson J. T., Beck T., Borgida A., Buchner N., Chadwick D., Hafezi-Bakhtiari S., Dick J. E., Heisler L., Hollingsworth M. A., Ibrahimov E., Jang G. H., Johns J., Jorgensen L. G., Law C., Ludkovski O., Lungu I., Ng K., Pasternack D., Petersen G. M., Shlush L. I., Timms L., Tsao M. S., Wilson J. M., Yung C. K., Zogopoulos G., Bartlett J. M., Alexandrov L. B., Real F. X., Cleary S. P., Roehrl M. H., McPherson J. D., Stein L. D., Hudson T. J., Campbell P. J. & Gallinger S. (2016),
Nature. 538, 7625, p. 378-382
-
A network-based analysis of colon cancer Splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1
Authors:
Hollander D., Donyo M., Atias N., Mekahel K., Melamed Z., Yannai S., Lev-Maor G., Shilo A., Schwartz S., Barshack I., Sharan R. & Ast G. (2016),
Genome Research. 26, 4, p. 541-553
-
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
Authors:
Kalaora S., Barnea E., Merhavi-Shoham E., Qutob N., Teer J. K., Shimony N., Schachter J., Rosenberg S. A., Besser M. J., Admon A. & Samuels Y. (2016),
Oncotarget. 7, 5, p. 5110-5117
-
The Anticancer Activity of Organotelluranes: Potential Role in Integrin Inactivation
-
Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its Fe-S clusters
Authors:
Darash-Yahana M., Pozniak Y., Lu M., Sohn Y., Karmi O., Tamir S., Bai F., Song L., Jennings P. A., Pikarsky E., Geiger T., Onuchic J. N., Mittler R. & Nechushtai R. (2016),
Proceedings of the National Academy of Sciences of the United States of America. 113, 39, p. 10890-10895
-
Can diffusion tensor anisotropy indices assist in breast cancer detection?
-
Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
-
Proteomic maps of breast cancer subtypes
-
Therapeutic Potential of T Cell Chimeric Antigen Receptors (CARs) in Cancer Treatment: Counteracting Off-Tumor Toxicities for Safe CAR T Cell Therapy
-
Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis
-
Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease
Authors:
Yaeger R., Shah M. A., Miller V. A., Kelsen J. R., Wang K., Heins Z. J., Ross J. S., He Y., Sanford E., Yantiss R. K., Balasubramanian S., Stephens P. J., Schultz N., Oren M., Tang L. & Kelsen D. (2016),
Gastroenterology. 151, 2, p. 278-287.e6
-
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
Authors:
Hao Y., Samuels Y., Li Q., Krokowski D., Guan B., Wang C., Jin Z., Dong B., Cao B., Feng X., Xiang M., Xu C., Fink S., Meropol N. J., Xu Y., Conlon R. A., Markowitz S., Kinzler K. W., Velculescu V. E., Brunengraber H., Willis J. E., LaFramboise T., Hatzoglou M., Zhang G., Vogelstein B. & Wang Z. (2016),
Nature Communications. 7, 11971
-
Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery
Authors:
Stock K., Estrada M. F., Vidic S., Gjerde K., Rudisch A., Santo V. E., Barbier M., Blom S., Arundkar S. C., Selvam I., Osswald A., Stein Y., Gruenewald S., Brito C., Van Weerden W., Rotter V., Boghaert E., Oren M., Sommergruber W., Chong Y., De Hoogt R. & Graeser R. (2016),
Scientific Reports. 6, 28951
-
The Proteome of Primary Prostate Cancer
Authors:
Iglesias-Gato D., Wikström P., Tyanova S., Lavallee C., Thysell E., Carlsson J., Hägglöf C., Cox J., Andrén O., Stattin P., Egevad L., Widmark A., Bjartell A., Collins C. C., Bergh A., Geiger T., Mann M. & Flores-Morales A. (2016),
European Urology. 69, 5, p. 942-952
-
Role of the microbiome in non-gastrointestinal cancers
-
Differentiation between treatment-related changes and progressive disease in patients with high grade brain tumors using support vector machine classification based on DCE MRI
-
Zooming in on selectins in cancer
Authors:
Kedmi R. & Peer D. (2016),
-
Vascular-Targeted Photodynamic Therapy in Prostate Cancer: From Bench to Clinic
Authors:
Scherz A., Salomon Y., Lindner U. & Coleman J. (2016), PHOTODYNAMIC MEDICINE: FROM BENCH TO CLINIC. p. 461-480
-
HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune Microenvironment
Authors:
Zigler M., Shir A., Joubran S., Sagalov A., Edinger N., Lau J., Yu S., Mizraji G., Globerson Levin A., Sliwkowski M. X. & Levitzki A. (2016),
Cancer Immunology Research. 4, 8, p. 688-697
-
The tumor as an organ: comprehensive spatial and temporal modeling of the tumor and its microenvironment.
-
Parkin Somatic Mutations Link Melanoma and Parkinson's Disease
Authors:
Levin L., Srour S., Gartner J., Kapitansky O., Qutob N., Dror S., Golan T., Dayan R., Brener R., Ziv T., Khaled M., Schueler-Furman O., Samuels Y. & Levy C. (2016),
Journal of Genetics and Genomics. 43, 6, p. 369-379
-
Tumor evolution inferred by patterns of microRNA expression through the course of disease, therapy, and recurrence in breast cancer
Authors:
Dadiani M., Ben-Moshe N. B., Paluch-Shimon S., Perry G., Balint N., Marin I., Pavlovski A., Morzaev D., Kahana-Edwin S., Yosepovich A., Gal-Yam E. N., Berger R., Barshack I., Domany E. & Kaufman B. (2016),
Clinical Cancer Research. 22, 14, p. 3651-3662
-
Cellular heterogeneity mediates inherent sensitivity-specificity tradeoff in cancer targeting by Synthetic circuits
-
A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells
Authors:
Volovitz I., Shapira N., Ezer H., Gafni A., Lustgarten M., Alter T., Ben-Horin I., Barzilai O., Shahar T., Kanner A., Fried I., Veshchev I., Grossman R. & Ram Z. (2016),
BMC Neuroscience. 17, 30
-
Conjugation of methotrexate-amino derivatives to macromolecules through carboxylate moieties is superior over conventional linkage to amino residues: Chemical, cell-free and in vitro characterizations
-
Increased number of volatile organic compounds over malignant glottic lesions
-
An essential role for UTX in resolution and activation of bivalent promoters
Authors:
Dhar S. S., Lee S., Chen K., Zhu G., Oh W., Allton K., Gafni O., Kim Y. Z., Tomoiga A. S., Barton M. C., Hanna J. H., Wang Z., Li W. & Lee M. G. (2016),
Nucleic Acids Research. 44, 8, p. 3659-3674
-
SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course
-
Erratum to: ‘Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells’
-
The Wnt target gene L1 in colon cancer invasion and metastasis
-
Protein Sialylation Regulates a Gene Expression Signature that Promotes Breast Cancer Cell Pathogenicity
Authors:
Kohnz R. A., Roberts L. S., DeTomaso D., Bideyan L., Yan P., Bandyopadhyay S., Goga A., Yosef N. & Nomura D. K. (2016),
ACS Chemical Biology. 11, 8, p. 2131-2139
-
The EGFR-HER2 module: A stem cell approach to understanding a prime target and driver of solid tumors
-
Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin-Fusion Protein Nanocarriers Bearing Proline, Serine, and Alanine Elements
Authors:
Falvo E., Tremante E., Arcovito A., Papi M., Elad N., Boffi A., Morea V., Conti G., Toffoli G., Fracasso G., Giacomini P. & Ceci P. (2016),
Biomacromolecules. 17, 2, p. 514-522
-
The ERK cascade inhibitors: Towards overcoming resistance
-
Chronic centrosome amplification without tumorigenesis
Authors:
Vitre B., Holland A. J., Kulukian A., Shoshani O., Hirai M., Wang Y., Maldonado M., Cho T., Boubaker J., Swing D. A., Tessarollo L., Evans S. M., Fuchs E. & Cleveland D. W. (2015),
Proceedings of the National Academy of Sciences of the United States of America. 112, 46, p. E6321-E6330
-
A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study
Authors:
Assi N., Fages A., Vineis P., Chadeau-Hyam M., Stepien M., Duarte-Salles T., Byrnes G., Boumaza H., Knueppel S., Kuehn T., Palli D., Bamia C., Boshuizen H., Bonet C., Overvad K., Johansson M., Travis R., Gunter M. J., Lund E., Dossus L., Elena-Herrmann B., Riboli E., Jenab M., Viallon V. & Ferrari P. (2015),
Mutagenesis. 30, 6, p. 743-753
-
Examination of HER3 targeting in cancer using monoclonal antibodies
Authors:
Gaborit N., Abdul-Hai A., Mancini M., Lindzen M., Lavi S., Leitner O., Mounier L., Chentouf M., Dunoyer S., Ghosh M., Larbouret C., Chardes T., Bazin H., Pelegrine A., Sela M. & Yarden Y. (2015),
Proceedings of the National Academy of Sciences of the United States of America. 112, 3, p. 839-844
-
Preleukemia: The normal side of cancer
-
AML evolution from preleukemia to leukemia and relapse
-
The Lys-Specific Molecular Tweezer, CLR01, Modulates Aggregation of the Mutant p53 DNA Binding Domain and Inhibits Its Toxicity
Authors:
Herzog G., Shmueli M. D., Levy L., Engel L., Gazit E., Klärner F. G., Schrader T., Bitan G. & Segal D. (2015),
Biochemistry. 54, 24, p. 3729-3738
-
Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth
Authors:
Harel S., Ben-Moshe N., Aylon Y., Bublik D., Moskovits N., Toperoff G., Azaiza D., Biagoni F., Fuchs G., Wilder S., Hellman A., Blandino G., Domany E. & Oren M. (2015),
Cell Death and Differentiation. 22, p. 1328-1340
-
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
-
A principle of organization which facilitates broad Lamarckian-like adaptations by improvisation
-
In the hunt for therapeutic targets: Mimicking the growth, metastasis, and stromal associations of early-stage lung cancer using a novel orthotopic animal model
Authors:
Weiss I. D., Ella E., Dominsky O., Smith Y., Abraham M., Wald H., Shlomai Z., Zamir G., Feigelson S. W., Shezen E., Bar-Shai A., Alon R., Izhar U., Peled A., Shapira O. M. & Wald O. (2015),
Journal of Thoracic Oncology. 10, 1, p. 46-58
-
An interactive tool for animating biology, and its use in spatial and temporal modeling of a cancerous tumor and its microenvironment
-
Erratum: A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism (vol 24, pg 242, 2013)
Authors:
Pribluda A., Elyada E., Wiener Z., Hamza H., Goldstein R. E., Biton M., Burstain I., Morgenstern Y., Brachya G., Billauer H., Biton S., Snir-Alkalay I., Vucic D., Schlereth K., Mernberger M., Stiewe T., Oren M., Alitalo K., Pikarsky E. & Ben-Neriah Y. (2015),
-
Development of APE1 enzymatic DNA repair assays: Low APE1 activity is associated with increase lung cancer risk
Authors:
Sevilya Z., Leitner Dagan Y., Pinchev M., Kremer R., Elinger D., Lejbkowicz F., Rennert H. S., Freedman L. S., Rennert G., Paz-Elizur T. & Livneh Z. (2015),
Carcinogenesis. 36, 9, p. 982-991
-
Quantitative computerized western blotting in detail
-
LPS-mediated septic shock is augmented in ceramide synthase 2 null mice due to elevated activity of TNFα-converting enzyme
-
Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells
-
The functional relevance of somatic synonymous mutations in melanoma and other cancers
-
Next generation HLA-haploidentical HSCT
-
Endothelial thermotolerance impairs nanoparticle transport in tumors
Authors:
Bagley A. F., Scherz-Shouval R., Galie P. A., Zhang A. Q., Wyckoff J., Whitesell L., Chen C. S., Lindquist S. & Bhatia S. N. (2015),
Cancer Research. 75, 16, p. 3522-3567
-
Hyperpolarized NMR of plant and cancer cell extracts at natural abundance
Authors:
Dumez J. D., Milani J., Vuichoud B., Bornet A., Lalande-Martin J., Tea I., Yon M., Maucourt M., Deborde C., Moing A., Frydman L., Bodenhausen G., Jannin S. & Giraudeau P. (2015),
Analyst. 140, 17, p. 5860-5863
-
Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation
Authors:
Kim H., Frederick D., Levesque M., Cooper Z., Feng Y., Krepler C., Brill L., Samuels Y., Hayward N., Perlina A., Piris A., Zhang T., Halaban R., Herlyn M., Brown K., Wargo J., Dummer R., Flaherty K. & Ronai Z. (2015),
Cell Reports. 11, 9, p. 1458-1473
-
Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer
Authors:
Mancini M., Gaborit N., Lindzen M., Salame T. M., Dall'Ora M., Sevilla-Sharon M., Abdul-Hai A., Downward J. & Yarden Y. (2015),
Science Signaling. 8, 379, ra53
-
Genomic Classification of Cutaneous Melanoma
-
Clonal evolution models of tumor heterogeneity
-
Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis
-
Size controlled protein nanoemulsions for active targeting of folate receptor positive cells
Authors:
Loureiro A., Nogueira E., Azoia N. G., Sarria M. P., Abreu A. S., Shimanovich U., Rollett A., Harmark J., Hebert H., Guebitz G., Bernardes G. J. L., Preto A., Gomes A. C. & Cavaco-Paulo A. (2015),
Colloids And Surfaces B-Biointerfaces. 135, p. 90-98
-
Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy
-
Peptide Anchor for Folate-Targeted Liposomal Delivery
Authors:
Nogueira E., Mangialavori I. C., Loureiro A., Azoia N. G., Sarria M. P., Nogueira P., Freitas J., Harmark J., Shimanovich U., Rollett A., Lacroix G., Bernardes G. J. L., Guebitz G., Hebert H., Moreira A., Carmo A. M., Rossi J. P. F. C., Gomes A. C., Preto A. & Cavaco-Paulo A. (2015),
Biomacromolecules. 16, 9, p. 2904-2910
-
Messenger RNA encoding constitutively active toll-like receptor 4 enhances effector functions of human T cells.
Authors:
Pato A., Eisenberg G., Machlenkin A., Margalit A., Cafri G., Frankenburg S., Merims S., Peretz T., Lotem M. & Gross G. (2015),
Clinical and Experimental Immunology. 182, 2, p. 220-229
-
PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition
-
Label-free in vivo molecular imaging of underglycosylated mucin-1 expression in tumour cells
Authors:
Song X., Airan R. D., Arifin D. R., Bar-Shir A., Kadayakkara D. K., Liu G., Gilad A. A., van Zijl Z. P. C. M., McMahon M. T. & Bulte J. W. M. (2015),
Nature Communications. 6, 6719
-
Mechanical interplay between invadopodia and the nucleus in cultured cancer cells
-
Target discovery for T cell therapy: Next steps to advance Immunotherapies
Authors:
Bot A., Brewer J. E., Eshhar Z., Frankel S. R., Hickman E., Jungbluth A. A., Morgan R., Peretz Y., Radvanyi L., Ramos C. A., Robbins P. F. & Wucherpfennig K. W. (2015),
Journal for ImmunoTherapy of Cancer. 3, 1, 31
-
Chemical cross-linking and native mass spectrometry: A fruitful combination for structural biology
-
TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer
Authors:
Azzouzi A., Barret E., Bennet J., Moore C., Taneja S., Muir G., Villers A., Coleman J., Allen C., Scherz A. & Emberton M. (2015),
World Journal of Urology. 33, 7, p. 945-953
-
Electron spin resonance microscopic imaging of oxygen concentration in cancer spheroids
-
Aging, clonal hematopoiesis and preleukemia: not just bad luck?
-
Development of pheochromocytoma in ceramide synthase 2 null mice
-
Runx3 at the interface of immunity, inflammation and cancer
-
P53-dependent non-coding RNA networks in chronic lymphocytic leukemia
Authors:
Blume C. J., Hotz-Wagenblatt A., Hüllein J., Sellner L., Jethwa A., Stolz T., Slabicki M., Lee K., Sharathchandra A., Benner A., Dietrich S., Oakes C. C., Dreger P., Te Raa D., Kater A. P., Jauch A., Merkel O., Oren M., Hielscher T. & Zenz T. (2015),
Leukemia. 29, 10, p. 2015-2023
-
Regulation and function of Myb-binding protein 1A (MYBBP1A) in cellular senescence and pathogenesis of head and neck cancer
Authors:
George B., Horn D., Bayo P., Zaoui K., Flechtenmacher C., Grabe N., Plinkert P., Krizhanovsky V. & Hess J. (2015),
Cancer Letters. 358, 2, p. 191-199
-
Dispersal of an ancient retroposon in the TP53 promoter of Bovidae: Phylogeny, novel mechanisms, and potential implications for cow milk persistency
Authors:
Dekel Y., Machluf Y., Ben-Dor S., Yifa O., Stoler A., Ben-Shlomo I. & Bercovich D. (2015),
BMC Genomics. 16, 1, 53
-
c-Abl forces YAP to switch sides.
-
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
Authors:
Ramishetti S., Kedmi R., Goldsmith M., Leonard F., Sprague A. G., Godin B., Gozin M., Cullis P. R., Dykxhoorn D. M. & Peer D. (2015),
ACS Nano. 9, 7, p. 6706-6716
-
From mass cytometry to cancer prognosis
Authors:
Winter D. R., Ledergor G. & Amit I. (2015),
-
Down-regulation of LATS kinases alters p53 to promote cell migration
-
Historic recollections: From polymers and proteins to autoimmunity and cancer.
-
Tumor-derived osteopontin reprograms normal mammary fibroblasts to promote inflammation and tumor growth in breast cancer
-
PAR1 signaling regulates the retention and recruitment of EPCR-expressing bone marrow hematopoietic stem cells
Authors:
Cohen S. G., Itkin T., Chakrabarty S., Graf C., Kollet O., Ludin A., Golan K., Kalinkovich A., Ledergor G., Wong E., Niemeyer E., Porat Z., Erez A., Sagi I., Esmon C. T., Ruf W. & Lapidot T. (2015),
Nature Medicine. 21, 11, p. 1307-1317
-
Folic acid-tagged protein nanoemulsions loaded with CORM-2 enhance the survival of mice bearing subcutaneous A20 lymphoma tumors
Authors:
Loureiro A., Bernardes G. J. L., Shimanovich U., Sarria M. P., Nogueira E., Preto A., Gomes A. C. & Cavaco-Paulo A. (2015),
Nanomedicine: Nanotechnology, Biology, and Medicine. 11, 5, p. 1077-1083
-
Methyl-CpG Binding Protein 2 Regulates Microglia and Macrophage Gene Expression in Response to Inflammatory Stimuli
Authors:
Cronk J. C., Derecki N. C., Ji E., Xu Y., Lampano A. E., Smirnov I., Baker W., Norris G. T., Marin I., Coddington N., Wolf Y., Turner S. D., Aderem A., Klibanov A. L., Harris T. H., Jung S., Litvak V. & Kipnis J. (2015),
Immunity. 42, 4, p. 679-691
-
Metabolic dysregulation in monogenic disorders and cancer-finding method in madness
-
C-Abl antagonizes the YAP oncogenic function
-
Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression
-
Overshoot during phenotypic switching of cancer cell populations
Authors:
Sellerio A., Ciusani E., Ben-Moshe N. B., Coco S., Piccinini A., Myers C., Sethna J., Giampietro C., Zapperi S. & La Porta P. C. (2015),
Scientific Reports. 5, 15464
-
PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop
-
Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy
-
The nuclear translocation of ERK1/2 as an anticancer target
Authors:
Plotnikov A., Flores K., Maik-Rachline G., Zehorai E., Kapri-Pardes E., Berti D. A., Hanoch T., Besser M. J. & Seger R. (2015),
Nature Communications. 6, 6685
-
Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy
Authors:
Moore C. M., Azzouzi A., Barret E., Villers A., Muir G. H., Barber N. J., Bott S., Trachtenberg J., Arumainayagam N., Gaillac B., Allen C., Schertz A. & Emberton M. (2015),
BJU International. 116, 6, p. 888-896
-
Photodynamic Quenched Cathepsin Activity Based Probes for Cancer Detection and Macrophage Targeted Therapy
-
Cancer immunotherapy: More is (much) better
-
Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors
Authors:
Cooper I., Last D., Guez D., Sharabi S., Goldman S. E., Lubitz I., Daniels D., Salomon S., Tamar G., Tamir T., Mardor R., Fridkin M., Shechter Y. & Mardor Y. (2015),
Journal of Cerebral Blood Flow and Metabolism. 35, 6, p. 967-976
-
Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase
-
Erratum to FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis [Cancer Cell 28, 285-295; September 14, 2015]
Authors:
Dahan R., Sega E., Engelhardt J., Selby M., Korman A. J. & Ravetch J. V. (2015),
-
The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner
-
Exercising 'veto' power to make haploidentical hematopoietic stem cell transplantation a safe modality for induction of immune tolerance
-
MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression.
-
Laparoscopic versus open liver resection for metastatic colorectal cancer
Authors:
Nachmany I., Pencovich N., Zohar N., Ben-Yehuda A., Binyamin C., Goykhman Y., Lubezky N., Nakache R. & Klausner J. M. (2015),
EJSO. 41, 12, p. 1615-1620
-
mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity
Authors:
Cafri G., Sharbi Yunger Y. A., Tzehoval E., Alteber Z., Gross T., Vadai E., Margalit A., Gross G. & Eisenbach L. (2015),
Molecular Therapy. 23, 8, p. 1391-1400
-
Haploidentical hematopoietic stem cell transplantation: State of art
-
Sonicated Protein Fractions of Mycoplasma hyopneumoniae Induce Inflammatory Responses and Differential Gene Expression in a Murine Alveolar Macrophage Cell Line
-
Tumor Suppressor Activity of Klotho in Breast Cancer is Revealed by Structure-function Analysis.
-
Tumor-specific expression and detection of a CEST reporter gene
-
EGF induces microRNAs that target suppressors of cell migration: MiR-15b targets MTSS1 in breast cancer
Authors:
Kedmi M., Ben Chetrit C. N., Koerner C., Mancini M., Ben-Moshe N. B., Lauriola M., Lavi S., Biagioni F., Carvalho S., Cohen-Dvashi H., Schmitt F., Wiemann S., Blandino G. & Yarden Y. (2015),
Science Signaling. 8, 368, p. ra29
-
Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant
-
Receptor tyrosine kinases: Structure, functions and role in human disease
Authors:
Wheeler D. L. & Yarden Y. (2015),
-
Modeling and Predicting Optimal Treatment Scheduling Between the Antiangiogenic Drug Sunitinib and Irinotecan in Preclinical Settings
Authors:
Wilson S., Tod M., Ouerdani A., Emde A., Yarden Y., Berkane A. A., Kassour S., Wei M. X., Freyer G., You B., Grenier E. & Ribba B. (2015),
CPT: Pharmacometrics and Systems Pharmacology. 4, 12, p. 720-727
-
Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma
Authors:
Kurscheid S., Bady P., Sciuscio D., Samarzija I., Shay T., Vassallo I., Criekinge W. V., Daniel R. T., van den Bent d. B. M. J., Marosi C., Weller M., Mason W. P., Domany E., Stupp R., Delorenzi M. & Hegi M. E. (2015),
Genome Biology. 16, 1, 16
-
Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera
-
Recurrent inactivating RASA2 mutations in melanoma
Authors:
Arafeh R., Qutob N., Emmanuel R., Keren-Paz A., Madore J., Elkahloun A., Wilmott J. S., Gartner J. J., Di Pizio A., Winograd-Katz S., Sindiri S., Rotkopf R., Dutton-Regester K., Johansson P., Pritchard A. L., Waddell N., Hill V. K., Lin J. C., Hevroni Y., Rosenberg S. A., Khan J., Ben-Dor S., Niv M. Y., Ulitsky I., Mann G. J., Scolyer R. A., Hayward N. K. & Samuels Y. (2015),
Nature Genetics. 47, 12, p. 1408-1410
-
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer
Authors:
Ben Chetrit C. N., Chetrit D., Russell R., Koerner C., Mancini M., Abdul-Hai A., Itkin T., Carvalho S., Cohen-Dvashi H., Koestler W. J., Shukla K., Lindzen M., Kedmi M., Lauriola M., Shulman Z., Barr H., Seger D., Ferraro D. A., Pareja F., Gil-Henn H., Lapidot T., Alon R., Milanezi F., Symons M., Ben Hamo H. R., Efroni S., Schmitt F., Wiemann S., Caldas C., Ehrlich M. & Yarden Y. (2015),
Science Signaling. 8, 360, ra7
-
The cancer genome
Authors:
Samuels Y., Bardelli A., Gartner J. J. & López-Otin C. (2015), DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology: Tenth Edition.
-
The BH3-only protein BID impairs the p38-mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in mice
Authors:
Orlik J., Schüngel S., Buitrago-Molina L. E., Marhenke S., Geffers R., Endig J., Lobschat K., Rössler S., Goeppert B., Manns M. P., Gross A. & Vogel A. (2015),
Hepatology. 62, 3, p. 816-828
-
Hepatitis B virus induces RNR-R2 expression via DNA damage response activation
-
Extracellular matrix regulation of ErbB3 in a subset of wild-type BRAF/NRAS melanoma
Authors:
Rosenbaum S., Capparelli C., Berman-Booty L., Gaborit N., Zhan T., Davies M., Setiady Y., Yarden Y. & Aplin A. (2015),
-
Pathway-based personalized analysis of breast cancer expression data
-
Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression
Authors:
Cohen-Dvashi H., Ben Chetrit C. N., Russell R., Carvalho S., Lauriola M., Nisani S., Mancini M., Nataraj N., Kedmi M., Roth L., Koestler W., Zeisel A., Yitzhaky A., Zylberg J., Tarcic G., Eilam R., Wigelman Y., Will R., Lavi S., Porat Z., Wiemann S., Ricardo S., Schmitt F., Caldas C. & Yarden Y. (2015),
EMBO Molecular Medicine. 7, 3, p. 299-314
-
P53 orchestrates between normal differentiation and cancer
-
ErbB3-ErbB2 complexes as a therapeutic target in a subset of wild-type BRAF/NRAS cutaneous melanomas
Authors:
Capparelli C., Rosenbaum S., Berman-Booty L. D., Salhi A., Gaborit N., Zhan T., Chervoneva I., Roszik J., Woodman S. E., Davies M. A., Setiady Y. Y., Osman I., Yarden Y. & Aplin A. E. (2015),
Cancer Research. 75, 17, p. 3554-3567